Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,rRNA binding (GO:0019843),0.7932657768922929,2.09106725837123,0.0,0.0,0.0,17/42,7.76%,RPL23;RPS3;RPS9;RPL11;RPS14;RPS5;RPL5;RPS13;RPLP0;RPL12;CAVIN1;ANG;DDX28;EMG1;SBDS;MRPS11;MRPL11
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.763868630745594,2.0571700589658404,0.0,0.0,0.0,39/57,15.41%,COX4I1;UQCR11;UQCR10;NDUFA2;COX6B1;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA4L2;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;UQCRC1;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A
prerank,MHC protein binding (GO:0042287),0.8556790671333222,2.011328157854845,0.0,0.0,0.0,8/20,6.05%,CD74;TUBB;CD81;ATP5F1B;TUBB4B;ATP5F1A;TAPBP;TAP2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.524708013312459,-1.9841793432935724,0.0,0.17521617380065854,0.093,21/44,15.66%,NSD1;KMT2C;SETD5;ASH1L;SETD2;SMYD3;EHMT1;KMT2A;KMT5C;KMT5B;ASH2L;NSD3;SETDB1;KMT2D;WDR82;SETD7;EHMT2;EZH2;SETD4;PRDM9;SETD1B
prerank,nucleotidyltransferase activity (GO:0016779),-0.6479456405289492,-1.973678863055979,0.0,0.10698295227251747,0.112,13/19,20.66%,REV1;NUDT5;TENT4B;CRPPA;TUT7;PAPSS2;TERT;PAPSS1;TUT1;CGAS;TUT4;TENT2;YRDC
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.7729011242173739,1.9540007475572385,0.0,0.0003365346908800525,0.002,28/34,18.07%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFV1;NDUFB2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.7729011242173739,1.9540007475572385,0.0,0.0003365346908800525,0.002,28/34,18.07%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFV1;NDUFB2
prerank,amyloid-beta binding (GO:0001540),0.6730089261719497,1.9147865034381437,0.0,0.0014022278786668854,0.01,40/79,18.27%,APOE;CST3;CD74;CLU;PFDN5;ITM2A;C1QA;ITM2C;ITM2B;PGRMC1;NLGN1;PRNP;ITGB2;TREM2;CRYAB;GRIA2;PFDN6;SORL1;GRIN1;CACNA1A;LRPAP1;ATP1A3;GSAP;GRIA4;GRIN2A;APBB1;RAMP3;GRIA1;MSR1;LILRB3;LILRB1;VBP1;TLR6;PFDN1;MAPK8IP2;ACHE;BACE1;CLSTN1;APBA2;GRIN2B
prerank,proton transmembrane transporter activity (GO:0015078),0.7384267867856831,1.9116720287342017,0.0,0.001322100571314492,0.011,16/39,10.32%,COX4I1;UQCR11;UQCR10;COX6B1;COX5B;COX8A;NDUFA4;ATP6V1F;COX6A1;COX7A2L;UQCRH;UQCRQ;NDUFA4L2;UQCRC1;SLC33A1;MFSD3
prerank,histone demethylase activity (GO:0032452),-0.5771235959566318,-1.910252390008082,0.0,0.14489029756592917,0.21,12/27,14.05%,KDM3B;KDM2A;KDM7A;JMJD1C;KDM5B;JARID2;KDM3A;FBXL19;KDM5C;KDM4C;PHF8;KDM4D
prerank,I-SMAD binding (GO:0070411),-0.7198626735510629,-1.9021171748544783,0.0,0.11667038495861157,0.223,11/13,13.79%,SMAD3;SMAD6;AXIN1;SMAD9;TGFBR1;SMURF1;SMAD1;SMAD7;SMAD4;TGFB1I1;SMAD2
prerank,tau-protein kinase activity (GO:0050321),-0.6054223293136674,-1.893490247843137,0.0,0.10277102501769395,0.241,9/20,14.72%,ROCK2;ROCK1;SIK3;MARK1;DYRK1A;MARK3;GSK3B;MARK2;TAOK1
prerank,cytochrome-c oxidase activity (GO:0004129),0.8512828807399034,1.886017153208442,0.0,0.002313675999800361,0.021,8/15,4.90%,COX4I1;COX6B1;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L;NDUFA4L2
prerank,mRNA 5'-UTR binding (GO:0048027),0.7869471902209044,1.8790187851659987,0.0,0.0027109738987559783,0.028,6/24,0.56%,RPL41;RPL26;RPS14;RPS7;RPL5;RPS13
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.7412623535121696,-1.8624533922504374,0.0034129692832764505,0.12130350493891745,0.325,7/10,18.12%,NSD1;SETD5;ASH1L;SETD2;NSD3;PRDM9;SETD3
prerank,MHC class I protein binding (GO:0042288),0.8555448314252625,1.858362960027167,0.0,0.004206683636000656,0.041,6/13,6.05%,TUBB;ATP5F1B;TUBB4B;ATP5F1A;TAPBP;TAP2
prerank,MHC class II protein complex binding (GO:0023026),0.8931393605878181,1.8483548615228065,0.0,0.004742079735128012,0.05,7/11,5.43%,HSPA8;CD74;CD81;HSP90AA1;HSP90AB1;PKM;YWHAE
prerank,R-SMAD binding (GO:0070412),-0.6257765766916472,-1.8347155809090696,0.003952569169960474,0.13815121395821153,0.411,8/18,13.79%,LDLRAD4;SMAD3;SMAD6;SMURF1;PMEPA1;DROSHA;SMAD4;SMAD2
prerank,ligand-gated channel activity (GO:0022834),0.7242475076466967,1.827994995944403,0.0,0.007782364726601213,0.093,19/29,22.37%,GABRB1;GRIA2;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;CNGA3;GRIA4;GRIN2A;GRID1;GRIA1;CHRNA4;CNGB1;GRIN2B;ANXA6;GRIA3;GRIK1;CHRNA3
prerank,ligand-gated ion channel activity (GO:0015276),0.7211006295193849,1.8243042415617376,0.0,0.00828393085243206,0.104,19/30,22.37%,GABRB1;GRIA2;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;CNGA3;GRIA4;GRIN2A;GRID1;GRIA1;CHRNA4;CNGB1;GRIN2B;ANXA6;GRIA3;GRIK1;CHRNA3
prerank,glutamate receptor activity (GO:0008066),0.7749631382852055,1.8177949009349805,0.0,0.008773940155087083,0.117,11/19,11.81%,GRM5;GRIA2;GRID2;GRIK5;GRIK2;GRM8;GRM7;GRIA4;GRID1;GRM1;GRIA1
prerank,active ion transmembrane transporter activity (GO:0022853),0.7051750135846957,1.8146434970769778,0.0011574074074074073,0.008581634617441339,0.123,15/37,9.48%,COX4I1;UQCR11;UQCR10;COX6B1;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L;SLCO1C1;UQCRH;UQCRQ;NDUFA4L2;UQCRC1;SLCO4C1
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.5057461324240778,-1.7949622468546067,0.0,0.17395259562421148,0.527,11/38,11.62%,SORBS1;GAB2;LRRK2;FRS2;IRS1;AXIN1;DLG5;SPAG9;MMS19;NCK1;SAV1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.7112306650385483,-1.7876427187567858,0.003257328990228013,0.16454595808843894,0.547,5/10,13.98%,SETD5;ASH1L;EHMT1;SETDB1;EHMT2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.7582990140624186,1.7827474566975352,0.0012738853503184713,0.015459562362302412,0.224,10/22,11.32%,APOE;CLU;SNX17;HSP90B1;AP2M1;SYT1;LRPAP1;CLTC;APBB1;DNAJA1
prerank,lipoprotein particle receptor binding (GO:0070325),0.729018490288925,1.7822768658124,0.0,0.014649157132425815,0.224,10/27,11.32%,APOE;CLU;SNX17;HSP90B1;AP2M1;SYT1;LRPAP1;CLTC;APBB1;DNAJA1
prerank,acetylation-dependent protein binding (GO:0140033),-0.5681741668329678,-1.7451184902752388,0.005025125628140704,0.1965055515614029,0.678,12/20,20.19%,MLLT3;BRD4;BAZ2A;ATAD2B;KMT2A;PSME4;TRIM24;BRD7;PHIP;CARM1;DPF2;TAF1
prerank,lysine-acetylated histone binding (GO:0070577),-0.5681741668329678,-1.7451184902752388,0.005025125628140704,0.1965055515614029,0.678,12/20,20.19%,MLLT3;BRD4;BAZ2A;ATAD2B;KMT2A;PSME4;TRIM24;BRD7;PHIP;CARM1;DPF2;TAF1
prerank,SUMO transferase activity (GO:0019789),-0.6152308657443926,-1.7332013298517064,0.012552301255230125,0.19908376157799182,0.712,7/16,9.56%,RANBP2;NSMCE2;HDAC4;PIAS1;PIAS2;TOPORS;CBX4
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.35485961250024334,-1.733014142534612,0.0,0.18415841935705307,0.713,65/232,14.77%,RNF220;PDZRN3;HECTD1;RNF216;UBR4;RNF152;NSMCE2;SMURF2;TRIP12;KCMF1;WWP1;RNF38;RNF19A;UBR5;COP1;PIAS1;CBLB;PIAS2;PRKN;BIRC2;TRAF3IP2;PELI2;SH3RF1;SH3RF3;ARIH2;RNF144A;UBR3;UBR1;SMURF1;RNF24;RNF135;BIRC3;ARIH1;TRIM5;HUWE1;RNF8;UFL1;UHRF2;UBR2;RNF41;NEURL2;ZNRF1;SH3RF2;NFX1;TOPORS;RNF138;CBX4;TRIM24;RC3H2;ASB2;ITCH;RNF217;RNF115;UBE3C;PPIL2;RNF43;RNF14;HECW2;SIAH3;UBE3B;TRIM41;DTX1;WWP2;TRIM7;RNF185
prerank,cell adhesion mediator activity (GO:0098631),0.7142296805639978,1.7238233470307842,0.0024875621890547263,0.039028675956228304,0.53,13/24,15.44%,BSG;DSCAM;CNTN4;SIRPA;LRRC4C;BCAM;ESAM;ROBO4;EMB;NINJ1;JAM3;IGSF9;DSCAML1
prerank,translation elongation factor activity (GO:0003746),0.795328980517616,1.7220259933876227,0.005442176870748299,0.03821439976703754,0.545,6/14,5.39%,EEF1A1;EEF2;EEF1B2;EIF5A;EIF5AL1;EEF1A2
prerank,poly(U) RNA binding (GO:0008266),-0.5708231763895857,-1.7125430572281561,0.014423076923076924,0.19856228487025177,0.764,14/20,26.78%,RBMS3;RBMS1;ATXN1;DAZAP1;PATL1;PABPC4;PABPC4L;RBMS2;FMR1;KHDRBS1;DIS3L2;HNRNPH1;PABPC5;PABPC1L
prerank,tau protein binding (GO:0048156),0.6509827954630323,1.7058441183319555,0.0011273957158962795,0.04833479497764753,0.636,9/40,4.81%,APOE;ACTB;CLU;HSP90AA1;HSP90AB1;LGMN;S100B;MAP1A;PIN1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.479252296591818,-1.6911083233332982,0.0,0.21733544634889376,0.808,11/38,10.18%,PARD3;ZFYVE1;PLA2G4A;PLEKHA4;SNX12;SESTD1;DENND1A;ATG2B;HIP1;ATG2A;KIF16B
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6485087167255719,-1.6904442728925368,0.015384615384615385,0.2045943664030526,0.81,7/12,14.05%,KDM3B;KDM7A;JMJD1C;KDM3A;KDM4C;PHF8;KDM4D
prerank,ubiquitin protein ligase activity (GO:0061630),-0.3413468611995559,-1.670741935605088,0.0,0.22090319649415602,0.855,62/228,14.77%,RNF220;PDZRN3;HECTD1;RNF216;UBR4;RNF152;SMURF2;TRIP12;KCMF1;WWP1;RNF38;RNF19A;UBR5;COP1;CBLB;PRKN;BIRC2;TRAF3IP2;PELI2;SH3RF1;SH3RF3;UBE4B;ARIH2;RNF144A;UBR3;UBR1;SMURF1;RNF24;RNF135;BIRC3;ARIH1;TRIM5;HUWE1;RNF8;UHRF2;UBR2;RNF41;NEURL2;ZNRF1;SH3RF2;NFX1;TOPORS;RNF138;TRIM24;RC3H2;ASB2;ITCH;RNF217;RNF115;UBE3C;PPIL2;RNF43;RNF14;HECW2;SIAH3;UBE3B;TRIM41;DTX1;WWP2;TRIM7;UBOX5;RNF185
prerank,microtubule minus-end binding (GO:0051011),-0.6061911823538205,-1.6707279761045035,0.016,0.20863079668892515,0.855,8/13,19.05%,MACF1;CEP290;CAMSAP1;NUMA1;TUBGCP6;HAUS7;TUBGCP5;CAMSAP2
prerank,lipoprotein particle binding (GO:0071813),0.709196578879378,1.6693126958731528,0.0050062578222778474,0.08124908965532696,0.836,8/20,12.32%,PLTP;TREM2;SORL1;HSPD1;MAPT;LPL;STAB1;MSR1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7236805102063497,1.6595639507343696,0.004037685060565276,0.08998478723190494,0.875,11/17,21.96%,GRIA2;GRIK5;GRIK2;GRIN1;GRIN3A;GRIA4;GRIN2A;GRIA1;GRIN2B;GRIA3;GRIK1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.48521176806793653,-1.6526291821962171,0.006802721088435374,0.22691203884407146,0.888,14/32,20.11%,FTO;KDM2A;TET2;KDM7A;TET3;TMLHE;P4HTM;KDM4C;PHF8;EGLN1;ALKBH3;EGLN3;PHYHD1;ALKBH4
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5112318026460523,-1.6420597922610627,0.01092896174863388,0.2329195771917408,0.903,11/25,10.18%,GAB2;FCHSD2;ZFYVE1;MAPKAP1;PLEKHA4;ADAP2;PLEKHA2;SESTD1;HIP1;DAPP1;KIF16B
prerank,transmitter-gated ion channel activity (GO:0022824),0.6642930646133008,1.6416153551909212,0.0035842293906810036,0.11094670841730425,0.932,12/29,11.99%,GABRB1;GRIA2;GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRIA4;GRID1;GLRA2;GABRA3;GABRB3
prerank,endopeptidase inhibitor activity (GO:0004866),0.5873774225474978,1.6378144154120473,0.002105263157894737,0.1114420606570507,0.935,21/82,13.02%,CST3;GAPDH;TIMP2;SERPINH1;A2M;SPOCK2;PRNP;SERPINF1;SERPINE2;UBE2Z;PCSK1N;AGT;SPOCK1;CSTB;SPOCK3;TIMP1;SERPING1;ITIH3;TIMP3;SERPINA9;BST2
prerank,ubiquitin protein ligase binding (GO:0031625),0.5441809789078667,1.615657689480776,0.0,0.14504645176930261,0.978,62/254,11.69%,RPL23;RPS27A;ACTG1;RPL11;HSPA8;RPL5;CLU;TUBB;UBC;GABARAP;UBB;TUBA1B;ATP6V0C;ELOB;HSP90AA1;HSP90AB1;CALR;LAPTM5;CKB;UBXN1;HSPA5;TPI1;SLC25A5;MAP1LC3B;TMBIM6;PRDX6;PINK1;MAP1LC3A;TXNIP;CCT2;GABARAPL2;CHEK2;PSMD1;AUP1;RTN4;HSPA1B;GABARAPL1;UCHL1;PRR5L;YWHAE;VCP;RPA2;BAG5;BAG1;UBA52;ARRDC1;ISG15;TRIM28;SCAMP3;HSPD1;SYT11;PRKAR1A;RBX1;NDUFS2;NEDD8;UQCRC1;JUN;MC1R;APBB1;SUMO2;DNAJA1;WFS1
prerank,retinoid X receptor binding (GO:0046965),-0.6368599184819764,-1.6124781986870855,0.019157088122605363,0.2677983462209699,0.95,6/11,20.70%,NSD1;NRIP1;RARG;PPARG;TACC1;NCOA6
prerank,retinoic acid receptor binding (GO:0042974),-0.5659953838975676,-1.6097121584488705,0.005,0.26037368484363593,0.952,6/17,9.60%,NSD1;NRIP1;RARG;CNOT1;ASXL1;PPARG
prerank,disordered domain specific binding (GO:0097718),0.6770708205336105,1.601437372620895,0.009937888198757764,0.16558153973396428,0.99,8/23,8.29%,CALM1;GAPDH;HSP90AA1;HSP90AB1;FKBP8;CALM3;FN1;CLTC
prerank,GTPase activator activity (GO:0005096),-0.30813766085365113,-1.6009367432290948,0.0,0.264216027967799,0.959,89/313,13.71%,ARHGAP29;AKAP13;RANBP3L;ARHGAP28;DOCK5;SIPA1L1;ARHGAP20;PLCE1;ARHGAP10;RAPGEF4;DOCK11;ASAP3;ALDH1A1;SBF2;DENND4A;ARHGEF11;ASAP1;ARHGAP17;LRRK2;ARHGAP42;DENND4C;FARP1;ARFGEF1;RANBP2;RAPGEF2;DENND2A;SGSM2;IQSEC2;NRP1;MON1A;ITSN1;USP6NL;TBC1D12;ERRFI1;RALGAPB;SMAP1;ARHGEF18;ARHGEF10L;FGD4;FNIP1;ANKRD27;EIF2B3;DENND5A;ASAP2;STARD13;SIPA1L3;TBC1D2B;RAPGEF6;RABGAP1;DENND1A;ARHGAP32;ARFGEF2;RAPGEF1;RIC8B;TBC1D9B;BCR;VAV2;RAPGEF5;TBC1D4;GAPVD1;ARHGEF6;SYDE2;ALS2;ARHGAP31;CCZ1;DNMBP;DENND1B;TBC1D8B;TBCK;OPHN1;RAPGEF3;DENND5B;DOCK1;MYO9B;SIPA1;ARHGAP18;RIC1;DENND3;SMAP2;RALGAPA1;ARHGEF2;STXBP5;ARHGEF17;DENND2C;WNT11;RGS16;EIF2B2;RAB3GAP2;RAP1GDS1
prerank,retinoic acid binding (GO:0001972),-0.6189197810336671,-1.6007808941309654,0.04912280701754386,0.2534878219527956,0.959,1/12,3.24%,NR2F2
prerank,thyroid hormone receptor binding (GO:0046966),-0.4820444269430547,-1.6005555133321483,0.012422360248447204,0.24361787241899252,0.959,12/28,22.22%,NSD1;MED13;TRIP12;JMJD1C;THRAP3;NCOR1;BRD8;TACC1;TAF7;MED1;NCOA6;NCOA3
prerank,mannose binding (GO:0005537),0.7567278127943868,1.5966471869357646,0.01544943820224719,0.16783109676666322,0.991,6/12,13.96%,MBL2;LMAN2;LMAN1;CLEC6A;CLN5;CLEC4D
prerank,ribosome binding (GO:0043022),0.6027830488784535,1.5895957511700873,0.0056433408577878106,0.17577928050431313,0.994,13/46,12.71%,RPSA;EEF2;RACK1;SEC61B;SHFL;TMEM147;EIF3C;SBDS;NOMO1;TMCO1;NAA10;SEC61A1;NCLN
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.5357235902920271,1.5886965842145409,0.0,0.17163269234882675,0.994,64/269,11.69%,RPL23;RPS27A;ACTG1;RPL11;HSPA8;RPL5;CLU;TUBB;UBC;GABARAP;UBB;TUBA1B;ATP6V0C;ELOB;HSP90AA1;HSP90AB1;CALR;LAPTM5;CKB;UBXN1;HSPA5;TPI1;SLC25A5;MAP1LC3B;TMBIM6;PTPRN;PRDX6;PINK1;MAP1LC3A;TXNIP;CCT2;GABARAPL2;CHEK2;PSMD1;AUP1;RTN4;HSPA1B;GABARAPL1;UCHL1;PRR5L;YWHAE;VCP;RPA2;BAG5;BAG1;UBA52;ARRDC1;ISG15;TRIM28;SCAMP3;HSPD1;SYT11;PRKAR1A;RBX1;NDUFS2;NEDD8;UQCRC1;JUN;MC1R;APBB1;SUMO2;SUMO3;DNAJA1;WFS1
prerank,poly-purine tract binding (GO:0070717),-0.47558114458295414,-1.5817793299679386,0.016666666666666666,0.26632340026653345,0.97,11/27,15.12%,RBMS3;RBMS1;RBPMS;ATXN1;DDX1;DAZAP1;PATL1;ZC3H14;PABPC4;PABPC4L;RBMS2
prerank,RNA binding (GO:0003723),0.5191319862190353,1.5813933727638372,0.0,0.18052281709957482,0.996,300/1321,14.53%,TMSB4X;RPL41;TPT1;FAU;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPL11;HSPA8;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;PPIA;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;CMSS1;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;ALDOA;EEF2;RPS20;RPS18;RPL36;RPL22;UBC;VIM;RPS25;RACK1;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;CAVIN1;TUBA1B;PCBP1;RPL23A;HSP90AA1;RPL7A;HSPB1;HSP90AB1;RPL14;GRN;SNRPG;RPL31;CALR;RPL36A;LGALS1;TUBB4B;RPS28;PPIB;RPL35;EIF1;RPL4;PARK7;SEC61B;RPL10;HNRNPAB;RPS6;SERPINH1;NDUFV3;SF3B5;RCAN3;RPL10A;TXN;CKAP4;SLC25A5;ATP5F1A;EIF4G2;NME1;EIF3D;RPN1;MAGOHB;MAGOH;POLR2D;SHFL;HNRNPK;NPM1;RPS27L;EIF1B;DDX39B;HSPE1;PEBP1;MRPL43;EIF5A;APOBEC2;RAN;S100A16;CANX;RALY;SYF2;HSP90B1;SRP14;QKI;LGALS3;ELAC2;BTF3;PKM;ANG;SNRPD2;ZFP36L1;PLEC;NCL;LSM4;DDX28;LSM8;MEX3D;LSM6;ENO1;RTN4;NOP10;EMG1;PUF60;HSPA1B;MRPL4;ZFP36L2;PARP1;RBFOX3;FLNA;YWHAE;RBM42;HMGB3;SNRPA;AHNAK;PCBP4;EIF3I;VCP;MANF;NUCKS1;SNRPF;MRPL28;PFN1;TFRC;MSN;EIF3C;SBDS;FBL;RPL22L1;SRSF9;MRPL14;SRFBP1;STRAP;MRPL41;MRPL27;LIN28B;CSTB;P4HB;RIMS1;CORO1A;MRPS11;TRIM28;EDF1;PDIA3;HNRNPA0;MRPL11;MRPS14;HSPD1;MYO5A;DDX49;ZYX;CLTC;NOL12;RBM15B;YWHAG;IFIT1;MAPT;CSRP1;METAP2;YBX1;NPM3;PRPF38B;SLC25A11;RRP1B;RRP1;SARS1;SARS2;JUN;DCN;PRDX1;NELFCD;KARS1;NHP2;EPPK1;HMGB1;AARS2;SLC3A2;ZFP36;POP7;WDR3;RTRAF;H1-0;TARDBP;POLR2G;DEK;EXOSC2;FASN;RNASEH1;KHDRBS3;PRPF8;EIF4A1;SUMO2;SRSF2;RALYL;APEX1;SF3A2;KCTD12;NIP7;ACAA2;PABPC1;FAM50A;SSRP1;NTPCR;DDX11;MRPL54;RTCB;ACTN1;RBM4B;SNW1;L1TD1;SORBS2;SF3B2;PRMT1;BST2;HSPA1A;ATXN2L;IMP4;TOE1;CARS1;YWHAZ;EIF3B;MRPL2;MRPL37;HNRNPU;MRPL44;MTCL1;POP4;NOL7;ZC3H8;SND1;TSN;RO60;NUFIP2;RRP7A;HEXIM1;MRPS24;PIN4;HNRNPA1;SUCLG1;GTPBP10;NONO;TUFM;CHCHD1;ARF1;TRUB2;CTU1
prerank,monocarboxylic acid binding (GO:0033293),0.693438496886125,1.5772422958603716,0.02038216560509554,0.18300430811324142,0.997,1/18,0.23%,PSAP
prerank,bHLH transcription factor binding (GO:0043425),-0.5092467723558776,-1.5731347374180815,0.037383177570093455,0.27143531197751586,0.975,5/19,6.24%,SMAD3;FHL2;TCF12;CREBBP;SP1
prerank,Toll-like receptor binding (GO:0035325),0.7573736446107134,1.5704427829161338,0.012875536480686695,0.192271733937955,0.998,8/11,16.24%,TOLLIP;S100A8;S100A9;TIRAP;TLR6;UNC93B1;TLR1;DAB2IP
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6403004988754466,1.5672429177790148,0.010804321728691477,0.19417031861685455,0.999,9/28,12.57%,CHRNA9;GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRID1;GABRA3;CHRNA4
prerank,poly-pyrimidine tract binding (GO:0008187),-0.49402913415229904,-1.5643448534511675,0.01015228426395939,0.2753998720761037,0.98,10/23,19.05%,RBMS3;RBMS1;ATXN1;DAZAP1;PATL1;PABPC4;PABPC4L;RBMS2;FMR1;KHDRBS1
prerank,nucleosomal DNA binding (GO:0031492),0.6706750781632634,1.563372396390776,0.017721518987341773,0.19600671223977173,0.999,3/21,3.83%,ACTB;H3-3A;MBD3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6785157263279316,1.5616783361003954,0.021491782553729456,0.1939160965235274,1.0,7/19,11.91%,GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRID1;GABRA3
prerank,endopeptidase regulator activity (GO:0061135),0.594308816876856,1.5494515803619304,0.01951779563719862,0.21556916588038916,1.0,9/40,11.79%,CST3;PSME1;A2M;PSME2;PCSK1N;PSENEN;CSTB;VSIR;ITIH3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.6295449173321754,-1.5484334335205183,0.07011070110701106,0.2908263150020214,0.984,4/10,13.40%,KDM2A;KDM7A;KDM4C;PHF8
prerank,histone methyltransferase activity (GO:0042054),-0.4565882865093864,-1.5476558176391222,0.026143790849673203,0.2829291934640121,0.984,13/32,16.75%,KMT2C;SETD2;SMYD3;EHMT1;KMT5B;NSD3;SETDB1;SETD7;EHMT2;CARM1;EZH2;PRDM9;PRMT6
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.5106592054970056,-1.5443292496578942,0.047619047619047616,0.27961762227183257,0.987,8/18,14.11%,TGFBR3;SMAD3;SMAD6;TGFBR1;SMAD7;FERMT2;SMAD2;TGFB3
prerank,Tat protein binding (GO:0030957),0.7516217133126618,1.542993913833534,0.034334763948497854,0.22563741470288923,1.0,6/10,16.95%,ACTB;NPM1;GABARAPL1;DNAJA1;DLL1;TRIM32
prerank,peptidase inhibitor activity (GO:0030414),0.6113158928544598,1.5401147456266846,0.02358490566037736,0.22691737150195118,1.0,7/33,11.79%,CST3;TIMP2;A2M;PCSK1N;CSTB;TIMP1;ITIH3
prerank,cholesterol binding (GO:0015485),0.5744159537830089,1.5390284554600406,0.009977827050997782,0.2236229875424759,1.0,17/47,18.97%,APOD;TSPO;CD81;NPC2;SCP2;ABCG1;TSPO2;STARD4;OSBPL6;PROM1;SYP;CAV1;SOAT2;STARD3NL;OSBPL3;ANXA6;VDAC2
prerank,nuclear receptor binding (GO:0016922),-0.34707726784344856,-1.5387201546615412,0.0,0.28130409153152597,0.989,33/111,13.79%,FOXP1;NSD1;SMAD3;TCF7L2;NRIP1;STAT5B;MED13;BCAS3;TACC2;NCOA1;TRIP12;BAZ2A;JMJD1C;THRAP3;ARID1A;CNOT1;NCOR1;KDM3A;ASXL1;LCOR;SMARCE1;STRN;MMS19;DCAF1;ESR1;PPID;DCAF13;KDM4C;BRD8;RNF14;TGFB1I1;SIRT1;PPARGC1B
prerank,protease binding (GO:0002020),0.53644813320082,1.5374336370771928,0.0010504201680672268,0.2218815283808546,1.0,26/99,13.50%,CST3;PSAP;UBC;COL1A1;PARK7;TIMP2;A2M;PRNP;PINK1;TNF;NTRK2;ECM1;FLOT1;ADAMTS4;VCP;TNFAIP3;FN1;SELL;CSTB;CLTC;COL3A1;TIMP1;SYVN1;TIMP3;COL1A2;RIPK2
prerank,phospholipase binding (GO:0043274),-0.5700180777839293,-1.5210608096001337,0.05058365758754864,0.3027482257103453,0.994,5/13,11.31%,ARHGAP6;PAFAH1B1;PRKN;PDPK1;DGKQ
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5951058941205095,1.5184582750282638,0.020361990950226245,0.2644259772366071,1.0,8/38,12.85%,SERPINH1;A2M;SERPINF1;SERPINE2;AGT;SPOCK1;SERPING1;SERPINA9
prerank,copper ion binding (GO:0005507),0.5830062770426016,1.518060242500316,0.012790697674418604,0.2590916483239642,1.0,13/42,16.09%,ATOX1;MT3;PARK7;SOD1;PRNP;S100A13;COX17;ANG;ATP13A2;AOC3;CUTA;HEPH;RNF7
prerank,phosphatidylinositol binding (GO:0035091),-0.37946224473316126,-1.515603220094517,0.0,0.303110106091241,0.996,35/91,16.96%,PARD3B;ITPR1;PARD3;FCHO2;PITPNC1;ZFYVE1;ITPR2;APPL2;BCAS3;PITPNM2;EEA1;SNX12;SESTD1;ZFYVE9;DENND1A;ANKFY1;HIP1;SNX24;WDFY3;PICALM;SNX9;TNFAIP8L3;DENND1B;TULP3;ESYT3;NUMA1;SNX2;PIGK;SNX1;ING2;RUBCN;PASK;SH3YL1;SNX13;APPL1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.4265193792698813,-1.4981821411112468,0.027586206896551724,0.3231390589900606,0.997,16/34,20.46%,SETD2;SMYD3;EHMT1;KMT5B;NSD3;SETDB1;CAMKMT;SETD7;EHMT2;EZH2;SETD4;PRDM9;SETD3;VCPKMT;METTL21A;SETD6
prerank,manganese ion binding (GO:0030145),-0.3842482735495219,-1.4980136076841424,0.009615384615384616,0.3146777651270374,0.997,10/48,13.90%,MPPED2;LARGE1;ABL1;B4GALT1;XPNPEP3;NEK4;ABL2;GALNT1;MGAT5;ME1
prerank,alanine transmembrane transporter activity (GO:0022858),0.7082896053147689,1.4940144936417041,0.04189944134078212,0.32342549071205046,1.0,4/12,9.99%,SLC38A5;SLC1A4;SLC6A6;SLC3A2
prerank,insulin-like growth factor I binding (GO:0031994),0.700644572271342,1.4861387992514812,0.03942181340341656,0.34150622608623504,1.0,4/13,4.18%,IGFBP6;IGFBP3;IGFBP4;IGFBP5
prerank,glutathione transferase activity (GO:0004364),0.6282560096506058,1.4856136246495755,0.0389768574908648,0.3350763738862389,1.0,9/23,17.03%,GSTM1;MGST1;GSTO1;GSTM5;MGST3;GSTM2;HPGDS;ALOX5AP;LTC4S
prerank,triglyceride lipase activity (GO:0004806),0.6331842545826873,1.4852445579891327,0.036989795918367346,0.3287431811890252,1.0,4/20,8.93%,PNPLA2;LIPG;LIPE;LPL
prerank,calcium ion binding (GO:0005509),0.49629314681188713,1.4832272596600669,0.0,0.328049720482332,1.0,100/323,20.40%,TPT1;SPARC;S100A6;CALM1;GSN;S100A1;SPARCL1;CALR;KCNIP4;S100A11;HSPA5;NRXN1;SPOCK2;RCN3;S100B;PRNP;S100A10;CALM3;TGM2;ANXA5;GJB2;S100A13;S100A16;CANX;HSP90B1;LTBP4;S100A8;S100A9;BNIP2;CDH20;SLC25A13;ADGRL3;SPOCK1;GRIN1;SYT1;F9;SELL;CLEC6A;CALB1;ENPP2;CDH18;SDF4;SYT12;SYT11;TUBB4A;CLEC3B;LCP1;LPL;CDK5R1;RPH3A;SYT6;SYT4;DNER;AOC3;RASGRP3;PLA2G4F;PDCD6;TRPM2;MAN1B1;AIF1;CDH12;PCDHB8;HPGDS;PCP4;CDH19;DCHS1;CETN3;FKBP9;DHH;KCNIP1;SLC8A1;SYT10;CDH7;RASGRP1;CDH24;EFHD1;CPNE6;RYR2;SYT2;EFHD2;CDH10;CETN2;CDH5;SLIT3;SLIT1;SRI;SCIN;S100A4;GCA;TKT;NCS1;ANXA6;PPP3CA;CALM2;SNCA;S100G;PKD2L1;AGRN;CANT1;CAPN3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7223048733772328,1.4829308181400769,0.04551920341394026,0.3222319665176502,1.0,5/11,15.93%,CNGA3;CNGA4;AQP1;HCN1;CNGB1
prerank,fibroblast growth factor binding (GO:0017134),0.6198941737287956,1.4798390986308954,0.0460772104607721,0.32458427532635264,1.0,3/21,3.22%,RPS19;RPS2;S100A13
prerank,ligand-gated anion channel activity (GO:0099095),0.6577545351302453,1.4794152280973565,0.04933333333333333,0.31920315429972984,1.0,9/17,18.84%,GABRB1;GABRG3;GABRA2;GLRA2;GLRA1;GABRA3;GABRB3;GABRB2;GLRA3
prerank,low-density lipoprotein particle binding (GO:0030169),0.6604569424297763,1.478413621425714,0.04084321475625823,0.3156992342829198,1.0,5/16,12.32%,PLTP;TREM2;SORL1;STAB1;MSR1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.599173614237552,-1.475702409781448,0.07167235494880546,0.34710834014615904,0.999,6/10,18.19%,CFLAR;CASP12;CASP3;CASP8;CASP7;CASP4
prerank,protein phosphatase activator activity (GO:0072542),0.6813348391090756,1.4722827965764345,0.03571428571428571,0.3287846852583436,1.0,8/13,21.19%,CALM1;CALM3;IGFBP3;B3GAT3;PPP2R5D;PPP1R15A;CALM2;PPP2R5A
prerank,peptidase activator activity (GO:0016504),0.6235615236654004,1.4630289188091932,0.05512820512820513,0.35107552941053016,1.0,8/22,9.55%,PSME1;PSME2;PINK1;PSENEN;MAL;VCP;VSIR;PCOLCE
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.436962301685091,-1.4596758088013428,0.03954802259887006,0.36745740092607737,0.999,14/27,14.62%,DCUN1D3;RNF19A;ZMYM2;PRKN;PPARA;ARIH2;RNF144A;ARIH1;RNF217;RNF14;DCUN1D4;SIAH3;DCUN1D1;DCUN1D2
prerank,metal ion binding (GO:0046872),0.4826850464478287,1.4531492091198843,0.0,0.3757035896241475,1.0,127/477,19.24%,APOE;TPT1;SPARC;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;S100A6;CALM1;GSN;S100A1;SPARCL1;CALR;MT3;KCNIP4;MT2A;S100A11;HSPA5;NRXN1;SPOCK2;RCN3;S100B;PRNP;S100A10;CALM3;NME1;TGM2;ANXA5;PINK1;GJB2;IGFBP3;S100A13;HSPE1;RAN;S100A16;CANX;HSP90B1;LTBP4;S100A8;S100A9;BNIP2;CDH20;SLC25A13;NT5C3A;ADGRL3;SPOCK1;GRIN1;SYT1;F9;SELL;CLEC6A;CALB1;ENPP2;CDH18;MAST1;SDF4;SYT12;SYT11;TUBB4A;CLEC3B;LCP1;LPL;CDK5R1;RPH3A;SYT6;SYT4;NUDT3;DNER;AOC3;RASGRP3;PLA2G4F;GNAI1;PDCD6;APEX1;TRPM2;MAN1B1;AIF1;NUDT22;CDH12;PCDHB8;HPGDS;CDC42BPA;STK11;PCP4;CDH19;DCHS1;CETN3;FKBP9;TSSK6;TSSK4;DHH;KCNIP1;RRAGC;SLC8A1;SYT10;CDH7;RASGRP1;CDH24;EFHD1;CPNE6;RYR2;PPA1;NUDT16;SYT2;EFHD2;CDH10;CETN2;CDH5;BRSK2;SLIT3;SLIT1;SRI;SCIN;S100A4;GCA;TKT;NCS1;ANXA6;YDJC;PPP3CA;CALM2;SNCA;S100G
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5666204856393708,-1.4526738206114664,0.08223684210526316,0.37134078648679997,0.999,4/11,5.63%,AKAP13;KSR1;SH3RF1;SPAG9
prerank,ferrous iron binding (GO:0008198),0.6218943452134202,1.4521062997936296,0.05867665418227216,0.37180964529684346,1.0,2/21,0.08%,FTH1;FTL
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6862512247287703,1.4519811499650979,0.0560875512995896,0.3656058795788427,1.0,7/13,22.39%,ARHGDIA;ARHGDIB;ARHGDIG;GDI1;CCDC88A;GDI2;RANBP1
prerank,water transmembrane transporter activity (GO:0005372),0.6949329876974704,1.44996071859229,0.06791907514450866,0.36550914694134823,1.0,2/11,8.41%,AQP4;AQP1
prerank,GABA receptor binding (GO:0050811),0.6986198828494288,1.4499526356556733,0.0688622754491018,0.35923627670881464,1.0,5/11,5.53%,GABARAP;GABARAPL2;SHISA7;GABARAPL1;LHFPL4
prerank,chemokine activity (GO:0008009),0.5842360756592495,1.4467597595695998,0.04062126642771804,0.36270168909042944,1.0,9/31,17.62%,CXCL12;CCL19;CXCL16;CXCL10;CCL2;PF4;CCL3;CCL28;CCL8
prerank,insulin-like growth factor binding (GO:0005520),0.6601506454253442,1.4454349792601333,0.0532994923857868,0.3612279238233764,1.0,4/15,4.18%,IGFBP6;IGFBP3;IGFBP4;IGFBP5
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.41189860326038236,-1.4439141911322828,0.014285714285714285,0.3808424623811429,1.0,12/34,11.07%,PARD3;GAB2;FCHSD2;ZFYVE1;MAPKAP1;OGT;MYO1B;ADAP2;GBF1;DAPP1;KIF16B;FERMT2
prerank,amino acid binding (GO:0016597),0.5627748404992553,1.4275982262779654,0.05790108564535585,0.4120067330315134,1.0,13/31,20.45%,AGXT;GRIN1;GRIN3A;GRM7;AARS2;GLRA2;GLRA1;DDAH1;DDAH2;NOS2;GRIN2B;GLRA3;SHMT2
prerank,chemokine receptor binding (GO:0042379),0.566407083241017,1.4271561478137809,0.038777908343125736,0.40692200707339243,1.0,10/35,17.62%,CXCL12;CCL19;CXCL16;CXCL10;CX3CR1;CCL2;PF4;CCL3;CCL28;CCL8
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.6730794552535746,1.4271288827157194,0.08205841446453407,0.4005564094546148,1.0,6/12,16.30%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2
prerank,cadherin binding (GO:0045296),0.47643577168839607,1.423435295495348,0.0,0.40603699207860083,1.0,91/315,17.28%,BSG;HSPA8;RPL24;RPL34;ALDOA;EEF2;RACK1;RPL29;RPL6;RPL15;RPS2;RPS26;PCBP1;RPL23A;RPL7A;HSP90AB1;RPL14;PPP1CA;TAGLN2;PARK7;FXYD5;S100A11;HSPA5;PSMB6;EEF1G;EIF4G2;HNRNPK;PRDX6;CTNNA2;ANK3;CNN2;CTNNA3;RAN;LYPLA2;EEF1D;YWHAB;PKM;PLEC;ENO1;LDHA;RTN4;TRIM29;CDH20;PUF60;CTNNB1;FLNA;YWHAE;AHNAK;CHMP2B;GLOD4;PFN1;NDRG1;CDH18;KDR;YKT6;CDK5R1;PRDX1;CCT8;SLC3A2;FASN;CHMP5;LASP1;FNBP1L;PLIN3;PTPRB;CLIC1;ANLN;HSPA1A;ATXN2L;CDH12;SHTN1;YWHAZ;EVPL;PROM1;CAPG;SND1;CDH19;DCHS1;EHD1;SH3GLB2;DNAJB1;CDH7;CDH24;DAB2IP;SPTBN2;EFHD2;CDH10;USP8;CDH5;NUDC;RANGAP1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.6407731764569162,1.4165854267100082,0.08015768725361366,0.42228631884468126,1.0,5/15,10.80%,P2RX7;GPR34;P2RY1;P2RY12;P2RX6
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5423808024539383,1.4139682259942192,0.04190260475651189,0.42512999775946025,1.0,14/42,15.44%,BSG;PPP1CA;S100A11;DSCAM;CNTN4;TRIM29;SIRPA;LRRC4C;ESAM;ROBO4;EMB;JAM3;IGSF9;DSCAML1
prerank,sodium channel regulator activity (GO:0017080),0.5547202078215376,1.409553212613135,0.05568181818181818,0.4335018880060138,1.0,12/37,15.85%,FXYD5;FXYD1;YWHAH;FGF14;SGK1;SCN4B;FGF11;FXYD7;FGF12;RSC1A1;PRSS8;FGF13
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5627153114469088,1.408719628126063,0.07923169267707082,0.42982408680783174,1.0,6/30,7.36%,CST3;MT3;UBE2Z;PRDX5;SPOCK1;CSTB
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.6301982674871397,1.4084638340540216,0.0859375,0.4244482822295154,1.0,3/16,10.53%,RPS3;DNPH1;NEIL1
prerank,calcium channel regulator activity (GO:0005246),0.5492992194154932,1.4061514633801453,0.05503512880562061,0.425836574924295,1.0,13/37,19.11%,CALM1;SLC30A1;NRXN1;FKBP1A;YWHAE;SGK1;PHPT1;NRXN2;INAFM2;CACNG8;SRI;FKBP1B;CALM2
prerank,carboxypeptidase activity (GO:0004180),0.5503778959093041,1.4061212083377792,0.07009345794392523,0.4199099755642796,1.0,9/35,11.66%,CTSZ;CPXM1;CPD;CPE;VASH1;AGBL4;AEBP1;CPXM2;CTSA
prerank,hormone activity (GO:0005179),0.5219951158707608,1.4043093087719838,0.04515418502202643,0.4196283779233876,1.0,18/54,22.33%,NPPC;TRH;POMC;AGT;AMH;PENK;CRH;CALCB;PPY;HCRT;CCK;ADCYAP1;NMB;EDN3;INHBA;SST;INHBB;ERFE
prerank,ligand-gated cation channel activity (GO:0099094),0.5020603823416618,1.4033975057420944,0.031746031746031744,0.4163579535182457,1.0,16/75,12.57%,ASIC2;CHRNA9;GRIA2;GRIK5;GRIK2;GRIN1;KCNJ10;GRIN3A;P2RX7;GRIA4;GRIN2A;P2RX6;TRPM2;KCNN2;GRIA1;CHRNA4
prerank,ribosomal small subunit binding (GO:0043024),0.6256323096882035,1.4029304125319368,0.08376963350785341,0.41200486919295076,1.0,4/17,3.18%,EIF1;NME1;NPM1;EIF1B
prerank,CoA-ligase activity (GO:0016405),-0.509716695080843,-1.3981300610329188,0.08108108108108109,0.4645036652539034,1.0,10/14,38.03%,ACSS3;ACSL1;SLC27A2;ACSS1;AACS;ACSBG1;ACSM3;SLC27A5;ACSM2B;ACSM2A
prerank,GABA-A receptor activity (GO:0004890),0.6125114371312026,1.396272186949475,0.07509881422924901,0.42723079007222664,1.0,6/18,16.30%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.3271460184812288,-1.395491623207654,0.0,0.4589396164041516,1.0,49/147,15.00%,AKAP13;DOCK5;PLCE1;RAPGEF4;DOCK11;SBF2;DENND4A;ARHGEF11;DENND4C;FARP1;ARFGEF1;RAPGEF2;DENND2A;IQSEC2;MON1A;ITSN1;ARHGEF18;FGD4;FNIP1;ANKRD27;EIF2B3;DENND5A;RAPGEF6;DENND1A;ARFGEF2;RAPGEF1;RIC8B;BCR;VAV2;RAPGEF5;GAPVD1;ARHGEF6;ALS2;CCZ1;DNMBP;DENND1B;RAPGEF3;DENND5B;DOCK1;RIC1;DENND3;ARHGEF2;ARHGEF17;DENND2C;EIF2B2;RAB3GAP2;RGL1;PREX2;NGEF
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.6628361325742664,1.3940700232062364,0.10110803324099724,0.42826253458505625,1.0,4/11,17.55%,RPS3;NEIL1;APEX1;NEIL2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6475232236860241,1.3927195363646439,0.09607577807848444,0.4269292200245548,1.0,4/13,12.81%,MIF;DDT;ECH1;HSD3B2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.6004086697681112,1.3900689275155202,0.08888888888888889,0.42994464033586194,1.0,5/21,12.57%,CHRNA9;GRIK2;P2RX7;P2RX6;CHRNA4
prerank,poly(A) binding (GO:0008143),-0.43657790713621675,-1.385021828262559,0.0963302752293578,0.4715791296656364,1.0,8/21,15.12%,RBMS3;RBMS1;RBPMS;DDX1;ZC3H14;PABPC4;PABPC4L;RBMS2
prerank,deoxyribonuclease activity (GO:0004536),0.6440525221929513,1.3846029297826234,0.0849933598937583,0.4414461858123119,1.0,2/14,2.70%,RPS3;NME1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.41138376184733855,-1.381368860310066,0.06282722513089005,0.46748563503763985,1.0,7/26,12.57%,SLC6A13;SLC16A12;SLC6A12;SLC16A9;ABCG2;SLC16A6;SLC16A13
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5930365846715012,1.379280505057683,0.10227272727272728,0.45260760910640063,1.0,7/19,18.24%,NRG3;NRG1;GRM5;CD24;GAS6;ERCC6;ERBB3
prerank,transaminase activity (GO:0008483),0.6538201628397234,1.3791545700208627,0.12083333333333333,0.44745610951919085,1.0,3/11,6.29%,AGXT;OAT;BCAT2
prerank,U6 snRNA binding (GO:0017070),0.628885678954489,1.3770429563124857,0.09152086137281291,0.44880184294131875,1.0,5/14,10.66%,DDX39B;EIF5A;LSM4;LSM8;PRPF8
prerank,cholesterol transfer activity (GO:0120020),0.6219614952043482,1.3754889014474563,0.09602194787379972,0.4487568463840603,1.0,4/16,9.19%,PLTP;NPC2;ABCG1;STARD4
prerank,ATPase activator activity (GO:0001671),0.5862664642220723,1.3731439904353984,0.09859154929577464,0.45099654943294654,1.0,8/20,18.89%,ATP1B2;DNAJA1;DNAJB2;DNAJB1;ATP1B1;ATP1B3;AHSA1;DNAJC10
prerank,ATPase regulator activity (GO:0060590),0.53054830718598,1.371777995951254,0.07497116493656286,0.4502240279226491,1.0,15/38,18.89%,ATP5IF1;BAG5;PFN1;BAG1;ATP1B2;PLN;DNAJA1;DNAJB2;HSPBP1;DNAJB1;ATP1B1;BRSK2;ATP1B3;AHSA1;DNAJC10
prerank,phosphatidic acid binding (GO:0070300),-0.46537942208550814,-1.3716310747937266,0.10344827586206896,0.47884932968171423,1.0,7/19,6.50%,PITPNC1;RAPGEF2;MAPKAP1;PACSIN2;MARK1;SESTD1;RAPGEF6
prerank,sterol binding (GO:0032934),0.5015471290423293,1.370023406863929,0.053964757709251104,0.4506629962232703,1.0,20/56,22.21%,APOD;TSPO;CD81;NPC2;SCP2;ABCG1;TSPO2;STARD4;OSBPL6;PROM1;SYP;CAV1;SOAT2;STARD3NL;OSBPL3;ANXA6;VDAC2;GPR183;OSBPL1A;GRAMD1A
prerank,retinoid binding (GO:0005501),0.5890289580304225,1.3689764162932339,0.08014796547472257,0.448664568487932,1.0,3/22,7.26%,PTGDS;RBP4;RBP1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.48924793729048754,-1.367124688770683,0.07818930041152264,0.478658063419901,1.0,7/15,9.94%,ZFYVE1;EEA1;SESTD1;ZFYVE9;WDFY3;PICALM;SNX9
prerank,phospholipase inhibitor activity (GO:0004859),0.6658188461742303,1.3651136175493515,0.11691884456671252,0.45545954939871647,1.0,2/10,3.07%,APOC1;ANXA5
prerank,glycine binding (GO:0016594),0.6565829841523468,1.364703523357816,0.10714285714285714,0.4515993048517378,1.0,6/11,18.84%,GRIN1;GRIN3A;GLRA2;GLRA1;GRIN2B;GLRA3
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5363018051911707,1.3621124924416528,0.09068923821039904,0.45445270729007975,1.0,11/32,24.20%,KCNQ3;KCNQ2;KCNC3;KCNC1;KCNE4;KCNA2;KCNE5;KCNA1;KCNQ5;KCNC2;KCNG3
prerank,estrogen receptor binding (GO:0030331),-0.39533996863217646,-1.3605161260198915,0.07547169811320754,0.48392355693717065,1.0,11/32,11.27%,NSD1;NRIP1;NCOA1;CNOT1;LCOR;STRN;MMS19;DCAF1;ESR1;PPID;DCAF13
prerank,chemorepellent activity (GO:0045499),0.5675603256431546,1.3602561855461637,0.10947109471094711,0.4550984512054863,1.0,8/25,13.41%,NRG3;NRG1;SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,sterol transfer activity (GO:0120015),0.607280802004539,1.3592629157052747,0.10960757780784844,0.45302324773956626,1.0,4/17,9.19%,PLTP;NPC2;ABCG1;STARD4
prerank,tRNA methyltransferase activity (GO:0008175),-0.4804740304160587,-1.3586310482640016,0.09913793103448276,0.477913345847309,1.0,6/16,15.31%,TRMT13;ALKBH8;THUMPD3;TRMT5;FTSJ1;TRMT9B
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6127517043317499,1.3585589831248974,0.11080332409972299,0.45034131483895196,1.0,8/15,12.67%,SLC17A8;SLC1A4;SLC1A2;SLC25A13;SLC17A7;SLC17A6;SLC1A1;SLC25A22
prerank,fatty acid synthase activity (GO:0004312),0.6642818083510071,1.3570239308832535,0.1072463768115942,0.450643222104249,1.0,4/10,11.14%,ELOVL1;ELOVL2;OXSM;ELOVL7
prerank,leak channel activity (GO:0022840),-0.4525971895541478,-1.3543823878214492,0.12719298245614036,0.4777872745553279,1.0,3/18,2.21%,KCNK2;NALCN;KCNK5
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5249910664688688,-1.3543436333868835,0.12758620689655173,0.4684000061544143,1.0,2/11,3.46%,EGFR;MAP3K13
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5853918018284331,1.3524495278364181,0.10745891276864729,0.45944070245987795,1.0,5/21,12.57%,GRM5;DRD5;GRM1;GRIA1;CHRNA4
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.40932682765543155,-1.3521918945603741,0.06557377049180328,0.4642700050140375,1.0,9/29,13.42%,ABL1;ATF7;PPM1D;NFATC1;DUSP16;DUSP10;MAPKAPK3;DUSP7;SIRT1
prerank,actin monomer binding (GO:0003785),0.5631712291190516,1.3510611919101154,0.10186335403726708,0.45897547646039655,1.0,5/22,7.45%,TMSB4X;TMSB10;MRTFA;PFN1;CORO1A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.6088789005544902,1.3509499240251006,0.12005457025920874,0.44997778795375176,1.0,12/16,28.13%,PTPRC;PTPRN2;PTPRD;PTPRB;PTPRR;PTPRZ1;PTPN6;PTPRU;PTPRO;PTPRE;PTPRT;PTPRG
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.6088789005544902,1.3509499240251006,0.12005457025920874,0.44997778795375176,1.0,12/16,28.13%,PTPRC;PTPRN2;PTPRD;PTPRB;PTPRR;PTPRZ1;PTPN6;PTPRU;PTPRO;PTPRE;PTPRT;PTPRG
prerank,semaphorin receptor binding (GO:0030215),0.5622769823475325,1.3481382761340877,0.12102689486552567,0.4547297535255012,1.0,6/23,13.41%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.5070626219783431,-1.34636448033454,0.1377952755905512,0.46804231633215854,1.0,3/13,9.96%,DICER1;SLX4;DNASE1L1
prerank,adenylate cyclase binding (GO:0008179),0.6633775117824161,1.3459327766612361,0.1223021582733813,0.45692997654239126,1.0,3/10,2.58%,CALM1;AKAP6;CALM3
prerank,endopeptidase activator activity (GO:0061133),0.6586920586396356,1.3457170228566169,0.125,0.45295570176469635,1.0,4/10,8.66%,PSME1;PSME2;PSENEN;VSIR
prerank,transcription corepressor binding (GO:0001222),-0.41328530358113724,-1.344892745755037,0.0625,0.4620722609518092,1.0,11/27,14.96%,ZBTB16;PER2;USP11;PER3;EHMT1;LCOR;NEK6;ESR1;RORA;EHMT2;EZH2
prerank,small GTPase binding (GO:0031267),-0.2791975916414553,-1.3438832204394129,0.0,0.45591772573878614,1.0,41/170,13.60%,AKAP13;STRN3;AFDN;PLCE1;RAPGEF4;GOLGA4;LRRK2;RANBP2;EXOC4;RNF152;SGSM2;BRAF;MAPKAP1;USP6NL;EPS8;FGD4;RAF1;ANKRD27;EXOC2;NOX1;DOCK7;UNC13B;NCKAP1;RAPGEF6;CDC42EP5;RABGAP1;ANKFY1;NUTF2;GGA2;TRIOBP;RNF41;PICALM;ALS2;OPTN;GOLGA5;PDE6D;MYO9B;RIC1;ARHGEF2;DVL3;RAB3GAP2
prerank,protein kinase inhibitor activity (GO:0004860),0.5084164753169836,1.340035946080549,0.10490307867730901,0.4656303881095549,1.0,15/42,19.11%,RACK1;NPM1;CAMK2N2;YWHAB;PPP1R1B;CDKN1C;INKA2;ITPRIP;CAMK2N1;MAPK8IP1;HEXIM1;GMFB;PRKRIP1;QARS1;SNCA
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4758063829592514,1.3377704913148782,0.054313099041533544,0.4679547549958089,1.0,31/85,28.07%,PNPLA2;PRDX6;LYPLA2;CA2;PLAAT3;PGLS;LIPG;ENPP2;LIPE;PNPLA7;LPL;AARS2;PLA2G7;PLA2G4F;GDE1;MRPL58;ABHD8;ACHE;GDPD1;FAAH;NOTUM;ESD;BCHE;APMAP;ABHD16A;GDPD3;ABHD12;PLA2G6;PON2;PGAP1;MGLL
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.6189699682969372,1.3370152614117192,0.11538461538461539,0.46590639223951885,1.0,7/14,13.02%,TIMP2;SPOCK2;SPOCK1;SPOCK3;TIMP1;TIMP3;BST2
prerank,gap junction channel activity (GO:0005243),0.5654676459951348,1.3360647157767207,0.1423125794155019,0.4642816569919734,1.0,5/22,13.23%,GJA4;GJB2;GJB5;GJD2;GJA1
prerank,kinase activator activity (GO:0019209),0.5283351684105739,1.332436241629653,0.1092436974789916,0.470640590340179,1.0,5/30,9.33%,RPLP1;MT3;TREM2;IL2;CDK5R1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6269381481373149,1.3291625798586904,0.13389121338912133,0.47630666903621627,1.0,10/13,32.99%,GABRG3;GABRA2;GLRA2;GLRA1;GABRA3;GLRA3;GABRA4;GABRG2;GABRA1;GABRG1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3042551965643371,-1.3284849056287387,0.0,0.4793326376980253,1.0,24/100,11.07%,PARD3;GAB2;FCHSD2;OSBPL8;ZFYVE1;MAPKAP1;PLA2G4A;OGT;MYO1B;PLEKHA4;ADAP2;SNX12;SESTD1;DENND1A;ANKFY1;ATG2B;GBF1;HIP1;DAPP1;ATG2A;SNX24;KIF16B;DENND1B;FERMT2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.603024512290989,1.323877274538845,0.14189189189189189,0.4876169546515279,1.0,6/14,17.37%,NME1;AK4;NME4;NME2;CMPK2;NME3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.2554805332572552,-1.3221768462151287,0.0,0.48331865249099915,1.0,29/173,11.42%,ZBTB20;FOXP1;FOXP2;ZEB1;ZNF148;PRDM5;KLF12;MXI1;ZBTB16;SKI;PPARA;ZFP90;FOXO3;NFATC4;FOXP4;NFKB1;FOXK2;ZFHX3;KCNIP3;ZBTB1;ZBTB26;NFX1;PPARG;ETV6;KLF8;FOXK1;ZKSCAN3;MZF1;NFATC3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.512918995886526,-1.3216064353142611,0.16376306620209058,0.47593300110293585,1.0,4/12,18.06%,TENT4B;TUT1;PAPOLB;TENT2
prerank,sodium:proton antiporter activity (GO:0015385),-0.5374053854244144,-1.3211996013071312,0.1501597444089457,0.4683663107363757,1.0,4/11,12.18%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,carboxylic acid binding (GO:0031406),0.5050176246043674,1.3210291113662258,0.10638297872340426,0.4921356732986529,1.0,13/38,21.81%,PSAP;GRIN1;EPDR1;GRIN3A;GRM7;GLRA2;GLRA1;NOS2;GLUD1;GRIN2B;GLRA3;SHMT2;MAG
prerank,phosphatase activator activity (GO:0019211),0.6058822400192796,1.3206211193261412,0.1426648721399731,0.48890842069169804,1.0,8/14,21.19%,CALM1;CALM3;B3GAT3;BMP2;PPP2R5D;PPP1R15A;CALM2;PPP2R5A
prerank,metalloendopeptidase activity (GO:0004222),-0.31335191600156903,-1.3194928456791575,0.028985507246376812,0.46439710471318607,1.0,17/76,11.77%,ADAMTS10;TRABD2B;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;ADAMTSL5;ADAMTS9;ADAMTSL4;NRDC;ADAMTS5;ADAM9;ADAM33;ADAM19;ADAMTS6;NLN;ADAMTS14
prerank,acid-thiol ligase activity (GO:0016878),-0.4833220399139967,-1.3183990441990876,0.11956521739130435,0.45935278641105337,1.0,9/13,38.03%,ACSS3;ACSL1;SLC27A2;ACSS1;AACS;ACSM3;SLC27A5;ACSM2B;ACSM2A
prerank,wide pore channel activity (GO:0022829),0.551321193543842,1.3163960775791708,0.15894868585732166,0.4977908969267443,1.0,5/23,13.23%,GJA4;GJB2;GJB5;GJD2;GJA1
prerank,platelet-derived growth factor binding (GO:0048407),0.6382883476421473,1.3161552494172633,0.13019390581717452,0.49412006465866276,1.0,7/11,15.48%,COL1A1;PDGFB;COL6A1;COL4A1;COL3A1;COL1A2;PDGFA
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.6038319695391525,1.3147302710748883,0.13941018766756033,0.4942443772123815,1.0,5/14,15.07%,RACK1;RPS27L;MAL;CTSH;BAD
prerank,translation initiation factor activity (GO:0003743),0.5208537949869635,1.3145339293613447,0.1332560834298957,0.4904993119576765,1.0,18/36,25.32%,EIF1;EIF3F;EIF4G2;EIF3D;EIF1B;EIF3K;EIF3I;EIF3C;EIF4A1;EIF3B;EIF2B5;EIF3M;EIF5B;EIF4E2;EIF3H;EIF2S1;EIF2A;EIF3G
prerank,glucuronosyltransferase activity (GO:0015020),-0.4397347824845047,-1.3134252799912407,0.1341991341991342,0.46140627356774927,1.0,2/19,1.07%,LARGE1;EXT1
prerank,protein tyrosine kinase binding (GO:1990782),0.47228546288418527,1.312470655476784,0.08235294117647059,0.4924453603875481,1.0,12/71,6.27%,RACK1;HSP90AA1;NRG3;NRG1;TREM2;GRM5;GRB14;LRP4;DUSP3;SIRPA;HYAL2;SHC3
prerank,metallocarboxypeptidase activity (GO:0004181),0.5486641459254945,1.3095730422412655,0.13291925465838508,0.4973387993175879,1.0,7/26,11.06%,CPXM1;CPD;CPE;VASH1;AGBL4;AEBP1;CPXM2
prerank,snRNA binding (GO:0017069),0.49976708775029693,1.3074929554472152,0.11901983663943991,0.4992650339273941,1.0,19/42,23.25%,DDX39B;EIF5A;LSM4;LSM8;SNRPA;PRPF8;TOE1;HNRNPU;HEXIM1;MEPCE;PRPF31;SNRPD3;LSM7;RBM7;SNRNP35;CDK9;SNU13;ISG20;SNRPB2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.5767839537057129,1.3070555556155685,0.1616294349540079,0.4963672791312842,1.0,7/17,17.37%,NME1;AK4;AK3;NME4;NME2;CMPK2;NME3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.6356559668382418,1.3043287172845035,0.1704225352112676,0.500439811440394,1.0,7/10,32.99%,GABRG3;GABRA2;GABRA3;GABRA4;GABRG2;GABRA1;GABRG1
prerank,mRNA binding (GO:0003729),0.4390332593635374,1.299924894478054,0.014056224899598393,0.5088194191924594,1.0,28/249,5.63%,RPL41;RPL26;MRPL13;RPS3;RPS14;RPS5;RPS7;RPL5;RPS13;RPS2;RPL13A;RPS26;RPL7;PCBP1;CALR;RPL35;PARK7;HNRNPAB;EIF4G2;EIF3D;SHFL;HNRNPK;QKI;PKM;ZFP36L1;NCL;RBFOX3;PCBP4
prerank,pentosyltransferase activity (GO:0016763),-0.36881031295327127,-1.2973428298062597,0.09836065573770492,0.48616510010353314,1.0,10/36,15.22%,LARGE1;PARP4;PARP9;PARP16;PARP3;UPP2;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,acetyltransferase activity (GO:0016407),-0.3843497180678503,-1.2905615755955577,0.08771929824561403,0.4936378742653168,1.0,12/31,19.32%,KAT6B;CREBBP;KAT2B;PAFAH2;SMARCE1;NAA16;NAA15;ESCO1;KAT6A;SPHK1;KAT8;DBT
prerank,histone acetyltransferase activity (GO:0004402),-0.37970831822111106,-1.289721705871617,0.12650602409638553,0.48758322883650795,1.0,9/30,13.32%,KAT6B;CREBBP;NAA40;EPC1;KAT7;KAT2B;ATF2;MCM3AP;KAT6A
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5047314905731464,-1.2879559606167783,0.1793103448275862,0.4841513181098374,1.0,6/11,18.19%,CFLAR;CASP12;CASP3;CASP8;CASP7;CASP4
prerank,CCR chemokine receptor binding (GO:0048020),0.5204617022503539,1.2872806748093106,0.1519138755980861,0.5432532107119525,1.0,7/28,18.31%,CCL19;NES;NARS1;CCL2;CCL3;CCL8;CCR2
prerank,aspartic-type peptidase activity (GO:0070001),0.635411169088883,1.2846019323784026,0.1724137931034483,0.5471447207873641,1.0,4/10,22.16%,CTSD;NAPSA;BACE1;CTSE
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5873028000214652,1.2822380357939058,0.18518518518518517,0.5504052229887232,1.0,7/14,12.67%,SLC17A8;SLC1A2;SLC25A13;SLC17A7;SLC17A6;SLC1A1;SLC25A22
prerank,GABA receptor activity (GO:0016917),0.5511850722566151,1.2819391277773828,0.16988416988416988,0.5468824426272981,1.0,10/21,29.78%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2;GABBR2;GABRA4;GABRG2;GABRA1
prerank,ion channel activity (GO:0005216),0.4507280682039605,1.2796427913083823,0.11158342189160468,0.550214027507433,1.0,27/80,22.37%,GABRB1;GRIA2;LRRC8A;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;TMEM63B;CNGA3;GRIA4;GRIN2A;GRID1;TRPM2;GRIA1;CHRNA4;TRPC1;KCNK3;CNGB1;UNC80;GRIN2B;ANXA6;CALHM6;PKD2L1;GRIA3;GRIK1;CHRNA3
prerank,GTPase regulator activity (GO:0030695),-0.2664099424854159,-1.2795288922601127,0.0,0.49496526952138237,1.0,54/212,13.71%,ARHGAP29;RANBP3L;ARHGAP28;SIPA1L1;ARHGAP20;ARHGAP10;ASAP3;ALDH1A1;ASAP1;ARHGAP17;LRRK2;ARHGAP42;ARFGEF1;RANBP2;RAPGEF2;SGSM2;SLIT2;NRP1;USP6NL;TBC1D12;ERRFI1;RALGAPB;SMAP1;ARHGEF10L;ASAP2;STARD13;SIPA1L3;TBC1D2B;RABGAP1;ARHGAP32;RIC8B;TBC1D9B;BCR;TBC1D4;ARHGEF6;SYDE2;ALS2;ARHGAP31;KRIT1;TBC1D8B;TBCK;OPHN1;PDE6D;DOCK1;MYO9B;SIPA1;ARHGAP18;SMAP2;RALGAPA1;STXBP5;WNT11;RGS16;RAB3GAP2;RAP1GDS1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.47894248113172383,-1.2792367649054899,0.17735849056603772,0.4880052073693141,1.0,4/12,10.33%,PAN3;CNOT1;PARN;CNOT7
prerank,anion channel activity (GO:0005253),0.47188391779472827,1.2747152055682347,0.12203023758099352,0.5610914697351351,1.0,16/61,18.97%,GABRB1;FXYD1;LRRC8A;SLC1A4;GABRG3;GABRA2;GLRA2;GLRA1;GABRA3;GABRB3;CLIC1;TTYH3;GABRB2;ANO4;GLRA3;VDAC2
prerank,potassium channel activity (GO:0005267),0.44688367493741304,1.2744262915132514,0.09633507853403141,0.5575015139962759,1.0,29/89,21.96%,KCNQ3;KCNQ2;KCNC3;KCND2;GRIK5;GRIK2;AQP1;KCNC1;KCNA2;KCNN2;KCNK9;ABCC8;KCNE5;KCNF1;HCN1;KCNK3;KCNA1;LRRC55;KCNK10;HCN3;KCNH7;KCNMA1;KCNH8;KCNK13;KCNQ5;PKD2L1;TMEM38B;KCNC2;GRIK1
prerank,histone methyltransferase binding (GO:1990226),0.6219679433344688,1.273863996448996,0.17174515235457063,0.554822133929399,1.0,6/11,21.93%,HSP90AB1;CTNNB1;PRDM12;CBX3;PHF1;NOP56
prerank,GTP binding (GO:0005525),0.4329130110134128,1.2736869905001993,0.04757085020242915,0.5509972924344859,1.0,48/172,19.62%,EEF1A1;TUBB;TUBA1A;TUBA1B;TUBB4B;RHOB;NME1;TGM2;TUBAL3;RAN;RHOC;ARF5;RAC1;TUBA4A;RHOG;RAB14;ADSS1;ARL11;TUBB4A;TUBB2B;SCG5;ARF6;RHOV;GNAI1;ARL4C;ARL4D;ARL1;HRAS;RHEBL1;RHOA;RHOU;GTPBP10;RRAS;ARF1;ARL2;RAB26;RRAGC;ARF4;RRAGD;NUDT16;RAC2;TUBB2A;GLUD1;AGAP2;TSR1;ANXA6;RAB31;RAB4A
prerank,chloride channel activity (GO:0005254),0.47266811666379266,1.2736290473239016,0.13507625272331156,0.5469465345318268,1.0,15/59,18.84%,GABRB1;FXYD1;SLC1A4;GABRG3;GABRA2;TTYH1;GLRA2;GLRA1;GABRA3;GABRB3;CLIC1;TTYH3;GABRB2;ANO4;GLRA3
prerank,outward rectifier potassium channel activity (GO:0015271),-0.4703817676921066,-1.2730138923655834,0.15018315018315018,0.4934644419665888,1.0,2/11,2.98%,KCNK2;KCNT2
prerank,endodeoxyribonuclease activity (GO:0004520),0.5496420354482968,1.2723344934972671,0.17418546365914786,0.5469523641110288,1.0,2/20,3.48%,RPS3;ENDOG
prerank,growth factor activity (GO:0008083),0.45164821316693216,1.2695809496004076,0.10554371002132196,0.551375123181074,1.0,21/74,25.44%,MDK;GRN;NRG3;NRG1;AGT;PDGFB;IL2;IL11;IGF2;PDGFA;JAG2;INHBA;IL6;HGF;OSGIN1;THPO;TGFA;PTN;FGF22;INHA;CSPG5
prerank,hexosaminidase activity (GO:0015929),0.5987887460455625,1.268055557087736,0.19099590723055934,0.551822005442474,1.0,3/12,5.82%,HEXB;HEXA;HYAL2
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5049118737768576,-1.2636997885205863,0.18,0.5062370305753976,1.0,4/12,12.18%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,exopeptidase activity (GO:0008238),0.4611940465976174,1.2630308472387974,0.15555555555555556,0.5629672858781535,1.0,13/50,16.29%,CTSZ;RCE1;METAP1;DPEP3;DPP10;CPE;DPEP2;DPP6;METAP2;CTSA;LAP3;CTSH;NUDT16
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4738713851375174,1.262987249576772,0.1415830546265329,0.5589280324366205,1.0,24/49,31.23%,ANXA5;SYT1;SYT12;SYT11;RPH3A;SYT6;SYT4;PLA2G4F;CPNE5;SYT10;CPNE6;SYT2;DOC2B;ANXA6;CPNE4;C2CD5;SYT3;SYT5;SYT17;CPNE3;PCLO;CPNE9;SYT7;MCTP1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3781382069499378,-1.2607307966569083,0.11290322580645161,0.5055997476690156,1.0,8/25,15.22%,PARP4;PARP9;PARP16;PARP3;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.5702236446474928,1.2584259669855435,0.17746113989637305,0.5648132954310252,1.0,4/16,11.17%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.5702236446474928,1.2584259669855435,0.17746113989637305,0.5648132954310252,1.0,4/16,11.17%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.48875978850254775,1.2544592565937724,0.1697459584295612,0.5727064455052604,1.0,12/37,18.79%,LARS2;GARS1;SARS1;SARS2;KARS1;AARS2;WARS1;NARS1;CARS1;TARS3;EPRS1;QARS1
prerank,neuropeptide hormone activity (GO:0005184),0.5286791758455748,1.2539151204009222,0.18238213399503722,0.57051103999263,1.0,8/22,18.27%,PENK;CRH;CALCB;PPY;HCRT;CCK;ADCYAP1;NMB
prerank,ATP hydrolysis activity (GO:0140603),0.4777275403108009,1.2534066397304628,0.15418994413407822,0.5680465200133229,1.0,21/41,32.14%,CLU;HSP90AA1;HSPA1B;ABCB6;VCP;KIF26A;ATP2B1;HSPA1A;ABCB10;CHD3;TDRD9;ABCA3;KIF20B;RUVBL2;DHX9;RHOBTB3;TOR3A;ABCD2;MYO1E;DNA2;DDX3X
prerank,calcium channel inhibitor activity (GO:0019855),0.5991243738336426,1.2508495725322972,0.20810055865921787,0.5717927273574963,1.0,6/11,19.11%,CALM1;SLC30A1;FKBP1A;PHPT1;FKBP1B;CALM2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3946618353757957,-1.2480522974413457,0.14146341463414633,0.526834979783616,1.0,5/21,7.04%,PDE1A;PDE7B;PDE5A;PDE8B;PDE7A
prerank,SUMO binding (GO:0032183),-0.4716369214478713,-1.246462380906107,0.20077220077220076,0.5228171703028998,1.0,5/13,20.35%,PML;TDG;CBX4;RNF111;HERC2
prerank,iron ion binding (GO:0005506),0.4683415533267001,1.2461622074709984,0.1664841182913472,0.5819502442417189,1.0,4/48,3.05%,FTH1;FTL;SCD5;DOHH
prerank,ankyrin binding (GO:0030506),0.5427114059994893,1.2453953704364713,0.20367936925098554,0.5802752358761855,1.0,6/19,15.65%,KCNQ2;PTPRC;PLEC;NRCAM;SLC8A1;SPTBN4
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.3746363639981323,-1.2429065150346725,0.12650602409638553,0.5235252484844755,1.0,5/27,6.28%,ITPR1;ITPR2;CNNM2;SLC9B2;TUSC3
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4771833367008703,-1.2427960816465211,0.1864406779661017,0.5166099531848679,1.0,3/12,4.54%,GAB2;FRS2;IRS1
prerank,chemoattractant activity (GO:0042056),0.5114384213038647,1.2417477755637858,0.18795180722891566,0.5867856262928025,1.0,6/26,9.82%,GPNMB;PDGFB;LGALS3;MIF;CXCL10;HMGB1
prerank,ATPase binding (GO:0051117),0.4489249983165863,1.2382534173760165,0.13978494623655913,0.5935253459450249,1.0,27/71,21.40%,S100A1;UBXN1;GABARAPL2;ATP6V1G1;ATP5IF1;FBL;ATP1B2;PLN;PIH1D1;TAF9;SVIP;WFS1;SYVN1;TMEM106B;TRPC1;BBC3;DNAJB1;ATP1B1;NR1H2;CAV1;BRSK2;ATP1B3;DNAJC10;PPP3CA;SNU13;RALB;SELENOS
prerank,protein kinase regulator activity (GO:0019887),0.4311890136528234,1.2375229392307028,0.13215400624349635,0.5915980211494511,1.0,28/95,19.11%,RPLP1;MT3;CCNI;CCND2;NPM1;CSNK2B;YWHAB;PPP1R1B;CDKN1C;CCND1;CXCL10;PRKAR1A;CDK5R1;PRKAR1B;ELP3;ITPRIP;CCNG1;MAPK8IP1;STK11;HEXIM1;FGF13;GMFB;PRKAR2B;CCNJL;PRKRIP1;AGAP2;QARS1;SNCA
prerank,zinc ion binding (GO:0008270),0.4150230400687299,1.2372122825080625,0.033099297893681046,0.588489285470557,1.0,38/293,9.76%,CRIP1;RPS29;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;RPS27;CRIP2;CALR;MT3;TIMM8B;TIMM13;SOD1;MT2A;TIMP2;S100B;S100A13;CA2;GLO1;CZIB;S100A8;S100A9;GALT;TRIM28;CALB1;ENPP2;GRIN2A;CSRP1;TIMP1;TRIM2;EGR1;ATP13A2;RPH3A;ALAD
prerank,protein kinase activator activity (GO:0030295),0.4527790656766123,1.2370780899159821,0.16146393972012918,0.5848142960183345,1.0,17/60,19.11%,RPLP1;CALM1;MT3;CALM3;NRG1;GRM5;CD24;CDK5R1;GAS6;STK11;IGF2;FGF13;ERCC6;AGAP2;ERBB3;MAP2K2;CALM2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5843628176879039,1.2329276481664047,0.2239010989010989,0.5937126947529194,1.0,4/12,15.07%,RACK1;RPS27L;CTSH;BAD
prerank,phosphate ion binding (GO:0042301),0.6071271545435815,1.231217007316885,0.21944035346097202,0.5951616008213728,1.0,6/10,24.94%,ADSS1;RPH3A;PNP;CHST14;RELA;PDE2A
prerank,potassium channel regulator activity (GO:0015459),0.4604246093925501,1.23044736531294,0.18008948545861297,0.5936159928205429,1.0,12/49,17.40%,KCNIP4;AKT1;DPP10;FLNA;YWHAE;SGK1;DPP6;KCNE4;KCNE5;KCNIP1;ARPP19;LRRC55
prerank,transition metal ion binding (GO:0046914),0.4088814439274312,1.227179908714545,0.022,0.599219943508104,1.0,59/397,13.12%,FTH1;FTL;CRIP1;RPS29;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;RPS27;ATOX1;SCD5;CRIP2;CALR;MT3;TIMM8B;TIMM13;PARK7;SOD1;MT2A;TIMP2;S100B;PRNP;DOHH;S100A13;COX17;CA2;GLO1;CZIB;ANG;S100A8;S100A9;GALT;TRIM28;CALB1;ENPP2;GRIN2A;CSRP1;TIMP1;TRIM2;EGR1;ATP13A2;RPH3A;ALAD;SMPD1;AOC3;SCD;MGAT2;LCN2;GLRA1;ISCU;ZCCHC4;KLF4;THAP11;CUTA;MSRB1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.5952495161988136,1.2238901751472908,0.24929971988795518,0.6051135695069074,1.0,5/11,18.54%,TERF1;RPA2;HNRNPA1;CTC1;TERF2IP
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.26337713443104427,-1.221396154385843,0.0,0.5569852601778627,1.0,38/188,11.45%,ZBTB20;PBX1;SMAD3;BNC2;TCF7L2;SMAD6;PRDM5;TCF12;SOX5;GABPB2;DHX36;HDAC4;PER2;NFYC;YAP1;PER3;FOXO3;NCOR1;TBL1X;SP1;NFKB1;BCOR;FOXK2;ARID4B;STAT3;VSX1;ARID5B;ASH2L;TBL1XR1;PPARG;FOXK1;SMAD4;ATF6;CREB3L2;HNRNPL;BRD7;MZF1;KMT2D
prerank,guanyl ribonucleotide binding (GO:0032561),0.413331103366141,1.221068906891489,0.08366935483870967,0.6096795762685262,1.0,55/196,19.62%,EEF1A1;TUBB;TUBA1A;TUBA1B;TUBB4B;RHOB;NME1;TGM2;TUBAL3;RAN;RHOC;ARF5;RAC1;TUBA4A;RHOG;RAB14;CNGA3;ADSS1;CNGA4;ARL11;TUBB4A;TUBB2B;SCG5;ARF6;RHOV;GNAI1;ARL4C;ARL4D;ARL1;HRAS;RHEBL1;RHOA;SLC19A1;NME2;RHOU;GTPBP10;RRAS;ARF1;ARL2;RAB26;RRAGC;ARF4;CNGB1;RRAGD;NUDT16;RAB5C;RAC2;TUBB2A;GLUD1;AGAP2;TSR1;ANXA6;RAB18;RAB31;RAB4A
prerank,CXCR chemokine receptor binding (GO:0045236),0.5950311941141883,1.2210652059147282,0.22535211267605634,0.6057461596474389,1.0,3/11,14.72%,CXCL12;CXCL10;PF4
prerank,kinesin binding (GO:0019894),0.5054193286412259,1.2175186885579317,0.21204819277108433,0.6126117874529673,1.0,8/27,19.11%,ACTB;NEFH;MAPK8IP1;MAPK8IP2;CLSTN1;FAM83D;ATCAY;SNCA
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5716663903472758,1.2155120197954996,0.2503556187766714,0.6148778179342054,1.0,4/12,27.18%,H3-3A;TBP;RELA;RUVBL2
prerank,receptor ligand activity (GO:0048018),0.4070502549217044,1.2119877595705097,0.074,0.6214762706851551,1.0,64/245,23.41%,MDK;GRN;GPNMB;NBL1;NRG3;NPPC;NRG1;POMC;AGT;TAFA1;TNF;SEMA3F;PDGFB;LGALS3;SEMA7A;AMH;MIF;SEMA4C;LRPAP1;LEFTY2;SEMA6D;CXCL10;TNFSF12;IL2;CRH;TIMP1;HMGB1;KITLG;SEMA4A;WNT5A;IL11;PPY;NTS;SEMA4G;BMP2;CCK;GAS6;WNT10B;LEFTY1;SLURP1;GDF15;IGF2;PDGFA;JAG2;CCL3;NMB;SCGB3A1;EDN3;INHBA;IL6;HGF;TGFB1;OSGIN1;THPO;GDF11;CRLF1;SST;INHBB;TGFA;SCG2;ERFE;WNT7A;PTN;FAM3C
prerank,AMP binding (GO:0016208),-0.4706685407026246,-1.2104236728165176,0.22758620689655173,0.574240861099729,1.0,2/11,0.48%,PRKAG2;MPPED2
prerank,neuropeptide receptor activity (GO:0008188),0.49110765920052657,1.2092437337110145,0.21976744186046512,0.6262402620385883,1.0,8/29,22.01%,NPY1R;SORCS1;SSTR4;TACR1;SORCS3;GRPR;NPY5R;SSTR2
prerank,DNA polymerase binding (GO:0070182),0.5374665343304366,1.2079988063014053,0.2619047619047619,0.6258598746550876,1.0,5/18,14.87%,HSP90AA1;HSP90AB1;HMGB1;PCNA;PTGES3
prerank,nucleoside-triphosphatase activity (GO:0017111),0.40724811926875026,1.207503843448217,0.07407407407407407,0.6234305148552973,1.0,68/248,23.21%,EEF1A1;MYL6;CLU;EEF2;HSP90AA1;GNAI2;RHOB;GNB2;GNG5;RAN;RHOC;GNG11;RAC1;GNA11;PIN1;HSPA1B;ABCB6;EEF1A2;VCP;DNM3;ARHGDIB;RHOG;SAR1A;RAB14;RAB3C;RHOV;KIF5A;GNG3;KIF26A;GNAI1;NKIRAS1;GNAO1;MYL6B;ARL1;HRAS;ATP2B1;RHEBL1;HSPA1A;RHOA;NKIRAS2;RHOU;GTPBP10;RRAS;ARL2;ABCB10;RRAGC;RRAGD;RAB20;RAB5C;DNM1L;RAC2;AGAP2;TSR1;RAB18;RAB31;RAB4A;CHD3;GPN3;RAB6B;RALB;RERG;TDRD9;RAB27B;RAB28;DNM1;MTG2;KIF1A;NUGGC
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.44968217482944184,-1.206355975192225,0.2109375,0.5762791690261919,1.0,5/12,10.49%,TGFBR3;ACVR1;BMPR1A;TGFBR1;LTBP1
prerank,methylated histone binding (GO:0035064),-0.3014264751766015,-1.2048589490261843,0.12,0.5728869055368425,1.0,26/62,23.61%,KDM7A;ZMYND11;TDRD3;CDYL;PYGO1;CHD1;MBTD1;TRIM24;MORC3;ZCWPW2;LRWD1;PHF8;ING2;FMR1;TAF7;KAT8;L3MBTL2;MORC4;ZCWPW1;DPF2;TAF1;CHD5;NCAPD3;RRP8;CBX8;ZMYND8
prerank,ion channel inhibitor activity (GO:0008200),0.4716515055063951,1.2025122617129325,0.21377672209026127,0.6351988421629238,1.0,7/35,12.48%,RACK1;CALM1;SLC30A1;FKBP1A;PHPT1;VAMP8;RSC1A1
prerank,transferrin receptor binding (GO:1990459),0.5837658913838293,1.202457483027674,0.2593103448275862,0.6314619255762997,1.0,1/10,1.05%,CD81
prerank,acylglycerol lipase activity (GO:0047372),0.5886400395123726,1.2015732140554332,0.24964739069111425,0.6304844050985909,1.0,5/11,28.07%,LIPE;FAAH;ABHD16A;ABHD12;MGLL
prerank,anion:anion antiporter activity (GO:0015301),0.523668816678653,1.2013332063559385,0.24088541666666666,0.6274893271877293,1.0,6/17,18.50%,SLC25A5;SLC25A4;SLC26A4;SLC25A11;SLC19A1;SLC4A2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4880649126540563,1.1994220751033977,0.22289156626506024,0.6295530134484162,1.0,10/26,23.31%,B4GALNT1;B4GALNT4;B3GNT9;CHPF2;CHPF;B3GNT3;CSGALNACT2;CHSY3;B3GALT5;B3GALT2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.41573998421965086,-1.195495228824796,0.22169811320754718,0.5881556544849514,1.0,5/16,12.80%,MTMR3;MTMR11;PTEN;SACM1L;MTMR10
prerank,peptidoglycan binding (GO:0042834),0.6000813492637324,1.1947991371468627,0.27586206896551724,0.6404839569006412,1.0,8/10,36.13%,PGLYRP1;NLRP3;RNASE7;TLR2;NOD2;JCHAIN;NOD1;HK1
prerank,G protein-coupled receptor binding (GO:0001664),0.40880329508056157,1.1945263858646535,0.1458966565349544,0.6375078811657708,1.0,25/132,14.29%,HSPA8;GNAI2;CXCL12;CCL19;POMC;HOMER2;GNA11;HSPA1B;FLNA;S1PR1;PENK;INSL5;PDYN;REEP2;GNAI1;GNAO1;CALCB;WNT5A;DNAJA1;PPY;NTS;GPRASP2;HSPA1A;WNT10B;SDCBP
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.5082249238199394,1.1904622979534725,0.2537128712871287,0.6459474735365173,1.0,8/22,23.58%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2;ATP6V1A;ATP2A2;ATP6V0A1;ATP6V0B
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2939915296350124,-1.1904431881780495,0.09230769230769231,0.5942608163830508,1.0,17/71,11.93%,EYA2;PTPN13;EYA1;PTPN21;PTPN9;PTPN14;TNS2;MTMR3;PTPN3;PALD1;CDC14A;EYA4;PTPN12;CDC25B;PTEN;EYA3;PTPN2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4884342267659987,1.1896423464617853,0.2324455205811138,0.6447608754096065,1.0,9/27,21.89%,POLR2E;POLR2D;POLR2F;POLR1B;POLR2G;MED21;POLR1D;POLR1H;POLR3K
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5731412248783203,1.1783121864007824,0.27873563218390807,0.6759525590825569,1.0,4/10,22.24%,LAPTM5;DNAJB2;ANKRD13D;FAAP20
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5073186693574279,1.17513216389795,0.2766497461928934,0.6821382090405064,1.0,4/20,7.01%,SLC30A1;SLC39A1;SLC39A10;SLC39A7
prerank,voltage-gated cation channel activity (GO:0022843),0.4047621624537088,1.1734202868217884,0.19937694704049844,0.6834669420072372,1.0,32/97,25.27%,KCNQ3;KCNQ2;KCNC3;KCND2;GRIN1;CACNA1A;GRIN3A;GRIN2A;HVCN1;KCNC1;KCNA2;KCNE5;KCNF1;HCN1;KCNA1;CACNG8;LRRC55;HCN3;GRIN2B;NCS1;KCNH7;KCNMA1;KCNH8;CACNG5;KCNQ5;CACNB4;KCNC2;CACNA1E;CACNG2;KCNG3;CACNA2D1;CACNA1B
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.46109485928759175,-1.172243483490953,0.2527881040892193,0.6334946587662224,1.0,6/11,20.60%,PRMT9;FBXO11;CARM1;PRMT6;NDUFAF7;PRMT8
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5500041658195151,1.172013203390865,0.2908093278463649,0.6840454413620837,1.0,3/13,9.10%,SLC38A5;SLC25A29;SLC15A4
prerank,voltage-gated potassium channel activity (GO:0005249),0.4158012556615867,1.169341602970727,0.21240799158780233,0.6887278601629098,1.0,23/80,24.68%,KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;KCNC1;KCNE4;KCNA2;KCNN2;KCNE5;KCNF1;HCN1;KCNA1;LRRC55;HCN3;KCNH7;KCNMA1;KCNH8;KCNQ5;KCNC2;KCNJ3;KCNG3;KCNJ6
prerank,galactosyltransferase activity (GO:0008378),-0.4507447690746762,-1.1687862759614485,0.24647887323943662,0.634603888388947,1.0,2/11,1.61%,A4GALT;B4GALT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5737986881172049,1.1678155369388623,0.29101283880171186,0.6898005098578348,1.0,5/10,27.73%,APOBEC2;APOBEC1;CDA;GDA;ADA
prerank,NAD+ binding (GO:0070403),-0.44509567108784087,-1.1677665190952402,0.2746478873239437,0.629779542207974,1.0,5/12,20.89%,CRYL1;PARP9;SIRT1;ZC3HAV1;SIRT6
prerank,lysine N-methyltransferase activity (GO:0016278),-0.3754142636109613,-1.1675102889941165,0.2132701421800948,0.6228838705990444,1.0,9/20,20.46%,SETD2;EHMT1;SETD7;EHMT2;SETD4;SETD3;VCPKMT;METTL21A;SETD6
prerank,semaphorin receptor activity (GO:0017154),-0.46776719914379,-1.1668522744097778,0.2508361204013378,0.6173397001352161,1.0,4/11,15.29%,PLXNA2;NRP1;NRP2;PLXNA4
prerank,phospholipase activity (GO:0004620),0.42478939956109946,1.165264480750332,0.23593073593073594,0.6937938344753172,1.0,14/67,14.12%,PRDX6;LYPLA2;PLD3;PLAAT3;LIPG;PDIA3;ENPP2;PNPLA7;LPL;SMPD1;PLA2G4F;GDE1;SMPDL3A;PLBD2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5586694586236804,1.1623056456604115,0.296875,0.6951368450796838,1.0,4/11,14.27%,BAG5;PFN1;BAG1;HSPBP1
prerank,adenyl nucleotide binding (GO:0030554),0.5586694586236804,1.1623056456604115,0.296875,0.6951368450796838,1.0,4/11,14.27%,BAG5;PFN1;BAG1;HSPBP1
prerank,cAMP response element binding (GO:0035497),-0.46495549231252764,-1.1617432390596563,0.2627986348122867,0.6220134989204729,1.0,4/10,11.14%,ATF7;CREB5;ATF2;CREB3L2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.46658832075172313,1.1601899343464968,0.27858880778588807,0.6978374001902911,1.0,8/28,16.29%,ELAC2;RNASEH2A;POP7;RNASEH1;APEX1;MRPL44;POP4;NUDT16
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.2830652381719594,-1.156102448792578,0.14084507042253522,0.6288262152580663,1.0,15/60,9.11%,EGFR;EPHA7;ROR1;EPHA3;CRIM1;NRP1;NTRK3;EPHA4;EFEMP1;IGF2R;INSR;MET;FGFR2;NRP2;PDGFRB
prerank,kinase binding (GO:0019900),0.3848486508678401,1.1546758850320697,0.09,0.7116174783273465,1.0,78/435,13.60%,ACTB;EEF1A1;RPS3;RPS7;RPS19;EEF2;CALM1;GSN;HSPB1;HSP90AB1;ACTA2;PGAM1;PARK7;RHOB;ATF4;RPS6;CALM3;ITGB2;CCND2;NPM1;PEBP1;CAMK2N2;PFKL;RHOC;EMP2;TOLLIP;PTPRC;HCLS1;RAC1;TUBA4A;ACVRL1;DLG2;CHEK2;CAV2;PARP1;DUSP3;CTNNB1;NEFH;FLNA;EEF1A2;SNAP91;BAG5;ADD2;SHC3;BTG1;FRMD5;TFRC;RHOG;MSN;CCND1;INKA2;HNRNPA0;CEBPA;CLTC;THY1;MAPT;CD24;UNC5C;CDK5R1;CADPS;ZFP36;ARHGEF7;PIH1D1;PIK3IP1;CDC37;ATF5;WARS1;FBXW5;ATP1A4;DOK7;CAMK2N1;SYN1;PTPRR;DCTN1;RHOA;SRCIN1;FBXO5;YWHAZ
prerank,potassium:proton antiporter activity (GO:0015386),-0.48036158425639963,-1.1544118534616634,0.2919254658385093,0.625605213208492,1.0,3/10,12.18%,SLC9A1;SLC9A2;SLC9A8
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.44271048862288825,-1.1529847797476638,0.29180327868852457,0.6219833429740965,1.0,9/11,43.54%,SLC2A9;SLC5A11;SLC23A1;SLC23A2;SLC2A10;SLC5A10;SLC5A1;SLC5A2;SLC5A9
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5050354121317873,1.1529326765842376,0.29878869448183043,0.7132871264119793,1.0,10/16,30.05%,SLC1A4;SLC25A13;SLC25A11;SLC1A1;SLC25A22;SLC25A18;SLC25A14;SLC25A12;SLC13A5;SLC25A30
prerank,neurexin family protein binding (GO:0042043),0.567080135473025,1.152696124264788,0.31462333825701627,0.7102123294051862,1.0,4/10,18.59%,NLGN1;CPE;SYTL2;SYTL1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3859202789666438,-1.1482184693207746,0.2995391705069124,0.6274461232318881,1.0,8/18,16.73%,TGFBR3;ACVR1;BMPR1A;TGFBR1;LTBP1;ACVR2A;BMPR2;ACVR2B
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5575337186604737,1.14805090464636,0.3223593964334705,0.721299924143295,1.0,4/11,27.92%,CHRNA9;CHRNA4;CHRNA3;CHRNA7
prerank,protein kinase C binding (GO:0005080),0.4344685319012478,1.1406612175242175,0.29318181818181815,0.7410812236805264,1.0,14/43,16.87%,RACK1;HSPB1;HINT1;TIRAP;CAVIN3;NELL1;PKN1;YWHAG;ADCY4;HDAC5;CCDC88A;DACT3;HDAC9;SQSTM1
prerank,ubiquitin-specific protease binding (GO:1990381),0.4898251761737027,1.1399148758486244,0.3040103492884864,0.7395440298403905,1.0,7/19,21.86%,PARK7;VCP;CLTC;SYVN1;RAD23A;SELENOS;AMFR
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.5180875513753574,1.1378871375146635,0.33198924731182794,0.7418970248227125,1.0,4/14,15.91%,CYBA;CYBB;MICAL1;NCF1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5315069794632526,1.1371261895336628,0.3151432469304229,0.7405150509921963,1.0,5/13,16.89%,PRKAR1A;PRKAR1B;SOX9;RYR2;PRKAR2B
prerank,ubiquitin binding (GO:0043130),0.41186162000111615,1.1367618376271142,0.2965738758029979,0.7377054096910357,1.0,25/73,22.19%,HSPB1;UBXN1;TOLLIP;AUP1;UCHL1;TNFAIP3;USP5;UBAP1L;RBCK1;BUB3;VPS28;DNAJB2;FBXW7;CXCR4;RNFT1;OTUB1;SQSTM1;TRIM32;WDR48;RAD23A;RAE1;USP13;SIRT2;UBXN11;VPS36
prerank,acetylcholine receptor activity (GO:0015464),0.484500604651455,1.135287268120286,0.32054455445544555,0.738534235312351,1.0,7/22,27.92%,CHRM3;CHRM2;CHRNA4;CHRM5;CHRNA3;CHRFAM7A;CHRNA7
prerank,G protein-coupled amine receptor activity (GO:0008227),0.475426764217351,1.131072910620234,0.3316582914572864,0.7401888718569982,1.0,5/22,17.09%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.475426764217351,1.131072910620234,0.3316582914572864,0.7401888718569982,1.0,5/22,17.09%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,serotonin receptor activity (GO:0099589),0.475426764217351,1.131072910620234,0.3316582914572864,0.7401888718569982,1.0,5/22,17.09%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4518153533039835,-1.1310251403624594,0.31970260223048325,0.6645402939983979,1.0,3/11,3.53%,SLC1A3;SLC6A13;SLC6A12
prerank,methylation-dependent protein binding (GO:0140034),-0.2764043940863735,-1.1308765226867228,0.1375,0.6576283462955109,1.0,22/57,23.61%,KDM7A;ZMYND11;TDRD3;CDYL;PYGO1;CHD1;MBTD1;TRIM24;MORC3;ZCWPW2;LRWD1;PHF8;ING2;FMR1;KAT8;L3MBTL2;MORC4;ZCWPW1;NCAPD3;RRP8;CBX8;ZMYND8
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4623098412221145,1.1298611124585392,0.3159806295399516,0.7400900919773772,1.0,9/27,21.89%,POLR2E;POLR2D;POLR2F;POLR1B;POLR2G;MED21;POLR1D;POLR1H;POLR3K
prerank,GTPase activity (GO:0003924),0.3837771641062253,1.1295954303205613,0.19637462235649547,0.7370843203317375,1.0,52/192,23.21%,EEF1A1;EEF2;GNAI2;RHOB;GNB2;GNG5;RAN;RHOC;GNG11;RAC1;GNA11;EEF1A2;DNM3;ARHGDIB;RHOG;SAR1A;RAB14;RAB3C;RHOV;GNG3;GNAI1;NKIRAS1;GNAO1;ARL1;HRAS;RHEBL1;RHOA;NKIRAS2;RHOU;GTPBP10;RRAS;ARL2;RRAGC;RRAGD;RAB20;RAB5C;DNM1L;RAC2;AGAP2;TSR1;RAB18;RAB31;RAB4A;GPN3;RAB6B;RALB;RERG;RAB27B;RAB28;DNM1;MTG2;NUGGC
prerank,protein kinase binding (GO:0019901),0.37497068950355783,1.1290952486415475,0.11311311311311312,0.7348775834690575,1.0,150/480,25.69%,ACTB;EEF1A1;RPS3;RPS7;RPS19;EEF2;RACK1;CALM1;HSP90AA1;HSPB1;ACTA2;PGAM1;RHOB;ATF4;RPS6;CALM3;ITGB2;CCND2;TREM2;HINT1;GRM5;NPM1;PINK1;PEBP1;CAMK2N2;RHOC;EMP2;PTPRC;HCLS1;RAC1;TUBA4A;ACVRL1;CHEK2;PIN1;CAV2;PARP1;DUSP3;TIRAP;SIRPA;NEFH;EEF1A2;PDE3B;CAVIN3;SNAP91;BAG5;ADD2;SHC3;FRMD5;TFRC;RHOG;MSN;CCND1;NELL1;INKA2;HNRNPA0;PKN1;CLTC;THY1;YWHAG;PRKAR1A;MAPT;CD24;UNC5C;CDK5R1;CADPS;ZFP36;ARHGEF7;PIH1D1;PRKAR1B;WARS1;FBXW5;DOK7;CAMK2N1;SYN1;PTPRR;DCTN1;SOX9;RHOA;SRCIN1;FBXO5;YWHAZ;ADCY4;HDAC5;CCDC88A;BAD;DCTN2;MAPK8IP2;MAPRE3;RYR2;DACT3;DAB2IP;HDAC9;CAV1;CDH5;CASS4;SQSTM1;PRKAR2B;SKAP1;RAC2;MAP4K2;PRKRIP1;FAM83D;PPP1R15A;AGAP2;CDC25A;ACSL3;CIR1;QARS1;WDR45;CALM2;ANKRA2;DCX;CNKSR2;ARHGAP33;PTPN6;BANK1;DUSP2;MAP2K7;IRF5;AP2A1;STX1B;TNIP1;RCC2;ADIPOR1;DUSP1;DNM1;TRIM68;PARD6A;LLGL1;TWF2;PTPN1;TBL2;PTN;ELAVL1;LYST;RELA;FOXM1;CAVIN2;TCF3;CCNA2;CDKN2B;PPP1CB;VRK1;DNAJC3;PRKACA;INKA1;MAPRE1;CRK;DUSP8;BLNK
prerank,GTPase binding (GO:0051020),-0.23902851992654697,-1.1290121580263683,0.0,0.6554302282989894,1.0,35/195,8.22%,AKAP13;STRN3;AFDN;PLCE1;RAPGEF4;GOLGA4;LRRK2;RANBP2;EXOC4;RNF152;SPTBN1;SGSM2;BRAF;MAPKAP1;USP6NL;EPS8;FGD4;RAF1;ANKRD27;EXOC2;NOX1;DOCK7;UNC13B;NCKAP1;RAPGEF6;CDC42EP5;RADIL;RRAGB;RABGAP1;ANKFY1;AMBRA1;NUTF2;GGA2;TRIOBP;RNF41
prerank,kinase inhibitor activity (GO:0019210),0.44572405116313757,1.1273722360811174,0.31479289940828403,0.7361482825760742,1.0,16/33,27.11%,NPM1;YWHAB;PPP1R1B;CDKN1C;WARS1;ITPRIP;MAPK8IP1;HEXIM1;GMFB;PRKRIP1;QARS1;SNCA;SOCS3;DNAJC3;TRIB1;CDKN1A
prerank,nuclear receptor coactivator activity (GO:0030374),-0.28876125923052853,-1.1273238066876483,0.22448979591836735,0.6529383399711528,1.0,20/52,22.90%,ZMIZ1;MED13;NCOA1;CCAR1;THRAP3;DCAF6;BRD8;PPARGC1B;CARM1;PRKCB;TACC1;NCOA7;HELZ2;FGF2;MED1;SS18;NCOA6;WDR77;NCOA3;SLC30A9
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2798304026434931,-1.1256839490927613,0.21311475409836064,0.6497540663672599,1.0,20/72,14.71%,PARD3;SVIL;FCHO2;SLC9A1;ACTN2;FRMPD4;MAPKAP1;MYO1B;PLEKHA4;ADAP2;MARK1;SESTD1;HIP1;PICALM;KRIT1;TULP3;KCNJ2;PLCD1;STXBP6;CGAS
prerank,snoRNA binding (GO:0030515),0.4539267329036779,1.1227374005045003,0.3237410071942446,0.7464823849714013,1.0,14/30,23.90%,NOP10;NHP2;WDR3;IMP4;NUDT4;GAR1;NUDT16;TSR1;DKC1;SNU13;IMP3;NOP56;ISG20;NOP14
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.41749354230975433,1.1219642755378891,0.3132664437012263,0.7452383160983272,1.0,12/53,12.67%,SLC38A5;SLC17A8;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC15A4;SLC3A2;SLC17A7;SLC17A6;SLC1A1;SLC25A22
prerank,G protein-coupled receptor activity (GO:0004930),0.3807829324689476,1.1217903923877204,0.20140280561122245,0.7420211332377917,1.0,47/239,21.11%,MTNR1A;MTNR1B;GRM5;GPR37L1;ADGRB3;C5AR1;SCTR;ADGRL3;S1PR5;APLNR;S1PR1;DRD5;GPR6;SSTR4;GRM8;ADGRG1;P2RY6;RXFP1;GPR34;TPRA1;VIPR1;LGR6;P2RY1;P2RY12;GRM1;ADGRB1;MC1R;GPR18;ADGRB2;GRPR;CXCR4;CX3CR1;F2RL1;ADGRL4;ADRA1D;ADRA1A;ADGRE1;HCRTR1;ADGRA1;GRM4;GPR83;GPR183;GPR149;NTSR2;GABBR2;ADRA2B;QRFPR
prerank,cysteine-type endopeptidase activity (GO:0004197),0.39692765393585994,1.1207194054123262,0.293558606124604,0.7416948327175484,1.0,9/78,7.53%,CTSB;CTSL;CTSZ;CAPNS1;CTSS;LGMN;UCHL1;USP5;PDIA3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.4529009899369394,1.11960209632298,0.3434466019417476,0.741442568461676,1.0,12/32,26.37%,SLC38A5;SLC7A5;SLC1A4;SLC6A6;SLC3A2;SLC1A1;MFSD12;SLC7A10;SFXN1;SLC43A2;SLC38A3;SLC6A9
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5301897732552401,1.1172569800677352,0.34573002754820936,0.7447943738828905,1.0,4/11,27.61%,KCNE4;KCNE5;KCNJ3;KCNQ1
prerank,titin binding (GO:0031432),0.5255114592142052,1.1134401249456083,0.3713892709766162,0.7527489188655292,1.0,2/13,2.58%,CALM1;CALM3
prerank,mRNA 3'-UTR binding (GO:0003730),0.3950334082157902,1.1126742101009943,0.2914466737064414,0.7514573402455805,1.0,17/79,15.65%,RPL41;RPS7;RPL5;ZFP36L1;MEX3D;ZFP36L2;PCBP4;HNRNPA0;ZFP36;TARDBP;ELAVL4;PABPC1;RNF40;HNRNPU;ELAVL3;CIRBP;YBX3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.45110062684929225,1.111747115071029,0.3265060240963855,0.7506071379052239,1.0,8/30,15.43%,SLC30A1;SLC39A1;SLC39A10;SLC39A7;TTYH1;SLC40A1;SLC11A1;SLC31A1
prerank,potassium ion antiporter activity (GO:0022821),-0.4090549627056169,-1.110175710080297,0.3187250996015936,0.6809457892266979,1.0,3/15,2.68%,SLC24A3;SLC9A1;SLC9A2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.44947829475420764,-1.10675904310383,0.33797909407665505,0.6820890524708229,1.0,5/10,15.70%,DSE;RPE;GLCE;GNE;RENBP
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2599700795801495,-1.1063373413646247,0.23404255319148937,0.6767449648413386,1.0,26/83,18.73%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;USP28;ZRANB1;USP46;STAMBPL1;UCHL5;USP45;USP37;USP53;USP33;USP9X
prerank,sodium channel activity (GO:0005272),0.43149699133097197,1.1061561863088925,0.3371824480369515,0.7643401911611007,1.0,12/37,26.73%,ASIC2;SCN1A;GRIK5;GRIK2;SCN4B;HCN1;HCN3;PKD2L1;SCN9A;GRIK1;SCN8A;SCN2A
prerank,FAD binding (GO:0071949),-0.3554938950768424,-1.1053341099552765,0.3238095238095238,0.6723767508609186,1.0,6/24,10.16%,MICAL3;MICAL2;DDO;MTHFR;SQOR;PRODH
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5235038627190205,1.1039683194336771,0.36527777777777776,0.7677238084582313,1.0,3/12,13.31%,SLC25A5;LRRC8A;SLC19A1
prerank,calcium-activated potassium channel activity (GO:0015269),0.53042936456778,1.1036880460976066,0.3821022727272727,0.7648515701819375,1.0,5/11,26.89%,KCNN2;KCNMA1;PKD2L1;KCNN4;KCNMB4
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.45452236157354375,1.103263845650301,0.3454773869346734,0.7625715840727285,1.0,8/24,18.57%,NME1;AK4;AK3;NME4;NME2;CMPK2;NME3;IP6K1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.342447518794401,-1.100749481338601,0.2625,0.6776653998830662,1.0,5/25,13.70%,MICAL3;MICAL2;FMO5;CYP27A1;POR
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.4501737398432919,-1.0992212377304091,0.3345070422535211,0.6749258956729288,1.0,2/10,3.53%,SLC6A13;SLC6A12
prerank,neuropeptide binding (GO:0042923),0.47349106895058124,1.09795603855148,0.351213282247765,0.7756845508335428,1.0,7/18,31.30%,SORL1;SSTR4;GPR149;SSTR2;NMUR2;OPRL1;GPR37
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.4360691119394902,1.0953774569954102,0.3423312883435583,0.780054077476431,1.0,8/29,13.31%,SLC1A4;SLC25A13;SLC26A4;SLC25A11;SLC1A1;SLC25A21;SLC25A22;SLC19A1
prerank,cysteine-type peptidase activity (GO:0008234),0.3919039481674754,1.0953146595775674,0.3404029692470838,0.7765774988318394,1.0,19/73,21.25%,CTSB;CTSL;CTSZ;CTSS;LGMN;UCHL1;USP5;PDIA3;OTULIN;TINAGL1;USP29;CTSH;USP26;USP8;CTSC;SFRP1;CAPN3;ATG4D;USP13
prerank,cytokine activity (GO:0005125),0.3778530178104399,1.0940959958034402,0.3070624360286592,0.7766953324869323,1.0,34/131,23.41%,CXCL12;CCL19;NRG1;TNF;MIF;LEFTY2;CXCL16;CXCL10;IL2;TIMP1;HMGB1;KITLG;WNT5A;IL11;BMP2;WNT10B;LEFTY1;CCL2;PF4;SLURP1;GDF15;CCL3;CCL28;CCL8;SCGB3A1;INHBA;IL6;TGFB1;GDF11;CRLF1;INHBB;SCG2;WNT7A;FAM3C
prerank,cation transmembrane transporter activity (GO:0008324),0.41662755702427196,1.0925888768843888,0.3665158371040724,0.7775242713375612,1.0,8/48,12.43%,SLC38A5;SLC39A1;SLC7A5;SLC1A4;SLC6A6;SLC15A4;SLC3A2;SLC1A1
prerank,double-stranded RNA binding (GO:0003725),0.3936027383017839,1.0924747178496905,0.3357972544878564,0.7742673887480059,1.0,17/70,19.35%,VIM;TUBA1B;HSP90AB1;TUBB4B;TFRC;MSN;HSPD1;CLTC;SLC3A2;EIF4A1;ACTN1;HNRNPU;MRPL44;AGO1;PRKRIP1;OAS3;EIF4H
prerank,calcium-release channel activity (GO:0015278),-0.3824594720450059,-1.0909632130867237,0.3472803347280335,0.6890712988891283,1.0,2/17,1.63%,ITPR1;ITPR2
prerank,Hsp90 protein binding (GO:0051879),0.4295448226763962,1.090813952580054,0.37856328392246297,0.7756426741785689,1.0,8/33,23.34%,RPS3;KDR;MAPT;UNC45B;PTGES3;AHSA1;STUB1;CYP2E1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.42092797636030427,-1.0900635016093934,0.3321678321678322,0.6845567671519194,1.0,4/13,12.18%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,lysophospholipase activity (GO:0004622),0.4680337804570376,1.0885018414715462,0.3888888888888889,0.779058512673395,1.0,10/20,28.07%,LYPLA2;ENPP2;PNPLA7;GDE1;GDPD1;ABHD16A;GDPD3;ABHD12;PLA2G6;MGLL
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3902894554451271,1.0872957763586353,0.36421725239616615,0.7791008597086146,1.0,25/75,25.34%,MDH1;LDHA;HSD17B6;RDH5;PHGDH;HSD17B13;GRHPR;SPR;HSD17B4;PRXL2B;DCXR;AKR1B10;HSD3B2;UGDH;PGD;CBR3;IMPDH1;AKR1A1;CBR1;HSD17B11;NSDHL;KCNAB1;IMPDH2;EHHADH;LDHB
prerank,phosphatidate phosphatase activity (GO:0008195),-0.4062919119085332,-1.0846488371915743,0.34051724137931033,0.6916308546824441,1.0,8/13,26.39%,PLPP3;PLPP5;PLPP1;PLPP2;PLPPR1;PLPPR3;LPIN2;LPIN3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.3793762263989492,-1.083900191412932,0.3281853281853282,0.6869853920581681,1.0,9/15,18.12%,KMT2C;KMT2A;ASH2L;KMT2D;WDR82;SETD4;PRDM9;SETD1B;SETD3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4006754012642879,1.0836870182987888,0.35223555070883317,0.7867607434097991,1.0,18/54,21.46%,HDAC11;HINT1;TGM2;AMDHD2;HDAC5;GLS2;GLS;ACY1;NAAA;PDF;MIER2;NIT1;HDAC9;FAAH;ASAH2;ACY3;SIRT2;SUDS3
prerank,single-stranded DNA helicase activity (GO:0017116),0.47263548947915723,1.0821758478970727,0.3877805486284289,0.7877157869168107,1.0,11/19,35.03%,MCM5;RFC2;RFC4;PIF1;RAD51;MCM7;MCM2;DHX9;DNA2;CHTF18;RFC3
prerank,hexose transmembrane transporter activity (GO:0015149),0.5142857583099248,1.0820788983696856,0.3914285714285714,0.7844555427922628,1.0,8/12,36.99%,SLC2A1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.41390574862850205,-1.0804231656236394,0.33962264150943394,0.6894368623867166,1.0,4/12,16.50%,LARP1;EIF4E3;CYFIP2;AGO2
prerank,peptide hormone receptor binding (GO:0051428),0.5130124912598992,1.0799315562317957,0.4019746121297602,0.787453448554964,1.0,4/11,27.72%,CCK;ADCYAP1;PTHLH;PSMC5
prerank,death domain binding (GO:0070513),0.5268961969992952,1.0717550794477966,0.39643347050754457,0.8085997141899689,1.0,2/11,11.32%,RACK1;BAX
prerank,phospholipase A2 activity (GO:0004623),0.4390186890072778,1.0703082095224374,0.3829268292682927,0.8096089843988284,1.0,4/26,10.56%,PRDX6;PLAAT3;PLA2G7;PLA2G4F
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3303223806750018,-1.069687739878203,0.34594594594594597,0.7100758258346781,1.0,5/23,7.04%,PDE1A;PDE7B;PDE5A;PDE8B;PDE7A
prerank,potassium ion leak channel activity (GO:0022841),-0.3831366304822794,-1.069664451193618,0.354978354978355,0.7035790483224094,1.0,2/15,2.21%,KCNK2;KCNK5
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4271465117588614,-1.0683051448118819,0.35036496350364965,0.7003855401754798,1.0,5/11,18.51%,SASH1;PPEF2;STK38;ROR2;TRAF6
prerank,carbohydrate kinase activity (GO:0019200),-0.4270974701577182,-1.0677211298332285,0.41825095057034223,0.695335583424484,1.0,5/11,19.30%,GALK2;HK2;FGGY;GNE;NAGK
prerank,metalloaminopeptidase activity (GO:0070006),-0.3735482005405485,-1.067472942188695,0.3413654618473896,0.6897087797709394,1.0,3/16,5.90%,NPEPPS;XPNPEP3;ANPEP
prerank,actinin binding (GO:0042805),-0.3548269283741023,-1.0674691806287866,0.3263598326359833,0.6835506656658418,1.0,7/21,14.17%,CACNA1C;PDLIM5;NFKB1;PDLIM4;PPARG;SYNPO2;CACNA1D
prerank,lipase activator activity (GO:0060229),-0.4418597847088326,-1.0664874410179408,0.3620689655172414,0.6796335999429219,1.0,2/10,4.69%,ARHGAP6;PDPK1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5213030176950528,1.061649683568604,0.4109985528219971,0.8322607141872377,1.0,4/10,22.24%,LAPTM5;DNAJB2;ANKRD13D;FAAP20
prerank,regulatory RNA binding (GO:0061980),-0.2914086213014448,-1.0604057866626313,0.34146341463414637,0.6897954548031154,1.0,13/38,21.34%,ZNF346;DICER1;ZC3H7A;TUT7;RBM4;ZC3H7B;PUM2;TARBP2;TUT4;AGO2;FMR1;AGO4;SOX2
prerank,ribonuclease activity (GO:0004540),0.3918581107907036,1.0599129801078202,0.3914940021810251,0.8338239979224454,1.0,15/56,21.53%,ENDOG;RNASE1;ELAC2;ANG;RNASE4;RNASEH2A;RNASEK;EXOSC2;RNASEH1;SND1;AGO1;EXOSC9;RNASE7;TSNAX;EXOSC4
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4117614323011679,-1.0591600084218613,0.3892857142857143,0.6869323723527657,1.0,5/11,14.79%,ITPR1;ITPR2;TRPC4;TRPC6;TRPC3
prerank,magnesium ion binding (GO:0000287),-0.22893152606840414,-1.0560928637001572,0.2857142857142857,0.689187489985813,1.0,23/135,12.21%,EYA2;ABL1;STK3;LRRK2;SIK3;CLYBL;DHX36;SIK2;MARK1;NUDT5;IRAK3;FOXK2;SNRK;MAST2;CDC42BPB;SIK1;NEK6;TDG;ABL2;SRR;EPHX2;STK38;NLK
prerank,death receptor binding (GO:0005123),-0.38214879863254597,-1.0547065728406457,0.3548387096774194,0.6867385391787644,1.0,4/15,15.41%,EDA;RIPK1;NGF;BDNF
prerank,BMP binding (GO:0036122),0.5049842114672147,1.0545291444927354,0.42358078602620086,0.8461817935282617,1.0,1/11,2.02%,NBL1
prerank,chloride channel inhibitor activity (GO:0019869),-0.4180266175394398,-1.0542032462913664,0.3501683501683502,0.6822465489643633,1.0,3/10,12.72%,STX8;WNK4;STX1A
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.47789858441127264,1.0507481603871562,0.4158815612382234,0.8539347343510887,1.0,1/14,1.52%,CAPNS1
prerank,NADPH binding (GO:0070402),0.4916081031048532,1.050312526480556,0.43306010928961747,0.8514583738269258,1.0,7/13,32.91%,GRHPR;QDPR;CBR3;KCNAB1;CRYZ;DHFR;MTRR
prerank,telomerase RNA binding (GO:0070034),-0.3406578922839401,-1.050277973724267,0.3804878048780488,0.6860840160294046,1.0,8/22,11.11%,SMG6;DHX36;TEP1;TENT4B;XRN1;PARN;SMG7;TERT
prerank,omega peptidase activity (GO:0008242),-0.2452327407430902,-1.0494009085721991,0.3488372093023256,0.6822760562513464,1.0,26/89,18.73%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;USP28;ZRANB1;USP46;STAMBPL1;UCHL5;USP45;USP37;USP53;USP33;USP9X
prerank,ephrin receptor activity (GO:0005003),-0.3734666166434979,-1.0478706826809652,0.35344827586206895,0.6745159830642626,1.0,4/17,10.73%,EPHA7;EPHA3;EPHA4;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.3734666166434979,-1.0478706826809652,0.35344827586206895,0.6745159830642626,1.0,4/17,10.73%,EPHA7;EPHA3;EPHA4;EPHB2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.33337062521777516,-1.0476159177882216,0.39106145251396646,0.6697580714767667,1.0,3/24,5.95%,OSBPL8;PLA2G4A;SESTD1
prerank,ADP binding (GO:0043531),0.43580067070259815,1.0474399769485425,0.4280442804428044,0.8565026411917388,1.0,5/25,7.20%,ATP5F1D;ATP5F1A;ABCG1;PGK1;MYO3A
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3485536680075681,1.045884718092559,0.36,0.8575832295184785,1.0,98/431,19.28%,EEF1A1;HSPA8;TUBB;TUBA1A;TUBA1B;HSP90AA1;HSP90AB1;ATP5F1D;TUBB4B;NDUFA13;RHOB;HSPA5;AKT1;ATP5F1A;NME1;TGM2;PINK1;TUBAL3;RAN;PFKL;RHOC;ARF5;RAC1;TUBA4A;ACVRL1;HSPA1B;ABCB6;ABCG1;UHMK1;TAP2;PGK1;RHOG;ATP1A3;RAB14;EPB42;P2RX7;ADSS1;MAST1;ARL11;TUBB4A;TUBB2B;SYN2;SCG5;P2RY1;ARF6;RHOV;SARS2;AARS2;MYO1F;BCKDK;GNAI1;ARL4C;P2RX6;ARL4D;ATP1A1;ARL1;HRAS;SYN1;RHEBL1;HSPA1A;RHOA;CARS1;HNRNPU;CDC42BPA;RHOU;STK11;GTPBP10;RRAS;ARF1;ARL2;TSSK6;TSSK4;PRPS1L1;PRPS1;RAB26;RRAGC;ARF4;PEX6;ABCA2;EIF4A3;RRAGD;NUDT16;BRSK2;HSPA4L;RAC2;TUBB2A;MAP4K2;ERCC6;GLUD1;GUK1;OAS3;AGAP2;TSR1;ANXA6;VPS4A;MKNK1;PSMA6;RAB31
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5034352987919612,1.0443934391123602,0.42857142857142855,0.858167072631375,1.0,3/10,15.91%,CYBA;CYBB;NCF1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4130779168763802,1.04357209432995,0.4371327849588719,0.856937411214325,1.0,9/35,20.52%,H3-3A;PARK7;NPM1;DRAP1;PIH1D1;UBTF;AGO1;TBP;MYC
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.37940712484934086,-1.0430434422057422,0.379746835443038,0.6754844367767943,1.0,4/14,12.80%,MTMR3;MTMR11;PTEN;MTMR10
prerank,myosin II binding (GO:0045159),0.5185607162626249,1.0428097689499132,0.4328147100424328,0.8554282223416618,1.0,2/10,9.95%,GSN;STXBP5L
prerank,pre-mRNA binding (GO:0036002),-0.3032578071241915,-1.0403490400607875,0.38323353293413176,0.6761726928639566,1.0,9/28,17.70%,CELF2;RBM41;ZRSR2;TRA2B;RBM4;HNRNPL;TARBP2;SLU7;CELF1
prerank,Hsp70 protein binding (GO:0030544),0.41284906027102436,1.0398749718130371,0.4467065868263473,0.8605020926468596,1.0,11/31,26.06%,RPS3;DNAJA1;DNAJB2;SACS;DNAJB1;DNAJC10;SNCA;STUB1;CYP2E1;DNAJC8;IQCG
prerank,transcription coregulator binding (GO:0001221),-0.27996698390245167,-1.0391727980446186,0.37623762376237624,0.6735072248427327,1.0,18/50,14.96%,SMAD3;VGLL4;ZBTB16;PER2;THRB;USP11;PER3;EHMT1;LCOR;NEK6;TEAD2;ESR1;SMAD4;TERT;AR;RORA;EHMT2;EZH2
prerank,endonuclease activity (GO:0004519),0.3909916702761515,1.0382763511632431,0.44017563117453345,0.8616814562447892,1.0,6/49,14.03%,RPS3;ENDOG;ANG;RNASEK;APEX1;SND1
prerank,actin binding (GO:0003779),0.3547600980839261,1.0377773274781246,0.4070707070707071,0.8596092883047425,1.0,45/170,17.69%,TMSB4X;ALDOA;TMSB10;GSN;FXYD5;PRICKLE4;TPM2;MAP1A;MOBP;ANG;MRTFA;ADD2;PFN1;IQGAP2;CCR5;P4HB;CORO1A;VASH1;TLNRD1;FMN2;MAPT;COTL1;LCP1;SLC6A2;MICAL1;MYO1F;FHDC1;GC;ANLN;MSRB1;FLII;CXCR4;HNRNPU;CDK5R2;CCDC88A;CAP1;SPTBN4;TMOD1;DMTN;ADCY8;PFN2;RUSC1;SYNE1;KLHL1;SCIN
prerank,metalloexopeptidase activity (GO:0008235),0.38479821109595963,1.0366745301566507,0.43329658213891953,0.8591561686774829,1.0,13/51,17.34%,METAP1;CPXM1;CPD;CPE;VASH1;AGBL4;METAP2;AEBP1;CPXM2;LAP3;RNPEPL1;NUDT16;MMP14
prerank,cytokine receptor activity (GO:0004896),0.36395226639555933,1.0358544555955513,0.4313929313929314,0.8580267445259638,1.0,26/83,23.51%,CD74;IL2RB;CSF3R;EPOR;CCR5;IL2RG;IL3RA;GFRA1;MPL;CX3CR1;IFNGR1;CSF2RB;IL17RB;GFRA2;CCR2;IL20RA;FLT3;IFNGR2;CSF2RA;IL10RB;IL1RAP;CRLF1;CRLF2;PRLR;IL12RB1;IL21R
prerank,C-C chemokine binding (GO:0019957),0.4351398507967161,1.0352558737183342,0.446229913473424,0.8563236922203394,1.0,5/22,18.31%,CCR5;ZFP36;CXCR4;CX3CR1;CCR2
prerank,"DNA binding, bending (GO:0008301)",0.478822699509235,1.0343232653210117,0.44129554655870445,0.8555455834152839,1.0,3/14,9.82%,TERF1;HMGB3;HMGB1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.4128987510193898,1.0331974815439111,0.44028103044496486,0.8553174584940989,1.0,5/33,7.72%,RPS3;PARK7;TOLLIP;AUP1;FOXL2
prerank,receptor tyrosine kinase binding (GO:0030971),0.38084911534780896,1.0330688478113015,0.4369565217391304,0.8521706616135034,1.0,8/56,6.27%,RACK1;NRG3;NRG1;GRB14;LRP4;DUSP3;HYAL2;SHC3
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.3673554884270284,-1.0316090645340363,0.398406374501992,0.6859803412501554,1.0,2/15,2.19%,ALDH1A1;ALDH1A2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.4085110681527735,-1.0304991281460039,0.3993174061433447,0.6833851970951165,1.0,1/11,0.15%,ITPR1
prerank,sialyltransferase activity (GO:0008373),-0.33309228175984024,-1.0286604927134144,0.43386243386243384,0.6826848417492563,1.0,8/20,19.97%,ST3GAL4;ST3GAL3;ST6GAL1;ST3GAL5;ST6GALNAC6;ST3GAL2;ST3GAL6;ST6GALNAC5
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.48691455247787274,1.0280210766800855,0.4521857923497268,0.86310159322868,1.0,5/12,27.52%,NDUFS7;DCXR;CBR1;NQO2;CRYZ
prerank,sulfotransferase activity (GO:0008146),-0.29553006274830307,-1.0273035094062835,0.4014084507042254,0.6809195996790237,1.0,6/33,10.27%,UST;HS3ST3A1;CHST15;HS2ST1;CHST11;TPST1
prerank,protein tyrosine kinase activity (GO:0004713),-0.23041693375254274,-1.0263094497994036,0.32,0.6779723882909214,1.0,23/108,10.73%,EGFR;EPHA7;FER;ABL1;ROR1;EPHA3;NTRK3;EPHA4;INSR;YES1;DYRK1A;TYK2;BAZ1B;MET;FGFR2;WEE1;FRK;PDGFRB;HIPK3;CLK1;ABL2;PTK2;EPHB2
prerank,heme binding (GO:0020037),0.37390631523438245,1.0254184706265668,0.4547413793103448,0.867147980371592,1.0,17/65,25.21%,HMOX1;PGRMC1;NR1D1;ABCB6;CYBB;STEAP4;PGRMC2;SLC48A1;CAT;NOS2;CYCS;CYB5A;TBXAS1;CYP2E1;SUOX;SDHD;HEBP2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.35328366865201327,1.024940863830215,0.463265306122449,0.8650372168675745,1.0,47/134,28.08%,SLC38A5;SLC17A8;LRRC8A;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;SLC25A13;SLC6A6;SLC26A4;MFSD2A;SLC15A4;SLCO4C1;SLC3A2;SLC17A7;SLC17A6;SLC1A1;SLC25A21;SLC25A22;GJA1;SLC19A1;SLC35A3;SLC16A1;SLC25A1;SLC2A2;MFSD10;SLC52A1;SLC19A2;SLC35A1;SLC25A18;SLC35B4;SLCO1B1;SLC25A23;MFSD12;SFXN1;SLC35B1;SLC6A8;SLC4A8;SLC38A3;SFXN5;ABCC5;SLC2A6;SLC6A9;SLC25A12;SLC16A7;SLC13A5;RTBDN
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3712696249377818,-1.0246225828789708,0.4029126213592233,0.6764738073724289,1.0,2/15,5.95%,PLA2G4A;SESTD1
prerank,pyridoxal phosphate binding (GO:0030170),0.43591916309083484,1.0211994947940977,0.45745992601726265,0.8721608622942456,1.0,6/20,21.89%,AGXT;OAT;SDS;PNPO;SHMT2;PYGL
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.2868090521080612,-1.0194520556461832,0.36551724137931035,0.6830922623048373,1.0,8/35,10.70%,FER;ABL1;YES1;DYRK1A;FRK;CLK1;ABL2;PTK2
prerank,thioesterase binding (GO:0031996),0.489955182425168,1.016917830384894,0.47714285714285715,0.8811160737436137,1.0,3/11,14.99%,RAC1;ARF6;TRAF3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.3826877045022598,-1.016338857324009,0.4028776978417266,0.6855131633275907,1.0,2/13,2.19%,ALDH1A1;ALDH1A2
prerank,protein heterodimerization activity (GO:0046982),0.3455416325001173,1.0155707847095357,0.47076612903225806,0.8815055079035743,1.0,59/178,24.89%,ATF4;CYBA;TPM2;HEXA;RAN;PDGFB;FZD9;TRMT112;EPAS1;LSM6;YWHAH;PPP2R1A;YWHAE;ABCG1;TENM2;TENM3;ADD2;CYBB;P4HB;ATP1B2;TUBB2B;MLXIPL;MLX;BHLHE41;AOC3;NPAS3;SUPT4H1;TENM4;BAX;ATP1A1;TLR6;SDCBP;ATP1B1;RRAGC;PDGFA;ADRA1A;RRAGD;ADCY8;SRI;ZHX1;GCA;ERBB3;TFAP2B;VAPA;GABBR2;MEF2C;BAK1;GADD45A;DDIT3;KATNA1;VAPB;LSM5;MTTP;USF2;RCC1;METTL3;BARD1;TCF3;BOK
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.39669319751176446,1.0132173058697012,0.4601449275362319,0.8847309314644056,1.0,11/31,20.01%,SLC12A5;AQP1;KCNA2;KCNK9;ABCC8;KCNF1;HCN1;KCNK3;KCNA1;KCNK10;TMEM38B
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4948293320026034,1.0123619799697956,0.47885402455661663,0.8836406068443885,1.0,2/11,6.56%,PPP1R14A;PPP1R14B
prerank,protein homodimerization activity (GO:0042803),0.3366748004405912,1.0089369680133065,0.439,0.8899879379469213,1.0,105/590,15.63%,APOE;PSAP;S100A6;RACK1;B2M;S100A1;TYROBP;HSP90AA1;HSPB1;HSP90AB1;HMOX1;PARK7;PGRMC1;S100A11;GSTM1;AKT1;TXN;S100B;TPI1;S100A10;TPM2;CRYAB;ERBB4;TERF1;NPM1;AGXT;S100A13;S100A16;RASIP1;PDGFB;FZD9;NTRK2;ANG;CHEK2;ENO1;CAV2;ATP5IF1;FLNA;ABCG1;HES1;TENM2;TENM3;ADD2;SPPL2B;TFRC;RDH5;SDS;CEBPB;BNIP3L;CORO1A;CEBPA;PLN;GRHPR;TRIM9;LPL;HSD17B4;MLXIPL;MLX;HSPB8;SARS1;KARS1;BHLHE41;SYT6;MFSD1;CSF1R;PECAM1;TENM4;PDCD6;GSTM2;MGAT2;KLHL7;BAX;BANF1;CEP131;WARS1;FLT4;KCNN2;CADM3;MAP3K21;ACTN1;ACOT7;SYNDIG1;ODC1;GNPTG;SLC11A1;CLN6;BST2;HPGDS;LILRB1;CRYM;RIPK2;RNF40;MTCL1;PNPO;CAT;CCDC88A;IKZF3;ABCB10;PRPS1L1;PRPS1;MFF;GDF15;DSCAML1;PDGFA;ACHE
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.40523370048059365,1.0086279640586644,0.48867699642431467,0.8873353222026045,1.0,9/29,21.95%,HYAL2;OVGP1;GUSB;GAA;MOGS;NEU1;HPSE;HPSE2;ENGASE
prerank,mechanosensitive ion channel activity (GO:0008381),-0.37535435038842585,-1.0072679154061204,0.41338582677165353,0.7018006790370392,1.0,7/12,29.46%,PIEZO2;PIEZO1;TMC6;TMC7;TMC3;TMC4;TMC8
prerank,histone deacetylase binding (GO:0042826),0.3545271804503757,1.0065467701525792,0.4785788923719958,0.8895766655859865,1.0,25/88,21.46%,HSP90AA1;HSP90AB1;YWHAB;SPI1;HSPA1B;YWHAE;HES1;CCND1;GMNN;PKN1;BHLHE41;NCOR2;HSPA1A;HDAC5;IKZF3;MIER2;HDAC9;CIR1;MTA2;ANKRA2;HIC1;MEF2C;TFAP4;SIRT2;SUDS3
prerank,lipase activity (GO:0016298),0.38353605037453875,1.0045240741489494,0.46674311926605505,0.8915770184060234,1.0,14/43,31.90%,PNPLA2;LIPG;LIPE;LPL;PLBD2;FAAH;ABHD16A;ABHD12;MGLL;PLBD1;PNPLA8;PITPNM3;CEL;LIPA
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.44308723937422023,1.0024652424891367,0.4929757343550447,0.8937680463551401,1.0,3/18,12.81%,HSD17B6;RDH5;HSD3B2
prerank,PDZ domain binding (GO:0030165),-0.2545447788529021,-1.001418715775841,0.44871794871794873,0.7104158596540134,1.0,13/61,11.47%,ARHGAP29;TGFBR3;CRIM1;RAPGEF2;PRKN;PLEKHA2;SLC22A4;GNG12;DLG4;PTEN;SRR;PSEN1;KIDINS220
prerank,tubulin binding (GO:0015631),0.33690096283543836,1.0004330132670225,0.509,0.8959160016309397,1.0,68/296,20.56%,RPS3;ALDOA;GABARAP;GAPDH;TPPP3;PRNP;MAP1LC3B;TERF1;MAP1LC3A;MAP1A;GABARAPL2;S100A8;S100A9;GABARAPL1;NEFH;DNM3;STMN3;SBDS;NEFM;NDRG1;NAV3;PAK1;ABRAXAS2;AGBL4;CLASP1;MAST1;MAPT;MAP2;STMN4;UNC5C;CDK5R1;KIF26B;KIF5A;ARHGEF7;REEP2;KIF26A;ARL4C;ATF5;FHDC1;DCTN1;GJA1;CLIP3;MTCL1;STMN1;TTLL7;VBP1;CCDC88A;KIF21B;CETN3;MAPRE3;CDK5;TBCA;FGF13;DNM1L;PDCD5;BRCA2;TOGARAM2;HOOK1;FAM83D;KIF5C;KIFC2;TTLL5;SNCA;DCX;VAPA;GIT1;MAP1B;RAE1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.2825937667228716,-1.0,1.0,0.6694698608784047,1.0,92/335,14.72%,ROCK2;GRK5;EGFR;MAPK4;STK3;ACVR1;DAPK1;BMPR1A;LRRK2;ROCK1;SIK3;FAM20A;BRD4;CAMK2D;BRAF;SIK2;PRKCE;CSNK1A1;MAP3K13;GRK3;CLK2;MARK1;SMG1;EIF2AK4;PDPK1;RAF1;ARAF;TLK2;TGFBR1;CASK;IRAK3;STK24;WNK4;SNRK;CDK12;CDK6;EIF2AK3;TLK1;MAST2;NEK4;CDC42BPB;DYRK1A;MYLK;MARK3;MAPKAPK3;TOP1;SIK1;PRKD3;TAOK3;BCR;PRKAA2;NEK6;AAK1;STK10;MAPK9;HIPK3;CLK1;NEK7;MAP4K4;ALPK1;NRK;RIPK1;MAP4K3;CCNK;TESK2;DMPK;PDIK1L;CDK13;NUAK1;SLK;DAPK2;TRIO;TBK1;LATS2;MAPK6;NEK3;STK38;CLK4;ATM;CSNK2A1;CSNK2A2;NLK;ULK2;PRKD1;SRPK2;IRAK4;GSK3B;MARK2;PRKCI;CDK7;CDKL3;TAOK1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.27291983403125397,-1.0,1.0,0.6694698608784047,1.0,164/731,16.37%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;PRDM5;ZNF423;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;FOXN3;GLI3;HLF;ZBTB16;NR6A1;ZIC4;HOXA3;GLI2;DHX36;CCAR1;ARNT2;MGA;SKI;HOXB4;ELF1;NR2F2;ATF7;HDAC4;NFYC;THRB;CHD2;HOXA5;HIVEP3;ZKSCAN2;KLF3;THRAP3;NRF1;TEF;PPARA;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;NFATC4;ZNF182;SMAD9;TBX15;TFCP2;FOXP4;MEOX2;SP1;NFKB1;NR1D2;FOXK2;HOXB5;ZSCAN26;STAT3;HIF3A;SMAD1;ZIC2;ZFHX3;ZBTB38;KCNIP3;ZFP30;TOP1;ZBTB1;MYNN;ZFHX4;EBF4;MEF2A;STAT2;PRDM15;ZBTB26;EBF1;MYBL1;ATF2;TEAD2;PPARG;SP4;KLF8;ESR1;NR2C2;FOXK1;HOXC6;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;HOXA6;GMEB1;PRRX2;MZF1;NFATC3;RBPJ;ZBTB34;AR;HOXC5;HIVEP1;IKZF2;ZNF8;RREB1;MKX;SIX1;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7;RORA;NFIC;SMAD2;ZFP62;TFCP2L1;PBX4;MLXIP;GMEB2;RUNX2;HEY2;FOXN2;STAT5A;ZBTB5;SOX13;IRF2;NFYB;ZSCAN12;ZBTB6;HOXA2;BATF;HINFP;ZNF483;ESRRA;FOXO1;FOXL1;TP53;NR3C1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.27082027064522685,-1.0,1.0,0.6694698608784047,1.0,164/730,16.37%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;PRDM5;ZNF423;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;GLI3;HLF;ZBTB16;NR6A1;ZIC4;HOXA3;GLI2;DHX36;CCAR1;ARNT2;MGA;SKI;HOXB4;ELF1;NR2F2;ATF7;HDAC4;NFYC;THRB;CHD2;HOXA5;HIVEP3;ZKSCAN2;KLF3;THRAP3;NRF1;TEF;PPARA;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;NFATC4;ZNF182;SMAD9;TBX15;TFCP2;FOXP4;MEOX2;SP1;NFKB1;NR1D2;FOXK2;HOXB5;ZSCAN26;STAT3;HIF3A;SMAD1;ZIC2;ZFHX3;ZBTB38;KCNIP3;ZFP30;TOP1;ZBTB1;MYNN;ZFHX4;EBF4;MEF2A;STAT2;PRDM15;ZBTB26;EBF1;MYBL1;ATF2;TEAD2;PPARG;SP4;KLF8;ESR1;TRIM24;NR2C2;FOXK1;HOXC6;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;HOXA6;CREB3L2;GMEB1;PRRX2;MZF1;NFATC3;RBPJ;ZBTB34;AR;HOXC5;HIVEP1;IKZF2;ZNF8;RREB1;MKX;SIX1;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7;RORA;NFIC;SMAD2;ZFP62;TFCP2L1;PBX4;MLXIP;GMEB2;RUNX2;HEY2;STAT5A;ZBTB5;SOX13;IRF2;NFYB;ZSCAN12;ZBTB6;HOXA2;BATF;HINFP;ZNF483;ESRRA;FOXO1;FOXL1;TP53;NR3C1
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.27376839133305003,-1.0,1.0,0.6694698608784047,1.0,78/346,13.10%,RNF220;PDZRN3;UBE2E2;HECTD1;CNOT4;BIRC6;TTC3;MIB1;RNF216;UBR4;RNF152;SMURF2;TRIP12;KCMF1;WWP1;RNF38;RNF19A;UBR5;COP1;CBLB;PRKN;BIRC2;TRAF3IP2;PELI2;SH3RF1;SH3RF3;RNF146;ARIH2;RNF144A;UBR3;UBR1;RNF213;SMURF1;TRAF5;UBE2R2;BCOR;UBE2Q2;RNF24;RNF135;BIRC3;ARIH1;TRIM5;HUWE1;RNF8;UHRF2;PML;UBR2;DDB2;RNF41;FBXO10;FBXO11;NEURL2;ZNRF1;SH3RF2;NFX1;BTRC;TOPORS;RNF138;FBXO4;UBE2J2;TRIM24;RC3H2;ZFP91;ASB2;ITCH;RNF217;FBXW11;CUL4B;RNF115;UBE3C;CUL4A;PPIL2;RNF43;RNF14;HECW2;SIAH3;UBE3B;ERCC8
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.24471342725877723,-1.0,1.0,0.6694698608784047,1.0,146/830,13.20%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;PRDM5;ZNF423;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;CUX1;BBX;GLI3;HLF;ZBTB16;NR6A1;ZIC4;HOXA3;GLI2;DHX36;CCAR1;ARNT2;MGA;SKI;HOXB4;ELF1;NR2F2;ATF7;HDAC4;NFYC;THRB;CHD2;NFXL1;HOXA5;HIVEP3;ZKSCAN2;KLF3;THRAP3;NRF1;TEF;PPARA;NFIX;HOXC4;CREB5;ZFP90;RARG;NFATC1;FOXO3;NFATC4;ZNF182;SMAD9;TBX15;TFCP2;FOXP4;MEOX2;SP1;NFKB1;NR1D2;FOXK2;HOXB5;ZSCAN26;STAT3;HIF3A;SMAD1;ZIC2;ZFHX3;ZBTB38;KCNIP3;ZFP30;TOP1;ZBTB1;MYNN;ZFHX4;EBF4;MEF2A;STAT2;RBAK;PRDM15;ZBTB26;EBF1;TFDP1;NFX1;MYBL1;ATF2;TEAD2;PPARG;CREBRF;ETV6;SP4;KLF8;ESR1;NR2C2;FOXK1;HOXC6;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;HOXA6;GMEB1;PRRX2;MZF1;NFATC3;RBPJ;ZBTB34;AR;HOXC5;HIVEP1;IKZF2;ZBTB8A;ZNF8;RREB1;MKX;SIX1;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.2594943966208767,-1.0,1.0,0.6694698608784047,1.0,60/254,16.61%,NFIA;NFAT5;SMAD3;NFIB;TCF4;HOXB3;PRRX1;TCF12;HLF;ZBTB16;ELF1;NFYC;HOXA5;NRF1;PPARA;HOXC4;NFATC1;FOXO3;TFCP2;MEOX2;SP1;NFKB1;FOXK2;MDM4;STAT3;SMAD1;MEF2A;PRDM15;TFDP1;MYBL1;ATF2;CREBRF;ESR1;NR2C2;SMAD4;ATF6;ELF4;GMEB1;MZF1;NFATC3;RBPJ;AR;RREB1;SIX1;HSF2;KLF7;NFIC;SMAD2;RLF;ZFP62;TFCP2L1;MLXIP;MDM2;IRF2;NFYB;HINFP;FOXO1;TP53;NR3C1;MITF
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.24238553629924314,-1.0,1.0,0.6694698608784047,1.0,95/597,11.45%,ZBTB20;PBX1;FOXP1;NFAT5;SMAD3;TEAD1;NFIB;BNC2;NR3C2;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;ABL1;SMAD6;PRDM5;KLF12;TCF12;ARNT;SOX5;MBNL2;GABPB2;CUX1;BBX;GLI3;HLF;NR6A1;ZIC4;GLI2;DHX36;ARNT2;HOXB4;ELF1;ATF7;HDAC4;PER2;NFYC;THRB;HOXA5;MLH3;YAP1;PER3;KLF3;TEF;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;KDM5B;KAT7;NFATC4;NCOR1;TBX15;TFCP2;TBL1X;MEOX2;SP1;NFKB1;NR1D2;BCOR;FOXK2;HOXB5;ARID4B;ELF2;STAT3;VSX1;ARID5B;ASH2L;ZBTB26;ATF2;TBL1XR1;TEAD2;PPARG;CENPC;ESR1;NR2C2;FOXK1;XPA;ZNF23;SMAD4;ZIC1;ATF6;ELF4;HOXA6;CREB3L2;GMEB1;HNRNPL;BRD7;PRRX2;MZF1;NFATC3;KMT2D
prerank,double-stranded DNA binding (GO:0003690),-0.20656063518387405,-1.0,1.0,0.6694698608784047,1.0,76/531,11.44%,ZBTB20;PBX1;FOXP1;NFAT5;RBMS1;TEAD1;NFIB;EGFR;NR3C2;TCF4;PKNOX2;RARB;HOXB6;ABL1;KLF12;TCF12;ARNT;MBNL2;CUX1;BBX;GLI3;HLF;NR6A1;ZIC4;GLI2;ARNT2;ZMYND11;HOXB4;ELF1;ATF7;THRB;HOXA5;KLF3;TEF;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;KDM5B;NFATC4;TBX15;TFCP2;MEOX2;SP1;NR1D2;HOXB5;ELF2;HDGFL3;VSX1;MSH3;TOP1;RBBP8;ZNF638;ZBTB26;TDG;ATF2;FBH1;TEAD2;PPARG;ESR1;NR2C2;FOXK1;XPA;ZNF23;ERCC5;ZIC1;ATF6;ELF4;HOXA6;RAD51B;GMEB1;PRRX2;NFATC3;TERF2
prerank,sequence-specific DNA binding (GO:0043565),-0.23582452358342232,-1.0,1.0,0.6694698608784047,1.0,121/590,16.37%,ZBTB20;PBX1;FOXP1;NFAT5;SMAD3;FOXP2;TEAD1;NFIB;ZNF148;NR3C2;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;ABL1;PRDM5;ZNF423;KLF12;TCF12;ARNT;FOXD1;MBNL2;KDM2A;CUX1;SMG6;BBX;GLI3;HLF;NR6A1;ZIC4;GLI2;ARNT2;HOXB4;ELF1;NR2F2;ATF7;HDAC4;THRB;HOXA5;KLF3;TET3;SMG1;KMT2A;TEF;PPARA;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;KDM5B;NFATC4;TBX15;TFCP2;MEOX2;FBXL19;SP1;NR1D2;FOXK2;HOXB5;ELF2;VSX1;ZBTB38;MEF2A;ZBTB26;UPF2;ATF2;TEAD2;PPARG;SP4;ESR1;NR2C2;FOXK1;SMG7;XPA;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;TERT;HOXA6;GMEB1;PRRX2;NFATC3;TERF2;RBPJ;LRWD1;SLTM;BCL2;HIVEP1;CXXC5;SIX1;NR2F1;HSF2;TINF2;RORA;CBFB;NFIC;STN1;ZBTB21;TFCP2L1;ZNF276;PBX4;GMEB2;RUNX2;HEY2;FOXN2;PRDM9;SOX13;IRF2;HOXA2;BATF;MECP2;ESRRA;FOXO1;FOXL1;NR3C1
prerank,tRNA binding (GO:0000049),0.3791783416684243,0.9956234192199699,0.4916387959866221,0.9054797195371729,1.0,13/43,24.97%,EEF1A1;SARS1;SARS2;KARS1;AARS2;CARS1;CTU1;SEPSECS;RPUSD4;YARS2;TRNT1;TRMT10C;EIF2A
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.23030456993722323,-0.9939505247741381,0.46808510638297873,0.6788934363171986,1.0,18/91,10.91%,PARD3;SVIL;FCHO2;SLC9A1;ACTN2;FRMPD4;MAPKAP1;MYO1B;PLEKHA4;ADAP2;MARK1;SESTD1;GBF1;HIP1;PICALM;KIF16B;KRIT1;TULP3
prerank,motor activity (GO:0003774),0.3685089777552252,0.9927778474000727,0.504875406283857,0.9097406390319912,1.0,11/60,14.30%,MYL6;PIN1;DYNLRB1;KIF26B;KIF5A;KIF26A;MYL6B;DNAH2;DNAH1;DYNLRB2;KIF21B
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3777736811858746,-0.9912429546513761,0.45416666666666666,0.6813007228924742,1.0,6/12,14.45%,BRD4;CDK12;CDK6;CCNK;CDK13;CDK7
prerank,phospholipase activator activity (GO:0016004),-0.40466397208683136,-0.9908998530131332,0.47019867549668876,0.6774372727960751,1.0,2/10,4.69%,ARHGAP6;PDPK1
prerank,nuclease activity (GO:0004518),0.368914027821833,0.9898344825596287,0.5136911281489595,0.9142654709402683,1.0,10/52,14.03%,NME1;ENDOG;RNASE1;ANG;RNASE4;RNASEH2A;RNASEH1;APEX1;PDE12;SND1
prerank,protein kinase C activity (GO:0004697),-0.36062959941196515,-0.9886627343430483,0.4329004329004329,0.6783520853654431,1.0,6/14,15.34%,PRKCE;SMG1;PRKD3;PRKD1;PRKCI;PRKCB
prerank,chemokine binding (GO:0019956),0.3975509790346755,0.9879521043417752,0.5088967971530249,0.9157179585441642,1.0,10/30,31.16%,CCR5;HMGB1;ZFP36;CXCR4;CX3CR1;CCR2;ACKR1;ITGB1;PLP2;ACKR3
prerank,protein phosphatase 2A binding (GO:0051721),-0.3169855233736642,-0.9876892008012997,0.46938775510204084,0.6759300858540789,1.0,10/23,18.21%,STRN3;ANKLE2;STRN;ENSA;SMG7;BOD1L1;SPHK1;FOXO1;TP53;CTTNBP2NL
prerank,protein phosphatase regulator activity (GO:0019888),0.36614609639119017,0.9872983613447001,0.513129102844639,0.9138996206719205,1.0,7/53,5.11%,CALM1;RCAN3;CALM3;PPP1R15B;LGALS3;PPP1R1B;PPP2R1A
prerank,gamma-tubulin binding (GO:0043015),0.4143443315463955,0.9863938894761709,0.4840357598978289,0.912863096538312,1.0,10/22,32.14%,NDRG1;PAK1;ARHGEF7;BRCA2;GIT1;BLOC1S2;B9D2;DIXDC1;TUBGCP2;DDX3X
prerank,voltage-gated chloride channel activity (GO:0005247),-0.406586259718747,-0.9808225406043753,0.45918367346938777,0.6870518052914513,1.0,1/10,1.69%,ANO6
prerank,endopeptidase activity (GO:0004175),0.32808435023741506,0.980380500636049,0.5605605605605606,0.9258799562892343,1.0,57/257,20.35%,CTSB;CTSL;PSMB4;CTSZ;CTSS;LGMN;PSMB6;PSMB8;CD5L;RCE1;UCHL1;ADAMTS4;OMA1;MMP21;F9;PSMA7;USP5;PDIA3;KLK8;KLK1;KLK6;PIK3IP1;PCSK2;PSMB9;PMPCB;MMP3;PSMB3;PLAT;USP29;PSMB11;PSMB10;CTSH;ADAMTS16;SPG7;USP26;GZMM;HPR;HP;PSMB1;MMP27;PSMB5;NAPSA;BACE1;USP8;PLAU;PSEN2;F10;MMP14;ADAM17;ADAMTS1;CTSC;PRSS12;PSMA6;HGF;ADAMTS20;SFRP1;PSMA4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4133670721111675,0.9793438996743905,0.4981549815498155,0.925046568636517,1.0,10/22,23.64%,ZFP36L1;MEX3D;ZFP36L2;HNRNPA0;ZFP36;ELAVL4;ELAVL3;EXOSC9;EXOSC4;ELAVL1
prerank,hormone receptor binding (GO:0051427),0.4524907736712209,0.9780083610608885,0.5308641975308642,0.9252592779698731,1.0,3/14,17.30%,NPPC;CCK;ADCYAP1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4445842400381018,0.9777483272464378,0.5129251700680272,0.9224911888973348,1.0,3/14,13.83%,ELAC2;POP7;POP4
prerank,glutamate receptor binding (GO:0035254),0.43272443648073367,0.9771208939048966,0.508519003931848,0.9208539946809345,1.0,8/17,31.97%,HOMER2;SHISA7;SYNDIG1;SQSTM1;SHISA6;HOMER1;SHANK1;HOMER3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.40150821991376195,0.9766645205796792,0.5078407720144753,0.9186711527395862,1.0,5/26,9.53%,LGALS3;PPP1R1B;PPP1R14A;PPP1R14B;SET
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.31886735935782373,-0.9682801242623671,0.5024390243902439,0.7106297160223697,1.0,2/21,3.48%,FGF1;FRS2
prerank,channel activity (GO:0015267),0.3717878635682488,0.9662417789188898,0.5298087739032621,0.9420084100522295,1.0,8/41,22.82%,AQP4;AQP1;P2RX6;BAX;SLC14A1;KCNK3;MPV17;PANX2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3493468220215618,0.966215110404932,0.5375661375661376,0.9386162862826463,1.0,12/73,16.99%,GPR37L1;SCTR;APLNR;SORCS1;RXFP1;VIPR1;MC1R;SORCS3;GRPR;CX3CR1;CCKBR;HCRTR1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.42335940190155297,0.9658520236232597,0.5186136071887034,0.9360841863248228,1.0,2/18,3.06%,MT3;PRDX5
prerank,glucose transmembrane transporter activity (GO:0005355),0.42698759781490736,0.9650770468706973,0.5342281879194631,0.9346514101914158,1.0,8/17,36.99%,SLC2A1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.298679108723539,-0.963979972683786,0.535,0.7161377490652229,1.0,6/23,10.18%,MAPKAP1;PLEKHA4;SESTD1;GBF1;HIP1;KIF16B
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.42685843803200546,0.9623512869015369,0.55198973042362,0.9381577577663224,1.0,3/18,4.83%,PPP1CA;S100A11;TRIM29
prerank,serine-type endopeptidase activity (GO:0004252),0.3409664232410369,0.95991760867427,0.5585774058577406,0.9409162448358075,1.0,16/80,19.68%,CD5L;F9;KLK8;KLK1;KLK6;PIK3IP1;PCSK2;PLAT;CTSH;GZMM;HPR;HP;PLAU;F10;PRSS12;HGF
prerank,voltage-gated sodium channel activity (GO:0005248),0.4050385902676757,0.9582006670567157,0.5357142857142857,0.941771678674235,1.0,8/22,29.42%,SCN1A;SCN4B;HCN1;HCN3;SCN9A;SCN8A;SCN2A;SCN1B
prerank,dynactin binding (GO:0034452),-0.36789750702194335,-0.9573202609020862,0.5129151291512916,0.7263550601474102,1.0,2/12,2.43%,SNX6;PAFAH1B1
prerank,damaged DNA binding (GO:0003684),0.3668536105396717,0.9566495664943772,0.5556805399325084,0.9424424012371888,1.0,13/44,26.74%,RPS3;RPA2;HMGB1;DDB1;APEX1;PCNA;DCLRE1C;ERCC1;POLD1;PNKP;RPA3;XPC;ERCC2
prerank,miRNA binding (GO:0035198),-0.28636087731189475,-0.9563748756385747,0.5850340136054422,0.7238536658967032,1.0,11/30,21.34%,ZNF346;ZC3H7A;TUT7;RBM4;ZC3H7B;PUM2;TUT4;AGO2;FMR1;AGO4;SOX2
prerank,leucine zipper domain binding (GO:0043522),0.4676360895568843,0.9561578049013716,0.5508720930232558,0.9401530828045079,1.0,4/10,21.15%,ATF4;MRTFA;NRL;DDIT3
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.2458793619336176,-0.9548012725317434,0.5813953488372093,0.7226047197256079,1.0,4/55,1.63%,SLC24A3;ITPR1;MCU;ITPR2
prerank,adenylyltransferase activity (GO:0070566),-0.30356202617820194,-0.9492675230685312,0.5572139303482587,0.7301067379272049,1.0,9/21,21.13%,ABL1;TENT4B;FLAD1;TUT1;OAS2;PAPOLB;TENT2;NMNAT2;NMNAT3
prerank,sequence-specific mRNA binding (GO:1990825),0.46588475601228907,0.9476294922624525,0.5395284327323162,0.9577116252160636,1.0,4/10,28.39%,SHFL;ETF1;DHFR;DHX9
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.31413508852879096,-0.9416869641796388,0.5303643724696356,0.7424828017230802,1.0,6/17,18.61%,DPYD;PTGR2;BDH2;PECR;TM7SF2;PTGR1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3151993231917568,-0.9404803598532715,0.5297029702970297,0.7402395925081039,1.0,4/18,12.45%,ALDH1A1;ALDH1A2;FAR1;AKR1B1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.4360623653959077,0.9346676254513961,0.5461741424802111,0.9860526324403132,1.0,5/12,22.16%,SPPL2B;NAPSA;BACE1;SPPL2A;CTSE
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.3519480098364515,-0.9338900113264154,0.5416666666666666,0.7506602051727852,1.0,7/12,23.22%,SULF1;ARSK;SULF2;ARSB;ARSI;ARSA;ARSJ
prerank,gated channel activity (GO:0022836),-0.33143130468691906,-0.9321994204367298,0.5517241379310345,0.7499218752538457,1.0,3/14,11.29%,PIEZO2;PIEZO1;TMC6
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.4248539527825352,0.9306138127349706,0.557980900409277,0.9923507028054116,1.0,2/14,6.68%,HSD17B6;RDH5
prerank,myosin V binding (GO:0031489),0.4264760858168172,0.9291069424212446,0.562992125984252,0.9924443709108319,1.0,6/15,22.13%,RAB14;RAB3C;RAB3D;RAB39B;RAB6B;RAB27B
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.296441818409862,-0.9287786033673331,0.583756345177665,0.7533317890312382,1.0,9/22,15.83%,OTUD7B;UIMC1;ZBTB1;RNF169;OPTN;TAB2;ZRANB1;PARP10;TAB3
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3554704783641294,0.9287535919374766,0.5905963302752294,0.9897289736866868,1.0,16/42,27.26%,CCNI;CCND2;CCND1;CDK5R1;CCNG1;CDK5R2;HEXIM1;CCNJL;CCNA2;CDKN2B;CCNC;CCNQ;CCNG2;CCNH;CDKN1A;CNPPD1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.36121150689516984,0.9274866779761511,0.5829493087557603,0.9894267514808139,1.0,5/34,7.70%,UBE2Z;UBE2G2;UBE2Q1;CDC34;UFC1
prerank,C-C chemokine receptor activity (GO:0016493),0.38978250971637196,0.9266803683469136,0.591304347826087,0.987835220258056,1.0,4/21,18.31%,CCR5;CXCR4;CX3CR1;CCR2
prerank,O-methyltransferase activity (GO:0008171),0.4469635118239403,0.9211728395209813,0.5902578796561605,0.9973504575889498,1.0,3/10,21.77%,CMTR1;MEPCE;FTSJ3
prerank,palmitoyltransferase activity (GO:0016409),0.3759583809138483,0.919219716562314,0.5992779783393501,0.9984213053077889,1.0,10/28,29.54%,GLUL;YKT6;ZDHHC5;GOLGA7B;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,CoA hydrolase activity (GO:0016289),0.41014614798047866,0.9162939473903221,0.5911528150134048,1.0,1.0,4/16,16.69%,ACAA2;ACOT1;ACOT7;ACOT4
prerank,single-stranded DNA binding (GO:0003697),0.3228383729154433,0.9161964817457692,0.6490683229813664,0.9986318812530164,1.0,37/93,29.78%,PCBP1;PARK7;POLR2D;MCM5;NUCKS1;RPA2;HSPD1;MAPT;HMGB1;POLR2G;DDX11;HNRNPU;HNRNPA1;SUB1;BRCA2;CTC1;WDR48;RAD23A;POU4F1;ERCC1;FAM111A;POLR2H;RADX;BLM;CDC45;LONP1;PCBP2;PURB;RPA3;XPC;RAD51;MCM7;MCM2;DHX9;WBP11;SMC6;POLR3C
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.42242054813378693,0.9152448600575245,0.5833333333333334,0.9973540942444634,1.0,8/14,32.10%,PYCR2;QDPR;CRYM;ALDH4A1;NOXRED1;BLVRB;DHFR;ALDH1L1
prerank,androgen receptor binding (GO:0050681),0.37662481787562885,0.913913893306435,0.5903465346534653,0.9968082630322951,1.0,5/25,12.40%,CALR;PARK7;PKN1;ZBTB7A;SNW1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.36287590371712475,-0.9116339949326497,0.5559440559440559,0.7868500273078535,1.0,3/11,9.86%,NAA40;NAA16;NAA15
prerank,signal sequence binding (GO:0005048),0.358087756245643,0.9115467008763894,0.6154776299879081,0.998844725483779,1.0,10/35,20.79%,PEX5L;AP2M1;KDELR1;SEC61A1;IPO4;CAT;TOMM20L;CABP1;BRAP;NFKBIA
prerank,beta-tubulin binding (GO:0048487),0.36465539397548347,0.9088744955512342,0.6175395858708892,1.0,1.0,7/31,17.19%,GABARAP;GABARAPL2;GABARAPL1;CDK5R1;TTLL7;FGF13;PDCD5
prerank,E-box binding (GO:0070888),-0.26104083190174326,-0.9079815530383192,0.6296296296296297,0.7900753690584572,1.0,2/34,0.90%,ZEB1;TCF4
prerank,cytokine receptor binding (GO:0005126),0.31618744623984046,0.9053594974880712,0.6469968387776607,1.0,1.0,22/83,23.32%,CXCL12;CCL19;FKBP1A;MIF;DDT;IL2;KITLG;IL11;TIMM50;SDCBP;TLR5;CD300LF;ADAM17;SYK;IL6;IL1RAP;CRLF1;PYCARD;CRLF2;ERAP1;PRLR;IL12RB1
prerank,pseudouridine synthase activity (GO:0009982),0.4246343005463187,0.9007376960680269,0.6238030095759234,1.0,1.0,5/13,20.54%,TRUB2;PUSL1;DKC1;PUS7;RPUSD4
prerank,mannosyltransferase activity (GO:0000030),-0.2867930322873535,-0.9005631790199601,0.572972972972973,0.801225987293932,1.0,10/21,24.38%,TMTC1;TMTC4;PIGM;DPY19L4;POMT1;DPM1;TMTC3;POMT2;ALG1;PIGB
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2732517416277829,-0.9004158397283154,0.634020618556701,0.7967545475003995,1.0,4/27,7.42%,SLC9A1;SLC9A2;SLC9B2;SLC8B1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.36045439401231605,0.9003670092244103,0.6330498177399757,1.0,1.0,7/29,16.89%,HSPB1;INKA2;YWHAG;PRKAR1A;PRKAR1B;HEXIM1;PRKAR2B
prerank,phosphatidylglycerol binding (GO:1901611),0.4180946895544322,0.8977009204707954,0.6008230452674898,1.0,1.0,2/13,12.26%,PLTP;NME4
prerank,WW domain binding (GO:0050699),0.367085647171814,0.8887428016323737,0.6303549571603427,1.0,1.0,9/26,28.93%,TCEAL9;DAZAP2;TCEAL7;TCEAL5;TCEAL8;KIF20B;TNK2;ENAH;WBP11
prerank,deubiquitinase activity (GO:0101005),-0.20879336928095313,-0.8880980090216913,0.813953488372093,0.8195956457703419,1.0,26/88,18.73%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;USP28;ZRANB1;USP46;STAMBPL1;UCHL5;USP45;USP37;USP53;USP33;USP9X
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3886673279171652,0.887123380913115,0.6230366492146597,1.0,1.0,6/17,26.52%,ACAA2;ACOT1;ACOT7;ACOT4;THEM4;PLA2G6
prerank,serine-type peptidase activity (GO:0008236),0.3106810501078781,0.8861703168925364,0.6994818652849741,1.0,1.0,18/96,19.68%,CD5L;F9;KLK8;KLK1;KLK6;PIK3IP1;PCSK2;PLAT;CTSH;GZMM;PRSS8;HPR;HP;KLK10;PLAU;F10;PRSS12;HGF
prerank,RNA stem-loop binding (GO:0035613),-0.33363161846365363,-0.8835184987147514,0.6370370370370371,0.82442458974235,1.0,6/12,23.40%,MYH10;CPEB3;RC3H2;FMR1;METTL16;LARP6
prerank,voltage-gated calcium channel activity (GO:0005245),-0.2512149515655217,-0.8832934916235919,0.7019867549668874,0.8200946359545616,1.0,3/37,3.82%,CACNA2D3;CACNA1C;CACHD1
prerank,N-acyltransferase activity (GO:0016410),0.34804413901376424,0.8806786538749383,0.6472642607683353,1.0,1.0,6/32,17.44%,TGM2;CERS2;PLAAT3;NAA10;GLYAT;NAT8L
prerank,alpha-actinin binding (GO:0051393),-0.2769914367384604,-0.8806744487552152,0.6403940886699507,0.8206816375810256,1.0,7/24,16.87%,CACNA1C;PDLIM5;PDLIM4;PPARG;SYNPO2;CACNA1D;PDLIM2
prerank,hydro-lyase activity (GO:0016836),0.34193708608905876,0.8775672347934652,0.6696528555431132,1.0,1.0,10/41,17.38%,PARK7;CA2;ENO1;HSD17B4;ALAD;CA4;FAHD2A;ENO3;NAXD;ECHS1
prerank,transcription coactivator binding (GO:0001223),0.37960116816406914,0.8749564243351637,0.6565272496831432,1.0,1.0,1/20,0.13%,RPL23
prerank,ribonuclease P RNA binding (GO:0033204),0.42868205956537586,0.8737574173391502,0.6510263929618768,1.0,1.0,2/10,13.83%,POP7;POP4
prerank,solute:proton symporter activity (GO:0015295),0.39464653324128235,0.8734896517196146,0.6397435897435897,1.0,1.0,4/16,15.43%,SLC15A4;SLC33A1;MFSD3;SLC15A2
prerank,ATP binding (GO:0005524),0.2939987786043626,0.8728444618550372,0.825,1.0,1.0,77/266,26.67%,HSPA8;HSP90AA1;HSP90AB1;ATP5F1D;NDUFA13;HSPA5;AKT1;ATP5F1A;NME1;PINK1;PFKL;ACVRL1;HSPA1B;ABCB6;ABCG1;UHMK1;TAP2;PGK1;ATP1A3;EPB42;P2RX7;MAST1;SYN2;P2RY1;SARS2;AARS2;MYO1F;BCKDK;P2RX6;ATP1A1;SYN1;HSPA1A;CARS1;HNRNPU;CDC42BPA;STK11;TSSK6;TSSK4;PRPS1L1;PRPS1;PEX6;ABCA2;EIF4A3;BRSK2;HSPA4L;MAP4K2;ERCC6;GUK1;OAS3;AGAP2;VPS4A;MKNK1;TWF1;HSPA2;HSPA9;MTHFS;PYGL;BLM;YARS2;TWF2;LONP1;PMVK;TRNT1;ACLY;DYRK2;PNKP;LANCL2;HSPA14;PIF1;ABCG5;RAD51;PIM1;OXSR1;TRIB1;CDK11B;PEX1;GALK1
prerank,mRNA methyltransferase activity (GO:0008174),0.4162905965545427,0.8703228705143887,0.646814404432133,1.0,1.0,5/12,25.03%,PCIF1;CMTR1;TRMT10C;METTL3;METTL14
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.36398208240606955,0.867127897076442,0.6774193548387096,1.0,1.0,8/24,28.67%,GLUL;YKT6;GOLGA7B;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3969618742375486,0.866379211545098,0.6427604871447903,1.0,1.0,4/14,27.61%,KCNE4;KCNE5;KCNJ3;KCNQ1
prerank,calcium activated cation channel activity (GO:0005227),0.38240323697445006,0.8662954450788743,0.643908969210174,1.0,1.0,7/17,26.89%,TMEM63B;TMEM63C;KCNN2;KCNMA1;PKD2L1;KCNN4;KCNMB4
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.4227151961878838,0.8660012816826312,0.660458452722063,1.0,1.0,5/11,24.22%,NUDT3;NUDT4;NUDT16;NUDT10;NUDT11
prerank,cyclic nucleotide binding (GO:0030551),0.3723395134756748,0.8653165424578645,0.6666666666666666,1.0,1.0,9/21,24.94%,PDE4B;CNGA3;CNGA4;SLC19A1;HCN1;CNGB1;PDE11A;POPDC3;PDE2A
prerank,Wnt-activated receptor activity (GO:0042813),-0.3108128735352212,-0.8644887513233481,0.6651376146788991,0.8504349119405894,1.0,3/15,4.09%,ROR1;LRP5;FZD6
prerank,GDP binding (GO:0019003),0.31213173056483295,0.8641600408335861,0.7254054054054054,1.0,1.0,25/63,30.96%,RAN;RAB14;ARF6;GNAI1;HRAS;RHEBL1;NME2;RRAS;RRAGC;RRAGD;RAB5C;RAB18;RAB31;RAB4A;RALB;RERG;RAB27B;RAB28;RAB42;RAB8A;RAP1B;RAP2A;RAB9B;RIT2;RALA
prerank,protein phosphorylated amino acid binding (GO:0045309),0.32768755642406455,0.863580377805662,0.6774193548387096,1.0,1.0,12/42,22.40%,YWHAB;PIN1;YWHAE;PFN1;SHC3;HCK;FBXW7;VAV1;SYK;PTPN6;SHE;PTPN5
prerank,adenyl ribonucleotide binding (GO:0032559),0.28990384265006053,0.8612889478288109,0.855,1.0,1.0,85/291,26.67%,HSPA8;HSP90AA1;HSP90AB1;ATP5F1D;NDUFA13;HSPA5;AKT1;PDE4B;ATP5F1A;NME1;PINK1;PFKL;ACVRL1;HSPA1B;ABCB6;ABCG1;UHMK1;TAP2;PGK1;APRT;ATP1A3;MYO3A;EPB42;P2RX7;MAST1;SYN2;P2RY1;SARS2;AARS2;MYO1F;BCKDK;P2RX6;ATP1A1;SYN1;HSPA1A;SLC19A1;CARS1;HNRNPU;CDC42BPA;STK11;TSSK6;TSSK4;PRPS1L1;PRPS1;HCN1;PEX6;ABCA2;EIF4A3;BRSK2;HSPA4L;MAP4K2;ERCC6;GLUD1;GUK1;OAS3;AGAP2;VPS4A;MKNK1;TWF1;HSPA2;HSPA9;MTHFS;PYGL;BLM;YARS2;TWF2;LONP1;PMVK;TRNT1;ACLY;DYRK2;PNKP;POPDC3;LANCL2;PDE2A;HSPA14;PIF1;ABCG5;RAD51;PIM1;OXSR1;TRIB1;CDK11B;PEX1;GALK1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.2758634827805248,-0.8598935043604953,0.67,0.8548547146749146,1.0,4/21,7.25%,ARFGEF1;AKAP7;AKAP9;ARFGEF2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.32052143746678097,0.8598187394182865,0.6905286343612335,1.0,1.0,19/49,25.73%,PPP1CA;DUSP3;DUSP28;SMPD1;APEX1;SMPDL3A;GDPD1;ENPP6;PGP;PTPRO;DUSP23;DUSP12;DUSP15;SBF1;GDPD3;ACP2;PPP1CB;DUSP8;PGAM5
prerank,cation channel activity (GO:0005261),0.297275451083688,0.8582439954469138,0.7385416666666667,1.0,1.0,28/94,21.59%,SLC24A4;SLC24A2;GRIN1;TMCO1;TMEM63B;AQP1;TMEM63C;HVCN1;KCNA2;TRPM2;KCNK9;SEC61A1;ABCC8;TRPC1;KCNF1;HCN1;KCNK3;RYR2;KCNA1;ORAI1;KCNK10;UNC80;ANXA6;CALHM6;PKD2L1;TMEM38B;PKDREJ;PKD1L2
prerank,myosin binding (GO:0017022),0.32238197994446605,0.8582416744785396,0.7199558985667034,1.0,1.0,21/55,27.20%,GSN;MOBP;RAB14;CORO1A;RAB3C;STXBP5L;RAB3D;HAP1;RHOA;CXCR4;RAB39B;TRIM32;RAB6B;PYCARD;RAB27B;USH2A;LLGL1;NCKIPSD;NKD2;MYOC;RAB8A
prerank,methyl-CpG binding (GO:0008327),-0.27717733274943995,-0.8571595607250927,0.7095238095238096,0.8556591084174777,1.0,15/22,34.08%,TET3;ZBTB38;LRWD1;CXXC5;ZBTB21;MECP2;ZCWPW1;WDR77;CHTOP;CXXC4;ERH;LHX4;TET1;MBD2;UHRF1
prerank,receptor antagonist activity (GO:0048019),0.3804822778310114,0.8569541469071129,0.660759493670886,1.0,1.0,2/17,6.62%,LRPAP1;WFIKKN2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3725694053517833,0.8546801611779447,0.6641123882503193,1.0,1.0,2/17,5.55%,PLTP;ABCG1
prerank,NAD binding (GO:0051287),-0.2620322606729779,-0.8546750871706545,0.6703296703296703,0.8560766351907285,1.0,8/26,16.50%,ALDH1A1;CRYL1;PARP9;BDH2;SIRT1;ME1;ZC3HAV1;NNT
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.31309316792774955,-0.8538471805961917,0.6967509025270758,0.8529561849665244,1.0,1/13,0.23%,BMP6
prerank,pyrophosphatase activity (GO:0016462),0.31950217207886944,0.8496664664733585,0.7144456886898096,1.0,1.0,12/50,19.21%,BNIP2;ENTPD3;NUDT3;TRPM2;NUDT22;NUDT4;PPA1;NUDT16;PRUNE2;ATCAY;NUDT10;NUDT9
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3373594397701629,0.8489700738961272,0.7016317016317016,1.0,1.0,11/35,20.27%,PLD3;PDIA3;ENPP2;SMPD1;APEX1;GDE1;SMPDL3A;GPCPD1;GDPD1;ENPP6;PDE11A
prerank,ionotropic glutamate receptor binding (GO:0035255),0.4189850327934242,0.8473800957037005,0.6713483146067416,1.0,1.0,7/10,39.95%,SHISA7;SQSTM1;SHISA6;SHANK1;NSF;GNAS;IGSF11
prerank,ion gated channel activity (GO:0022839),0.35754970189961116,0.8467644819730575,0.6847960444993819,1.0,1.0,6/24,19.70%,TMEM63B;TTYH1;TMEM63C;TTYH3;ANO4;PKD2L1
prerank,hyaluronic acid binding (GO:0005540),0.40929129761011207,0.8464039794121166,0.673352435530086,1.0,1.0,3/10,23.52%,HYAL2;LYVE1;C1QBP
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.335014334330463,0.8455397796975287,0.7008244994110718,1.0,1.0,4/31,6.19%,UBE2Z;UBE2G2;UBE2Q1;CDC34
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.33752902533705603,-0.8451557742169549,0.6941580756013745,0.8655701959901194,1.0,2/10,6.12%,B4GALT1;B3GALT1
prerank,kinase activity (GO:0016301),0.2957403417024282,0.8446822813109071,0.779835390946502,1.0,1.0,25/109,21.45%,CHKB;CKB;AKT1;RFK;PINK1;CKMT1A;PGK1;FN3KRP;DGKH;DGKI;CDK5R1;PIK3C2G;BCKDK;DOLK;CDK5;CCL3;PIK3CD;COASY;CERKL;IP6K1;MAPK15;NEK1;SPHK2;DGKK;DGKB
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.2562854816836192,-0.8420910432349299,0.7415730337078652,0.8670287948352989,1.0,4/28,9.73%,EDA;BABAM2;TRAF5;RIPK1
prerank,transforming growth factor beta binding (GO:0050431),0.34828522021273217,0.8420747816870808,0.6897810218978102,1.0,1.0,4/23,6.62%,LTBP4;ACVRL1;HYAL2;WFIKKN2
prerank,voltage-gated ion channel activity (GO:0005244),0.38198477304398576,0.8415282672470251,0.6878306878306878,1.0,1.0,5/14,22.84%,KCND2;HVCN1;HCN1;VDAC2;CACNA1E
prerank,tropomyosin binding (GO:0005523),0.3715177438426049,0.8411088219470393,0.6819407008086253,1.0,1.0,1/16,0.66%,S100A6
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3369163130114062,-0.8409028594549379,0.639344262295082,0.8641738926289826,1.0,1/10,0.05%,PRKAG2
prerank,microtubule binding (GO:0008017),0.2836979512573847,0.8393015150623993,0.8495486459378134,1.0,1.0,57/222,25.39%,RPS3;GAPDH;PRNP;MAP1LC3B;TERF1;MAP1LC3A;MAP1A;GABARAPL2;S100A8;S100A9;NEFH;DNM3;SBDS;NEFM;NDRG1;NAV3;ABRAXAS2;CLASP1;MAST1;MAPT;MAP2;KIF26B;KIF5A;REEP2;KIF26A;FHDC1;DCTN1;CLIP3;MTCL1;CCDC88A;KIF21B;CETN3;MAPRE3;CDK5;FGF13;DNM1L;TOGARAM2;HOOK1;FAM83D;KIF5C;KIFC2;DCX;VAPA;MAP1B;RAE1;KATNA1;RCC2;SYBU;DNM1;SUN2;KIF1A;VAPB;SGIP1;KIF27;GAS2L3;MAPRE1;KIF20B
prerank,cAMP binding (GO:0030552),-0.3220372444704755,-0.8368611384947421,0.6816608996539792,0.8662734316859159,1.0,3/11,9.52%,RAPGEF4;RAPGEF2;CNBD2
prerank,alkali metal ion binding (GO:0031420),-0.3016383142334793,-0.8364631665776753,0.6856060606060606,0.8622095885774071,1.0,3/13,8.98%,HDAC4;ATP1A2;TDG
prerank,BMP receptor binding (GO:0070700),-0.31309330587666334,-0.8345076207827116,0.6607773851590106,0.8609365471389879,1.0,1/12,0.23%,BMP6
prerank,histone acetyltransferase binding (GO:0035035),0.3559782350324756,0.8333582975294641,0.6951530612244898,1.0,1.0,8/21,22.66%,EID1;EPAS1;EGR1;ZBTB7A;PCNA;CITED2;SIRT2;TRIM68
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4020158530826836,0.8333391414756134,0.7046413502109705,1.0,1.0,3/11,22.04%,LRRC8A;SLC19A1;SLC25A23
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.34347244790736275,-0.833278982241566,0.672077922077922,0.8537461465547639,1.0,3/10,10.87%,DUSP16;DUSP10;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.34347244790736275,-0.833278982241566,0.672077922077922,0.8537461465547639,1.0,3/10,10.87%,DUSP16;DUSP10;DUSP7
prerank,vinculin binding (GO:0017166),-0.32217704620685866,-0.8312002760159154,0.6606498194945848,0.8529610509197505,1.0,4/11,13.83%,SORBS3;PXN;UTRN;CTNNA1
prerank,frizzled binding (GO:0005109),-0.23580030541478245,-0.8310774310921483,0.8208955223880597,0.8485599086485321,1.0,12/34,21.54%,LRP6;WNT5B;WNT16;RNF43;DVL3;WNT11;WNT4;WNT9A;RYK;FZD7;ZNRF3;WNT2B
prerank,single-stranded RNA binding (GO:0003727),0.3162271688947976,0.8276347795302762,0.7435028248587571,1.0,1.0,12/43,23.06%,POLR2D;POLR2G;DDX11;L1TD1;HNRNPU;HNRNPA1;AGO1;CNBP;EIF4H;RBM7;HNRNPF;LONP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3981122526790005,0.826503450866889,0.7059620596205962,1.0,1.0,2/11,16.45%,DDAH1;DDAH2
prerank,5'-nucleotidase activity (GO:0008253),-0.3070312624527803,-0.8250736891811942,0.6920415224913494,0.854776669211153,1.0,5/13,19.86%,NT5DC1;NT5C2;NT5C1A;NT5M;ACP3
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2958660579795307,0.8247116761464136,0.767590618336887,1.0,1.0,18/70,24.71%,HEXB;HEXA;B4GALNT1;B4GALNT4;POGLUT3;B3GNT9;CHPF2;B3GAT3;CHPF;GCNT1;B3GNT3;RFNG;CSGALNACT2;CHSY3;B3GALT5;LFNG;B3GALT2;MGAT4B
prerank,ribosomal large subunit binding (GO:0043023),0.39263718858045116,0.8215238076865232,0.7052186177715092,1.0,1.0,1/11,3.04%,NPM1
prerank,TBP-class protein binding (GO:0017025),0.3477171201521282,0.8188983725517645,0.7021013597033374,1.0,1.0,9/21,33.25%,DRAP1;THRA;PSMC1;HHEX;RUVBL2;TAF13;PSMC5;PSMC2;TAF11
prerank,epidermal growth factor receptor binding (GO:0005154),-0.2563604316951076,-0.8188739549348368,0.7566137566137566,0.8614404801496279,1.0,6/25,15.86%,FER;ATXN2;EFEMP1;HIP1;SNX2;SNX1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.367089337609249,0.8168316364625536,0.6971736204576043,1.0,1.0,3/15,18.31%,CCR5;CX3CR1;CCR2
prerank,O-acyltransferase activity (GO:0008374),0.3204348411176234,0.8167103763081619,0.7478890229191797,1.0,1.0,10/30,27.16%,PRDX6;MOGAT2;DGAT2L6;LRAT;SOAT2;DGAT1;LPCAT2;MOGAT1;MBOAT7;GPAM
prerank,general transcription initiation factor binding (GO:0140296),0.3371752367954858,0.8165722398925569,0.7347670250896058,1.0,1.0,10/25,30.42%,DRAP1;THRA;TBP;PSMC1;RELA;HHEX;RUVBL2;TAF13;PSMC5;PSMC2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.23752274744995056,-0.8160588552805204,0.825503355704698,0.861921624189205,1.0,8/34,13.81%,PAN3;CNOT1;PARN;ERI3;CNOT7;ERI2;DIS3L;ANGEL1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.21376197866445407,-0.8155558925218446,0.9052631578947369,0.858288262017837,1.0,12/55,13.68%,SLC6A13;SLC7A2;SLC16A12;SLC38A9;SLC6A12;SLC16A9;SLC22A4;SLC38A6;SLC16A6;SLC16A13;SLC36A4;SLC38A11
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.302488322146832,-0.8136645219633817,0.7087719298245614,0.856892215151844,1.0,6/13,17.51%,ITGA5;PDGFRB;IL1R1;VEGFD;PDGFC;PDGFRA
prerank,RNA polymerase binding (GO:0070063),0.35101164413583014,0.8124929744380417,0.7164750957854407,1.0,1.0,3/18,10.02%,PPIB;TAF10;ZFP36
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.39860090634218515,0.811426396944128,0.711340206185567,1.0,1.0,6/10,29.63%,CRMP1;OPLAH;DPYS;DPYSL2;DPYSL5;CAD
prerank,CARD domain binding (GO:0050700),-0.2944533711180457,-0.8100747308695235,0.7470817120622568,0.858183485966566,1.0,2/14,5.60%,CARD16;CARD14
prerank,phosphotyrosine residue binding (GO:0001784),-0.22823671974323873,-0.808151100965718,0.8695652173913043,0.8567498778733422,1.0,7/37,10.19%,ABL1;IRS1;PTPN3;YES1;VAV2;BCAR3;ABL2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3274799528351369,0.8054413648779987,0.7464114832535885,1.0,1.0,11/28,28.99%,AKT1;SGK1;PAK3;MAPK10;MAP2K2;MAP2K7;PRKACA;TNK2;MAP3K9;RPS6KA1;AURKB
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3153368070814238,-0.8040595318631968,0.7338403041825095,0.859573605917549,1.0,12/12,68.50%,GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4;OPN3;GPR88;ELOVL4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3162746991067791,0.8032721975415645,0.7587006960556845,1.0,1.0,9/33,19.53%,MAF1;ELOF1;RTRAF;SUPT4H1;HNRNPU;RECQL5;AGO1;CCAR2;ESRRB
prerank,solute:anion antiporter activity (GO:0140323),-0.2932182543800401,-0.8013678685820231,0.7338709677419355,0.8598150138521907,1.0,3/14,12.83%,SLC26A7;SLC7A11;SLC26A2
prerank,aminopeptidase activity (GO:0004177),0.32319801378442037,0.8004706843909859,0.7496932515337423,1.0,1.0,6/26,17.34%,METAP1;METAP2;LAP3;CTSH;RNPEPL1;MMP14
prerank,Notch binding (GO:0005112),0.333290742399259,0.7998983101131573,0.7459324155193993,1.0,1.0,7/22,17.49%,KCTD10;DNER;SNW1;NCOR2;DLL1;JAG2;ADAM17
prerank,cardiolipin binding (GO:1901612),0.39309561161257156,0.797443667850204,0.7186147186147186,1.0,1.0,3/10,27.02%,NME4;STOML2;PLEKHN1
prerank,calcium:sodium antiporter activity (GO:0005432),0.38827252161603515,0.7964270098219706,0.7384615384615385,1.0,1.0,4/10,15.38%,SLC24A4;SLC24A2;SLC3A2;SLC8A1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.3258438019967031,-0.7956624964826516,0.75,0.8653501743356192,1.0,1/10,0.51%,CACNA1C
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.33723982561342,0.7954621495410201,0.7598522167487685,1.0,1.0,10/22,25.90%,DUSP3;DUSP2;DUSP23;PPM1F;DUSP12;DUSP1;DUSP15;SBF1;DUSP8;DUSP6
prerank,syntaxin-1 binding (GO:0017075),0.3379927296593789,0.7950695632994538,0.7554417413572343,1.0,1.0,5/22,9.25%,SNAP25;SYT1;SYPL1;VAMP3;VAMP2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.3883753214285408,0.7938497253209704,0.7347826086956522,1.0,1.0,1/10,5.31%,SIRPA
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.29982100238992704,-0.7935915825606344,0.7132075471698113,0.8642960684596945,1.0,7/13,23.90%,THUMPD3;TRMT5;FTSJ1;TRMT1L;TARBP1;TRMT1;TRMT10B
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.376250515014796,0.7935483917574834,0.7418478260869565,1.0,1.0,2/12,5.48%,PDE4B;PDE3B
prerank,adrenergic receptor binding (GO:0031690),0.35010561906606225,0.7921846923729675,0.7503392130257802,1.0,1.0,5/16,23.52%,UCHL1;APLP1;ARRDC3;GRK2;C1QBP
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3708493181740173,0.7905059042533407,0.7414965986394558,1.0,1.0,4/12,16.81%,CADM4;CCDC88A;DAB2IP;CDH5
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3363433706158126,0.7875753416855307,0.7673521850899743,1.0,1.0,5/20,18.09%,DLG2;AK4;AK3;CMPK2;GUK1
prerank,vitamin D receptor binding (GO:0042809),-0.2775060030292048,-0.7873954484130231,0.76171875,0.8694102024880391,1.0,2/14,4.37%,MED13;THRAP3
prerank,LRR domain binding (GO:0030275),0.35773685160134744,0.7870575064922304,0.7526737967914439,1.0,1.0,5/14,21.70%,ATF4;MRTFA;NRL;DDIT3;ZXDC
prerank,DNA secondary structure binding (GO:0000217),-0.23126164686303322,-0.7867333337120588,0.8024691358024691,0.8660573330312076,1.0,11/31,21.79%,ABL1;KMT2A;RBBP8;ERCC5;RAD51B;CLSPN;FANCM;YY1;WRN;XRCC3;XRCC2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.29411474548889704,0.7850405740218445,0.8006795016987542,1.0,1.0,13/46,24.71%,HEXB;HEXA;PIGQ;MGAT2;B3GNT9;GCNT1;B3GNT3;RFNG;B3GALT5;MGAT1;LFNG;B3GALT2;MGAT4B
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.31784944004329263,0.7842813094286042,0.7703523693803159,1.0,1.0,3/27,9.20%,LRRC8A;SLC26A4;SLC25A11
prerank,amino acid transmembrane transporter activity (GO:0015171),0.2978832599276278,0.7840989770781889,0.7790304396843292,1.0,1.0,6/47,11.29%,SLC38A5;SLC7A5;SLC25A29;SLC6A6;SLC3A2;SLC7A14
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.29502864933921824,0.7815013662710698,0.8044943820224719,1.0,1.0,16/49,25.43%,UBXN1;VCP;TNFAIP3;ABRAXAS2;OTUD7A;PRPF8;UBQLN2;SQSTM1;RAD23A;FAAP20;TNIP1;ZFAND2B;UBQLN4;ATRIP;MINDY1;PSMD4
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3077254394302436,0.7784447706026311,0.7937062937062938,1.0,1.0,10/33,19.53%,ELOF1;DRAP1;RTRAF;SUPT4H1;HNRNPU;RECQL5;AGO1;CCAR2;TBP;ESRRB
prerank,lipid phosphatase activity (GO:0042577),-0.2904363677621318,-0.77771045267019,0.7763713080168776,0.875412040353783,1.0,7/14,22.11%,PLPP3;EPHX2;PLPP1;PLPP7;PLPP2;PLPPR1;PLPPR3
prerank,histone deacetylase activity (GO:0004407),0.3368580543692097,0.7776913246337125,0.7724399494310998,1.0,1.0,6/19,21.46%,HDAC11;HDAC5;MIER2;HDAC9;SIRT2;SUDS3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3891674947645103,0.7752678786715804,0.7835926449787836,1.0,1.0,2/10,16.92%,PIK3C2G;PIK3CD
prerank,nuclear import signal receptor activity (GO:0061608),-0.26998239500924015,-0.7744200738584587,0.7985074626865671,0.8760303258762348,1.0,10/15,35.36%,KPNA4;KPNA2;TNPO2;KPNA3;KPNA6;HIKESHI;TNPO3;IPO5;KPNA7;IPO9
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.37842872495808616,0.7739223024853343,0.7426573426573426,1.0,1.0,4/11,25.35%,AKR1B10;DHRS13;AKR1A1;RDH14
prerank,phosphatase binding (GO:0019902),0.2714394514744882,0.7730913431477701,0.8574380165289256,1.0,1.0,20/105,18.54%,RACK1;MAPK3;RCAN3;HSP90B1;LGALS3;SIRPA;CTNNB1;VCP;RPA2;CD22;MTMR9;SYTL2;FLT4;TRAF3;BAD;SPTBN4;CDH5;SKAP1;CTSC;TERF2IP
prerank,store-operated calcium channel activity (GO:0015279),0.3858810946259328,0.7730648377064934,0.7503486750348675,1.0,1.0,3/10,16.89%,TRPC7;TRPC1;ORAI1
prerank,protein phosphatase binding (GO:0019903),0.26770512284073467,0.772209872560946,0.8699186991869918,1.0,1.0,23/117,18.09%,RACK1;SOD1;HSP90B1;LGALS3;SIRPA;CTNNB1;VCP;RPA2;GRIN3A;MAPT;CD22;MTMR9;FLT4;LILRB1;TRAF3;BAD;ARPP19;DAB2IP;ADCY8;CDH5;SKAP1;PPP1R3D;PPP1R15A
prerank,symporter activity (GO:0015293),0.38213766456650194,0.7689208452873723,0.7645390070921986,1.0,1.0,2/10,20.59%,MFSD2A;SLC46A2
prerank,SH2 domain binding (GO:0042169),0.3071275877371461,0.7683958760625967,0.7921146953405018,1.0,1.0,7/31,17.01%,RACK1;LILRB1;CCDC88A;SH2B2;DLC1;SQSTM1;SKAP1
prerank,nuclear export signal receptor activity (GO:0005049),0.3714779639350828,0.7682909153810682,0.7610872675250357,1.0,1.0,3/11,17.32%,RAN;XPO1;EIF4ENIF1
prerank,phospholipase C activity (GO:0004629),-0.23815914727276202,-0.7649480737552147,0.8333333333333334,0.8855440846663688,1.0,4/25,7.49%,PLCE1;EDNRA;PLCL1;PLCD3
prerank,chloride transmembrane transporter activity (GO:0015108),0.33837938760011754,0.7648826672591867,0.7566489361702128,1.0,1.0,3/16,12.43%,SLC12A5;SLC26A4;SLC1A1
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.27496765667368256,0.7598921078341142,0.8403001071811361,1.0,1.0,16/60,19.63%,ERBB4;ACVRL1;NTRK2;LTK;MUSK;KDR;EPHA5;CSF1R;FLT4;TIE1;EPHB1;FLT1;TYRO3;DDR2;ERBB3;FLT3
prerank,chemokine receptor activity (GO:0004950),0.3131549681679686,0.7598688991869603,0.7890243902439025,1.0,1.0,7/24,31.16%,CCR5;CXCR4;CX3CR1;CCR2;GPR17;GPR35;ACKR3
prerank,antiporter activity (GO:0015297),0.3282987147591046,0.7592476050465756,0.7881899871630296,1.0,1.0,6/20,23.84%,ATP1A3;SLC25A11;SLC35E1;SLC35A1;SLC25A14;SLC25A16
prerank,insulin-like growth factor receptor binding (GO:0005159),0.36620712665526556,0.7590183334172373,0.7803867403314917,1.0,1.0,3/12,15.42%,YWHAH;YWHAG;IGF2
prerank,ribonuclease P activity (GO:0004526),0.362505741536969,0.758853005353227,0.7706552706552706,1.0,1.0,2/11,13.83%,POP7;POP4
prerank,phosphatase activity (GO:0016791),0.2741757737781806,0.7557849472453686,0.8636847710330139,1.0,1.0,25/73,29.30%,PPP1CA;DUSP3;BPNT2;DUSP28;DUSP26;NUDT16;NT5C;PLPP6;PLPPR2;PGP;PTPRO;PTPMT1;DUSP23;DUSP12;DUSP15;SBF1;ACP2;PPP1CB;PLPPR4;DUSP8;PGAM5;ENOPH1;ACP5;PLPP4;ACP4
prerank,phospholipid transfer activity (GO:0120014),0.3133289512979908,0.7517313621290412,0.7902439024390244,1.0,1.0,10/21,31.06%,PLTP;GLTP;PRELID1;MTTP;ABCA3;PRELID3B;CERT1;CPTP;C2CD2L;PRELID2
prerank,ligand-gated calcium channel activity (GO:0099604),0.3217449211660419,0.7500348279699974,0.8,1.0,1.0,5/19,18.27%,GRIN1;GRIN2A;TRPM2;RYR2;GRIN2B
prerank,cGMP binding (GO:0030553),0.36446651152764686,0.7458182597457668,0.7801120448179272,1.0,1.0,5/11,24.94%,CNGA3;CNGA4;CNGB1;PDE11A;PDE2A
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.30093997480371415,-0.7448879171745003,0.7532467532467533,0.9086920285406391,1.0,3/10,18.15%,NAA40;ATF2;KAT8
prerank,MAP kinase activity (GO:0004707),0.3376953928603065,0.7414980166804573,0.7837837837837838,1.0,1.0,4/14,19.80%,MAPK3;MAPK10;MAPK11;MAPK15
prerank,four-way junction DNA binding (GO:0000400),-0.25961487203007616,-0.7400572324700644,0.8246445497630331,0.9106145228108211,1.0,7/17,21.79%,ABL1;RAD51B;FANCM;YY1;WRN;XRCC3;XRCC2
prerank,hexosyltransferase activity (GO:0016758),0.2563012640826562,0.7361023948461315,0.8978102189781022,1.0,1.0,23/101,23.44%,HEXB;HEXA;TMTC2;B4GALNT1;PIGZ;B4GALNT4;B4GALT6;POGLUT3;B3GNT9;CHPF2;B3GAT3;CHPF;GCNT1;FUT9;B3GNT3;DPY19L1;RFNG;CSGALNACT2;CHSY3;B3GALT5;LFNG;B3GALT2;B4GALT3
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2927296483798386,0.7359318434211738,0.8346915017462165,1.0,1.0,7/34,19.11%,CALM1;CALM3;CDK5R1;CDK5R2;IGF2;MAP2K2;CALM2
prerank,syntaxin binding (GO:0019905),0.2662250688919701,0.7358405443776733,0.8680709534368071,1.0,1.0,15/61,16.41%,SNAP25;CACNA1A;SYT1;SYPL1;SYT12;VAMP3;VAMP2;SYT6;STXBP5L;TMED9;VAMP8;SYP;SYT10;NAPA;SYT2
prerank,DNA-binding transcription factor binding (GO:0140297),0.24794263269028594,0.7312263143680662,0.9537688442211055,1.0,1.0,25/189,13.79%,PTMA;HSPB1;CHCHD2;PARK7;ATF4;NPM1;BEX1;HCLS1;SPI1;TLE5;CTNNB1;HES1;HIPK2;HES6;DUSP26;JUN;HMGB1;BHLHE41;ZBTB49;TAF9;CTBP1;ZBTB7A;KLF4;YWHAZ;HDAC5
prerank,GTPase inhibitor activity (GO:0005095),0.33696864634817547,0.7309065824136788,0.7973333333333333,1.0,1.0,7/13,33.63%,IQGAP2;ARL2;CDC42SE1;RTKN;TNK2;GPS1;GPS2
prerank,metallopeptidase activity (GO:0008237),0.24912637984454275,0.7276070272949311,0.9175257731958762,1.0,1.0,22/113,18.08%,RCE1;COPS6;ADAM15;METAP1;ADAM23;ADAMTS4;ADAM12;OMA1;MMP21;METAP2;PMPCB;PRPF8;MMP3;LAP3;ADAMTS16;SPG7;MMP27;NUDT16;MMP14;ADAM18;ADAM17;ADAMTS1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3472148723058311,0.7267086490521061,0.8205479452054795,1.0,1.0,6/12,37.81%,PIK3C2G;PIK3CD;PIK3R6;IPMK;PIK3C2B;PIK3CB
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.23087832520561202,-0.7263579632747285,0.8716577540106952,0.9236673883019066,1.0,3/23,7.49%,PLCE1;EDNRA;PLCD3
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.2998153782794044,-0.7256982778822226,0.8156028368794326,0.9199342228213186,1.0,3/10,10.88%,ECHDC1;ECHDC3;AUH
prerank,phosphatase inhibitor activity (GO:0019212),0.3114706194345486,0.7236171711104595,0.8170103092783505,1.0,1.0,6/20,23.15%,LGALS3;PPP1R1B;SET;ARPP19;ANP32E;PTN
prerank,DNA replication origin binding (GO:0003688),0.298791856977123,0.7203118966545543,0.8351920693928129,1.0,1.0,7/23,28.39%,MCM5;HSPD1;DDX11;CDC45;MCM7;MCM2;DHX9
prerank,alpha-tubulin binding (GO:0043014),-0.20884605353888502,-0.7165426764052754,0.9251700680272109,0.9260515010944999,1.0,6/31,14.72%,EML4;SETD2;OFD1;INO80;WASHC1;TAOK1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.24288669100477772,0.715814414008134,0.9505050505050505,1.0,1.0,31/181,19.20%,ACTB;HSPB1;ATF4;NPM1;BEX1;HCLS1;SPI1;GABARAPL1;CTNNB1;HES1;HIPK2;HES6;DUSP26;PROX1;JUN;BHLHE41;DNAJA1;SNW1;NCOR2;KLF4;HDAC5;MIER2;DLL1;GATA4;TRIM32;PPARGC1A;COMMD7;MTA2;TBP;PSMA6;DDRGK1
prerank,NF-kappaB binding (GO:0051059),0.2931820608762999,0.7151498518010937,0.8387909319899244,1.0,1.0,6/24,27.39%,NPM1;COMMD7;PSMA6;NFKBIA;RELA;HIF1AN
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2932168563526362,0.7108283787540702,0.8516209476309227,1.0,1.0,6/24,19.13%,PNCK;CAMK1D;CAMK1;CAMKV;CAMKK1;MKNK1
prerank,intracellular chloride channel activity (GO:0061778),0.3224942968335051,0.7073809631735902,0.8257477243172952,1.0,1.0,3/16,18.12%,TTYH1;TTYH3;ANO4
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3224942968335051,0.7073809631735902,0.8257477243172952,1.0,1.0,3/16,18.12%,TTYH1;TTYH3;ANO4
prerank,SH3 domain binding (GO:0017124),0.26101553918662784,0.7062566911653442,0.9032608695652173,1.0,1.0,11/62,17.18%,GPX1;CYBA;ADAM15;ADAM12;ELMO1;MAPT;MICAL1;NCF1;DAB2IP;SKAP1;CRB3
prerank,inward rectifier potassium channel activity (GO:0005242),0.2947357466898954,0.7046130240610587,0.8626716604244694,1.0,1.0,5/24,24.68%,KCNJ10;KCNN2;ABCC8;KCNJ3;KCNJ6
prerank,voltage-gated anion channel activity (GO:0008308),-0.25014374654373545,-0.7020886062578872,0.8879668049792531,0.9371884049051573,1.0,1/15,1.69%,ANO6
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.3438940180197656,0.7004186448010689,0.8314285714285714,1.0,1.0,2/10,9.48%,SLCO1C1;SLCO4C1
prerank,nucleotidase activity (GO:0008252),0.3183933259066444,0.6998637532079982,0.825136612021858,1.0,1.0,2/15,6.02%,NT5C3A;BPNT2
prerank,dipeptidyl-peptidase activity (GO:0008239),0.343418863791035,0.6980124013378125,0.845360824742268,1.0,1.0,2/10,7.87%,DPP10;DPP6
prerank,anion transmembrane transporter activity (GO:0008509),0.3297030991641544,0.6977673341159819,0.8299319727891157,1.0,1.0,5/12,28.62%,SLC19A1;MFSD10;SLC4A2;ABCC5;SLC26A11
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3208378903908559,0.6962852223337443,0.8459495351925631,1.0,1.0,5/14,28.68%,SDHB;ISCU;RSAD2;EXO5;CIAO3
prerank,glycerophospholipid flippase activity (GO:0140333),0.33207794966901294,0.6960996422978984,0.8349650349650349,1.0,1.0,2/11,10.95%,ATP8A2;ATP8A1
prerank,diacylglycerol kinase activity (GO:0004143),0.33423661368237706,0.6959197898052142,0.8214783821478382,1.0,1.0,6/11,30.98%,DGKH;DGKI;DGKK;DGKB;DGKZ;DGKG
prerank,filamin binding (GO:0031005),0.3345436296031822,0.6931484863309418,0.844950213371266,1.0,1.0,2/11,6.93%,RFLNB;CRMP1
prerank,P-type ion transporter activity (GO:0015662),0.3228752237037669,0.6927384735869329,0.8240866035182679,1.0,1.0,5/12,29.23%,ATP2B1;ATP2A2;ATP2B4;ATP2B2;ATP2C1
prerank,3'-5' exonuclease activity (GO:0008408),0.261515301208189,0.6892012383558245,0.9122609673790776,1.0,1.0,15/45,26.95%,EXOSC2;APEX1;TOE1;PDE12;EXOSC9;USB1;POLG;EXOSC4;ISG20;ERI1;POLD1;PAN2;PNPT1;TRIR;RAD9A
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3098824602237901,0.6859665458319693,0.8546433378196501,1.0,1.0,6/15,25.67%,HS6ST3;HS3ST6;HS3ST5;HS3ST2;HS6ST1;HS6ST2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.24603517353012655,-0.6851841625548424,0.9114391143911439,0.9500892907866052,1.0,2/14,4.66%,MINDY3;OTUD7B
prerank,MAP kinase phosphatase activity (GO:0033549),0.32596804702170146,0.6840384493455213,0.867043847241867,1.0,1.0,5/12,25.90%,DUSP3;DUSP2;DUSP1;DUSP8;DUSP6
prerank,exoribonuclease activity (GO:0004532),0.317803607725577,0.6730433904761149,0.8957142857142857,1.0,1.0,3/12,21.53%,EXOSC2;EXOSC9;EXOSC4
prerank,microtubule motor activity (GO:0003777),0.25194896518571536,0.6705991619457031,0.9251925192519251,1.0,1.0,16/51,29.38%,DYNLRB1;KIF26B;KIF5A;KIF26A;DNAH2;DNAH1;DYNLRB2;KIF21B;KIF5C;KIFC2;KIF1A;KIF27;KIF20B;DNAH17;KIF6;KIF1B
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.25416079496269134,-0.6673661768177228,0.8983050847457628,0.961851024010608,1.0,2/12,5.94%,BABAM2;TRAF5
prerank,C2H2 zinc finger domain binding (GO:0070742),0.318035250867848,0.666590639274795,0.8605974395448079,1.0,1.0,4/11,26.78%,GATA2;TAF9;ZXDC;LEF1
prerank,transcription cis-regulatory region binding (GO:0000976),0.22213455064813814,0.6650801386404868,1.0,1.0,1.0,78/406,22.29%,RPS3;JUND;PARK7;ATF4;SOX18;ERBB4;NPM1;PRDX5;TNF;DRAP1;NR1D1;SPI1;EPAS1;ENO1;NKX2-2;TBX22;KLF17;FOXF2;CEBPB;ARID4A;FOXD3;SALL2;CREBZF;CEBPA;PROX1;BASP1;CREB3;MLX;EGR1;HOXD4;JUN;HMGB1;TAF9;PHOX2A;NPAS3;AEBP1;SOX17;ATF5;MSX1;DBP;THRA;KLF4;HOXD8;SOX9;ZBTB43;HDAC5;ATMIN;IKZF5;NONO;GATA4;GLIS2;TWIST1;RBBP5;AGO1;ZNF22;SOX11;TBP;SNCA;ZFP41;ZBTB14;ESRRB;TFAP2B;KLF11;CHD3;MEF2C;FOXA2;TFAP4;MYC;FOSL2;CDC5L;DDIT3;SOX10;FOXA1;DACH1;MEN1;REST;HOXB8;GRHL2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.3078569306292032,0.6639640238460603,0.8706666666666667,1.0,1.0,4/12,23.31%,B3GNT9;B3GNT3;B3GALT5;B3GALT2
prerank,calcium channel activity (GO:0005262),0.23338386070189976,0.6621980548144432,0.955067920585162,1.0,1.0,24/84,25.27%,SLC24A4;SLC24A2;GRIN1;CACNA1A;TMCO1;TRPM2;TRPC7;SEC61A1;TRPC1;RYR2;CACNG8;ORAI1;NCS1;ANXA6;CACNG5;PKD2L1;PKDREJ;CACNB4;PKD1L2;CACNA1E;SLC24A5;CACNG2;CACNA2D1;CACNA1B
prerank,DNA binding (GO:0003677),0.21900672833077445,0.6615964951068612,1.0,1.0,1.0,148/694,24.63%,RPS3;RPS15;RPS27;RPL6;RPL7;PCBP1;CALR;CHCHD2;PARK7;ATF4;KLF2;POLR2D;TERF1;LYL1;ETS2;MBD3;DRAP1;SYCP2;ANG;EPAS1;JUNB;GTF3C6;MCM5;CENPB;HMGB3;HES1;NUCKS1;RPA2;HMGN1;TBX22;FOXF2;CEBPB;PQBP1;ARID4A;TRIM28;CENPX;FOXL2;HSPD1;CREBZF;CEBPA;APLP2;PROX1;NR2F6;CSRNP3;MAPT;YBX1;IKZF1;NUPR1;MLXIPL;MLX;EGR1;JUN;HMGB1;ZBTB49;DDB1;TAF9;H1-0;TARDBP;POLR2G;MYRF;APEX1;ATF5;BANF1;POU3F1;ZBTB7A;PCNA;DDX11;SOX8;MAEL;THAP11;SOX9;PAX3;NME2;FOXS1;HNRNPU;TSN;MAFA;IKZF3;HNRNPA1;IRF7;REPIN1;ZMYM3;NR1H2;SUB1;E2F4;GATA4;PCID2;BRCA2;PPARGC1A;DCLRE1C;ERCC6;CNBP;ZNF22;CTC1;NRL;TIGD4;IMPDH1;HIC1;ZBTB14;WDR48;NLRP3;ESRRB;TFAP2B;RAD23A;MLF1;CHD3;POU4F1;RNF11;FOXA2;TFAP4;MYC;ERCC1;FAM111A;TSNAX;CAMTA1;CDC5L;POLR2H;DDIT3;CEBPZ;CDK9;SOX10;FOXA1;POLG;PHF1;MEN1;IRF5;HLX;RADX;BLM;GRHL2;SOX1;CDC45;CSRNP1;SAFB;ERF;LONP1;MEIS2;POLD1;PCBP2;OSR2;PURB;PNKP;RELA;MAFB;USF2;APP;TCF7L1;TCF3
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.23390894819466246,-0.6584577020933884,0.9147286821705426,0.9647880683491663,1.0,16/16,76.64%,SLC22A4;SLC25A26;SLC25A42;SLC22A5;SLC22A1;SLC22A3;SLC25A17;SLC22A16;SLC44A4;SLC22A2;SLC18A3;SLC7A8;SLC29A4;SLC44A1;SLC44A2;SLC5A7
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.25699024501211865,-0.6584185086625153,0.8914473684210527,0.9602555365300216,1.0,4/11,17.60%,SGMS2;PIGN;PIGO;PIGF
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.31715954825930254,0.6579654260114604,0.8713286713286713,1.0,1.0,1/11,6.94%,SLC25A29
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.23699663093644763,-0.6573983183004226,0.9361702127659575,0.9564492092448593,1.0,2/15,12.01%,PI4KA;ATM
prerank,RNA polymerase II complex binding (GO:0000993),0.26030442536248866,0.6565309663837621,0.9148936170212766,1.0,1.0,9/32,19.53%,ELOF1;RTRAF;SUPT4H1;PCIF1;HNRNPU;RECQL5;AGO1;CCAR2;ESRRB
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.23796151865525658,0.647999474967959,0.9343379978471474,1.0,1.0,20/60,26.68%,PPP1CA;CTDSP2;CTDNEP1;CTDSP1;PHLPP1;TIMM50;PDP2;PPP1R3D;PPM1J;PDP1;TAB1;PPP3CA;PPEF1;PPM1F;DUSP1;PPP3R1;CAMK2G;PPP1CB;PGAM5;MTMR6
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.31331230252412867,0.6479543872288568,0.8993103448275862,1.0,1.0,4/12,22.04%,SDHB;ISCU;CIAPIN1;CISD1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.27906489501325554,0.6456804501680047,0.9021879021879022,1.0,1.0,1/20,1.82%,EIF3F
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.31538475776974734,0.6456041321680348,0.883480825958702,1.0,1.0,2/10,19.30%,TNFAIP3;DESI2
prerank,5'-3' exonuclease activity (GO:0008409),-0.23185790614645027,-0.6432796528944097,0.9372549019607843,0.9624945877994371,1.0,8/14,36.43%,XRN1;EXOG;DXO;EXO1;DCLRE1A;CPSF3;DCP2;MRE11
prerank,exonuclease activity (GO:0004527),0.2413597094547448,0.6427863660473045,0.9423728813559322,1.0,1.0,12/46,26.95%,ENPP2;EXOSC2;APEX1;PDE12;DCLRE1C;EXOSC9;POLG;EXOSC4;ISG20;ERI1;TRIR;RAD9A
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.2272326034328959,-0.6365817935594551,0.9426229508196722,0.9627993338853134,1.0,1/15,3.64%,PLA2G4A
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.2716578577292062,0.6364504255392573,0.9181818181818182,1.0,1.0,6/20,23.70%,MOGAT2;AGPAT5;DGAT1;LPCAT2;MOGAT1;AGPAT2
prerank,neuropeptide receptor binding (GO:0071855),0.29091825482638917,0.6360155158631254,0.9048843187660668,1.0,1.0,5/14,31.80%,PPY;NTS;NPY;NMU;SHANK1
prerank,FMN binding (GO:0010181),0.303648728257303,0.6354815315021808,0.904054054054054,1.0,1.0,2/11,17.56%,PNPO;NOS2
prerank,muscle alpha-actinin binding (GO:0051371),0.2852378775767188,0.632608958986191,0.8981481481481481,1.0,1.0,1/15,2.04%,PRICKLE4
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.22827007626624485,-0.6323804448739511,0.9446640316205533,0.9611892260537823,1.0,10/15,38.52%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A11;SLC26A3;SLC26A5;SLC26A1;CFTR;SLC26A9
prerank,RNA cap binding (GO:0000339),0.2841014567155916,0.6289943077420199,0.9198423127463863,1.0,1.0,2/16,10.68%,EIF3D;EIF4A1
prerank,sulfate transmembrane transporter activity (GO:0015116),0.28399035037192943,0.6267615971126652,0.9061662198391421,1.0,1.0,2/14,9.20%,SLC26A4;SLC25A11
prerank,flavin adenine dinucleotide binding (GO:0050660),0.2299673187515408,0.6165294999033263,0.9592511013215859,1.0,1.0,14/53,24.87%,ACADVL;CYB5R3;CYBB;STEAP4;MICAL1;PPOX;KDM1B;NOS2;CYB5R1;QSOX1;SDHA;ILVBL;ACOX3;NQO2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.23084203416495272,0.615447097886877,0.9599555061179088,1.0,1.0,11/51,23.84%,SLC7A5;SLCO1C1;MFSD2A;SLC25A11;SLCO4C1;SLC35E1;SLC35A1;SLCO1B1;SLC46A2;SLC25A14;SLC25A16
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.27214505334032574,0.6146523107702923,0.9313077939233818,1.0,1.0,4/18,25.17%,CCKBR;AGAP2;SOCS3;PIK3R5
prerank,NADP binding (GO:0050661),0.24559365658557897,0.6146248704131205,0.951073985680191,1.0,1.0,8/32,18.51%,GRHPR;SPR;QDPR;CRYM;CAT;PGD;NOS2;CBR3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.22589585998794914,0.6111658851093261,0.9560315670800451,1.0,1.0,8/48,19.70%,ATP6V1F;SLC39A1;AQP1;TRPM2;TRPC1;UNC80;CALHM6;PKD2L1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2199894654353084,0.6097112635774828,0.9766206163655685,1.0,1.0,14/74,21.45%,CHKB;RFK;PKM;NT5C3A;DGKH;DGKI;PIK3C2G;DOLK;PIK3CD;COASY;SPHK2;KHK;DGKK;DGKB
prerank,N-acetyltransferase activity (GO:0008080),-0.20342119728287789,-0.6078713045996756,0.9705882352941176,0.9710676284648497,1.0,3/19,12.67%,KAT2B;SMARCE1;ESCO1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.21934241750097974,0.6077206142135401,0.9751619870410367,1.0,1.0,15/69,22.75%,CERS2;SCP2;PLAAT3;ZDHHC5;NAA10;MOGAT2;ELP3;GLYAT;DGAT2L6;SOAT2;PORCN;DGAT1;ZDHHC12;ZDHHC8;MOGAT1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.29512672278785024,0.605267692349964,0.902332361516035,1.0,1.0,4/10,30.85%,APEX1;DCLRE1C;POLD1;MGME1
prerank,microtubule plus-end binding (GO:0051010),0.2586719110717099,0.6027222338212663,0.9267080745341615,1.0,1.0,4/20,15.68%,CLASP1;DCTN1;CLIP3;MAPRE3
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.2941508804416729,0.6026446558208397,0.9188405797101449,1.0,1.0,4/11,21.86%,PRPF19;RBX1;STUB1;AMFR
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.2225977867880875,-0.6017732649485286,0.9672727272727273,0.9699000928692603,1.0,4/12,21.97%,NUDT5;ENTPD5;ENTPD7;SLC25A42
prerank,RNA methyltransferase activity (GO:0008173),0.2604206512511674,0.6012446385052808,0.931077694235589,1.0,1.0,6/19,26.12%,FBL;MEPCE;FTSJ3;METTL3;LCMT2;TYW3
prerank,ephrin receptor binding (GO:0046875),0.2557877709422806,0.5997556514455216,0.951530612244898,1.0,1.0,10/21,33.36%,ANKS1B;EFNB1;EFNA1;PTPN1;CRK;EFNA2;EFNB3;ANKS1A;GRB2;FYN
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.2678392855053926,0.5956361633819015,0.9224489795918367,1.0,1.0,4/15,23.70%,ABHD8;AGPAT5;LPCAT2;AGPAT2
prerank,telomeric DNA binding (GO:0042162),0.23554823423797794,0.5946439530645298,0.9524913093858632,1.0,1.0,12/32,32.71%,TERF1;NCL;APEX1;CTC1;TERF2IP;BLM;PIF1;XRCC6;HNRNPA2B1;UPF1;HNRNPD;ACD
prerank,carboxy-lyase activity (GO:0016831),0.24836718356684198,0.5933982599687809,0.9588528678304239,1.0,1.0,8/23,35.77%,ODC1;UROD;GAD1;FAHD1;ACOD1;PISD;AZIN1;BCKDHA
prerank,N-methyltransferase activity (GO:0008170),0.25627275135357336,0.5930011142669332,0.9422110552763819,1.0,1.0,3/20,13.19%,ZCCHC4;PRMT1;METTL18
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.23249603785299497,0.585354508699569,0.9589201877934272,1.0,1.0,10/33,25.42%,EXOSC2;TOE1;PDE12;EXOSC9;USB1;EXOSC4;ISG20;ERI1;PAN2;PNPT1
prerank,clathrin adaptor activity (GO:0035615),0.26125645490020916,0.5800595931557532,0.9335180055401662,1.0,1.0,2/15,9.52%,AP2M1;AP2S1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.247337380625918,0.5778802564478267,0.9590062111801242,1.0,1.0,7/21,26.47%,CDK8;CDK19;CDKL4;CDK5;CDK9;CDK10;CDK11B
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.247337380625918,0.5778802564478267,0.9590062111801242,1.0,1.0,7/21,26.47%,CDK8;CDK19;CDKL4;CDK5;CDK9;CDK10;CDK11B
prerank,chloride channel regulator activity (GO:0017081),0.2611584634269717,0.5742623665574867,0.9470198675496688,1.0,1.0,2/14,11.89%,SGK1;VAMP8
prerank,growth factor receptor binding (GO:0070851),0.1980193099518541,0.5697836286417364,0.9937694704049844,1.0,1.0,21/95,25.44%,ERBB4;PDGFB;IL2;IL11;TIMM50;CCDC88A;SDCBP;TLR5;ARF4;PDGFA;CD300LF;ADAM17;KLB;IL6;IL1RAP;PYCARD;TGFA;ERAP1;IL12RB1;FGF22;TNK2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.27977737679510073,0.5652690791607373,0.9475920679886686,1.0,1.0,4/10,31.87%,NAA10;NAA25;NAA30;NAA60
prerank,nucleotide diphosphatase activity (GO:0004551),0.26154962709871515,0.5636938526634453,0.9396782841823056,1.0,1.0,5/14,24.22%,NUDT3;NUDT4;ENPP5;NUDT10;NUDT11
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.2634578335467852,0.5610200383893491,0.9626038781163435,1.0,1.0,2/13,16.92%,PIK3C2G;PIK3CD
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.22124746112039848,0.5596895036028764,0.9684947491248541,1.0,1.0,4/35,12.31%,ELAC2;NT5C3A;AARS2;MRPL58
prerank,solute:sodium symporter activity (GO:0015370),-0.16654467178353582,-0.5513782904398072,0.9883720930232558,0.9862246987936502,1.0,1/27,1.99%,SLC4A10
prerank,MAP kinase kinase activity (GO:0004708),0.2493550702592539,0.5490533914334302,0.9598965071151359,1.0,1.0,5/15,25.85%,PAK3;MAPK10;MAP2K2;MAP2K7;MAP3K9
prerank,3'-5' DNA helicase activity (GO:0043138),0.24668207891718685,0.5487643955192769,0.9601029601029601,1.0,1.0,6/16,28.39%,MCM5;RECQL5;BLM;MCM7;MCM2;DHX9
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.24468398333350522,0.5338221736061882,0.9716216216216216,1.0,1.0,3/15,25.17%,CCKBR;SOCS3;PIK3R5
prerank,endoribonuclease activity (GO:0004521),0.2131763268181301,0.5330102121080194,0.9776470588235294,1.0,1.0,5/32,20.98%,ENDOG;RNASEK;SND1;AGO1;TSNAX
prerank,nuclear localization sequence binding (GO:0008139),0.2342162156263813,0.5282292220651613,0.9674355495251018,1.0,1.0,6/18,28.35%,IPO4;CABP1;BRAP;NFKBIA;KPNB1;RANBP6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.25363832875370906,0.5176277112519483,0.9695712309820194,1.0,1.0,6/10,39.28%,HEXIM1;CDKN2B;CDKN1A;CDKN2D;HEXIM2;CDKN2C
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.1966527209898435,0.5139096241170196,0.9932049830124575,1.0,1.0,6/40,19.63%,FBL;ICMT;METTL18;MEPCE;DNMT3B;GAMT
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.18847982346110217,-0.512170909984051,0.9859154929577465,0.9910068621718928,1.0,4/13,21.01%,AGPAT4;GPAT3;ABHD5;PNPLA3
prerank,death receptor activity (GO:0005035),0.24360859058945905,0.5114951307879086,0.97677793904209,0.9989055262575028,1.0,4/11,32.58%,TNFRSF1A;TNFRSF11A;TNFRSF1B;TNFRSF25
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.21697541648313817,0.5100756335796053,0.9802955665024631,0.9970995701238738,1.0,8/21,31.56%,POLE4;POLD4;POLG;POLD1;POLE3;POLN;POLD3;POLK
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.21671191914170518,0.48602958170823857,0.9763157894736842,1.0,1.0,3/16,27.44%,IDO2;BCO2;ADI1
prerank,protein phosphatase 1 binding (GO:0008157),0.2010899174718134,0.47197035891910943,0.9838909541511772,1.0,1.0,8/21,32.68%,LILRB1;PPP1R3D;PPP1R15A;KCNQ1;PPP1R9B;PPP1R11;PPP1R16B;PPP1R3E
prerank,methyltransferase activity (GO:0008168),0.17676035792456307,0.4697388306765088,1.0,0.9987115425600738,1.0,16/46,35.42%,EEF1AKMT2;PRMT1;MEPCE;DNMT3B;GAMT;FTSJ3;EEF1AKMT4;METTL3;EEF1AKMT3;COMTD1;LCMT1;DNMT1;NSUN2;NNMT;GCSH;PRMT5
prerank,cation:chloride symporter activity (GO:0015377),0.22495077028819283,0.46115097960732016,0.9870875179340028,0.9978092477560688,1.0,1/10,7.90%,SLC12A5
prerank,DNA polymerase activity (GO:0034061),0.18182863929361803,0.42925600624249544,0.9913258983890955,0.9989453544847366,1.0,8/22,31.56%,POLE4;POLD4;POLG;POLD1;POLE3;POLN;POLD3;POLK
prerank,steroid hydroxylase activity (GO:0008395),0.19352558635433512,0.42919645289327907,0.9904891304347826,0.9968378573007352,1.0,5/16,30.69%,CH25H;CYP2E1;CYP2U1;CYP39A1;CYP46A1
